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Abstract 
Protein biosynthesis is an essential process for all cells. It involves the translation of 
genetically encoded information into peptides, folding and assembly of peptides into three-
dimensional molecules and complexes, and post-translational modification. Molecular 
chaperones facilitate protein folding so that a native state is achieved. Misfolded proteins and 
aggregates are toxic within the cell and accumulate due to stress conditions, mutations, and 
cell aging. Moreover, essential proteins rely on chaperones and co-chaperones for their 
regulation and activity.  
The TTT complex, consisting of Tel2, Tti1, and Tti2, is considered an Hsp90 co-
chaperone with specificity for phosphatidylinositol 3-kinase-related kinases (PIKKs). I show 
that yeast expressing low levels of Tti2 are viable under optimal growth conditions, but are 
sensitive to a number of stress conditions that involve PIKK pathways. In agreement with 
this, depleting Tti2 levels decreased expression of Tra1, Mec1, and Tor1, and affected their 
localization. I also find that overexpressing Hsp90 or its co-chaperones is synthetic lethal 
when Tti2 is depleted, an effect possibly due to imbalanced stoichiometry of a complex 
required for PIKK assembly. These results indicate that Tti2 does not act as a general 
chaperone, but may have a specialized function in PIKK folding and/or complex assembly.  
Using a stress sensitive tti2 allele with a Leu to Pro mutation at residue 187, I 
performed a genetic selection of spontaneous second site mutations. The selection identified 
a single nucleotide mutation at the same position (C70U) in four tRNAProUGG genes. Since the 
mutation incorporates the identity element (G3:U70) for alanyl-tRNA synthetase into 
tRNAPro, I hypothesized that suppression results from mistranslation of Pro187 in Tti2L187P as 
Ala. In vitro, tRNAProUGG (C70U) was mis-aminoacylated with alanine by alanyl-tRNA 
synthetase. Mass spectrometry from protein expressed in vivo and a novel GFP reporter for 
mistranslation confirmed substitution of alanine for proline at a rate of ~6%. Mistranslating 
cells expressing SUF9G3:U70 induce a partial heat shock response but grow nearly identically 
to wild-type. 
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Chapter 1  
Scope of Thesis 
There are two focuses of this thesis: the role of Tti2 in stress response and PIKK 
regulation, and defining the mechanism and consequences of mistranslation caused by a 
missense suppressor tRNA.  
This thesis begins with an overview of peptide synthesis and protein folding. It 
will provide detail on tRNA maturation, aminoacylation, and mRNA decoding, which 
will be required for later discussions on mistranslation. This will be followed by a review 
on protein folding in relation to the Hsp90 and Hsp70 chaperone systems. Next, the 
importance of molecular chaperones and protein quality control pathways in managing 
translation infidelities and toxic aggregates will be introduced.  
Chapter 2 will characterize the role of Tti2, a proposed Hsp90 co-chaperone 
protein part of the TTT complex, in stress response and regulation of a family of proteins, 
known as the PIKKs. Following the investigation on the function of Tti2, Chapter 3 will 
describe how a defective tti2 allele was used to identify a missense suppressor tRNA. 
This study investigates the mechanism of the suppressor tRNA and the protein quality 
control pathways that permit mistranslation.  
Chapter 4 will briefly review the findings presented in each data chapter and 
provide future directions of the research. The main discussion topics will include the 
emerging theme of mistranslation as an adaptive response and the pathways that maintain 
the stability of a mistranslated proteome. The thesis will conclude with examples of how 
engineered translation systems are being used for designing therapeutic proteins and 
describe the potential for suppressor tRNAs in gene therapy.  
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1 Protein Biosynthesis  
Protein biosynthesis is an essential process for cell viability, growth, and proliferation. It 
is a critical aspect of the central dogma, which describes the flow of information from 
DNA to protein molecules. This process starts with transcription of the coding regions of 
DNA and processing of the transcript into a messenger RNA (mRNA). The subsequent 
decoding of mRNA by the cell’s translation machinery determines the amino acid 
sequence of the polypeptide being synthesized.  
While translation is considered a high fidelity aspect of protein biosynthesis, 
translational errors are surprisingly frequent (1). Amino acid mis-incorporation, or 
mistranslation, can exploit proteome diversity as an adaptive response (2-6). Molecular 
chaperones and protein quality control pathways maintain the stability of the proteome in 
the midst of mistranslation (7-11). 
As a polypeptide is synthesized it becomes available for folding and assembly of 
a functional molecule. Protein folding, modification, and complex assembly achieves a 
three-dimensional stable structure. Molecular chaperones and co-chaperones ensure that 
folding and assembly occurs in a controlled manner. Furthermore, chaperones are 
required for managing aggregations and misfolded proteins within the cell (12,13). Thus, 
protein folding, managing toxic protein species, and introducing proteome diversity relies 
on the work of chaperones. 
Co-chaperones are involved in recruiting proteins to chaperone systems, 
chaperone remodeling and catalytic regulation, and assembly of protein complexes (14-
20). The TTT complex is a proposed co-chaperone of Hsp90, and is required for the 
stability of a family of kinases, known as phosphatidylinositol 3-kinase-related kinases 
(PIKKs). In addition to discussing the relationship between protein quality control 
pathways and mistranslation, this chapter will introduce Tti2, a member of the TTT 
complex, and describe its role in PIKK protein function and stress response.  
  
3 
1.1 Translation of the Genetic Code 
The standard genetic code is considered universal across all organisms and consists of 61 
codons that specify translation of 20 amino acids, and three additional codons designating 
termination. Translation involves the covalent attachment of amino acids, sequentially 
defined by the genetic code. As a prerequisite for peptide synthesis, a diverse pool of 
aminoacyl-tRNA molecules is found in the cytoplasm, ready for recruitment to the 
ribosome by translation factors. The fidelity of translation relies on two processes: tRNA 
aminoacylation and codon reading at the ribosome. Aminoacyl-tRNA synthetases 
(aaRSs) are responsible for charging the correct tRNA molecule with an amino acid. 
With a few exceptions, each tRNA has its own aaRS that recognizes both structural and 
chemical features of a tRNA molecule and in some cases has an editing domain to 
hydrolyze mis-activated amino acids or mischarged tRNAs (21,22). If correct pairing 
between a codon and an aminoacyl-tRNA anticodon is met in the ribosome A site, a 
peptide bond will attach the amino acid to the growing peptide. While the genetic code 
was considered a “frozen accident” that all forms of life universally translate (23), 
deviations from the standard genetic code are evident and suggest that the code is 
evolving (24-28). 
The concept of tRNA molecules as carriers of amino acids for translation of an 
RNA template was first postulated by Francis Crick. He hypothesized that, “the amino 
acid is carried to the template by an adaptor…” and that each adaptor molecule may 
contain a di- or tri-nucleotide sequence to base pair with an RNA template (29). While 
some of Crick’s predictions on peptide synthesis have been refuted, such as a unique 
aaRS being required for the synthesis of each aminoacyl-tRNA (30,31), many were 
surprisingly accurate considering the experimental evidence available at that time. 
The tRNA molecule is represented as a cloverleaf in secondary structure. 
Nucleotide pairing results in stem-loops that form the three arms of the cloverleaf. From 
5’ to 3’ tRNAs contain an acceptor stem, dihydrouridine (D) arm, anticodon stem-loop, 
variable loop, and the ribothymidine (T) arm (32). In three dimensions, tRNAs take on a 
similar L-shaped structure (33-36). To adopt an L-shape, the acceptor stem stacks on top 
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of the T-arm to form the shorter branch, and the long branch consists of an anticodon 
stem interaction with the D-arm.  
Transfer RNA maturation involves a series of events that regulate tRNA levels, 
availability, and decoding properties (37-39). Once a tRNA gene is transcribed, the pre-
tRNA will undergo processing that includes nucleotide excision of 5’ and 3’-ends, 
addition of the 3’-end CCA sequence, intron splicing, and modification of nucleotides. 
Pre-tRNAs contain 5’ and 3’ nucleotide extensions that require processing for tRNA 
maturation and function. The 5’ leader sequence is cleaved by RNase P (40), an 
endonuclease that contains an RNA catalytic subunit and is conserved in all three 
domains of life (41-43). Processing of the 3’ trailer sequence requires both exonucleases 
and tRNase Z, which cuts the phosphodiester bond at the 3’ end of the discriminator base 
(the first unpaired base of the acceptor stem just prior to the CCA sequence) (44-48). 
Once end processing is complete, tRNA nucleotidyltranferase catalyzes the addition of a 
CCA tail to the 3’end of the discriminator base, and likely plays a role in tRNA end 
repair (49,50).  
Introns are present in tRNAs of bacteria, archaea, and eukaryotes, and their 
removal is essential for tRNA function (51,52). Intron splicing is accomplished by a 
tRNA splicing endonuclease, tRNA ligase, and 2’-phosphotransferase (53-55). While end 
processing and modification typically occur in the nucleus, evidence from yeast suggests 
that premature tRNAs are exported to the cytoplasm and tRNA splicing endonuclease 
localizes to the mitochondrial surface (56,57). In some cases, a spliced tRNA structure is 
a prerequisite for recognition of tRNA modification enzymes (58-60) and retrograde 
nuclear import of processed tRNAs can be a way of separating nucleoside modification 
from tRNA splicing (61).  
Nucleotides throughout the tRNA molecule undergo extensive modifications 
(illustrated in Figure 1-1) (62; for schematics of tRNA processing and modifications see 
Phizicky and Hopper (63)). As indicated in the RNA Modification Database, there are 
currently 108 different tRNA modifications found across eukaryotes, bacteria, and 
archaea (http://mods.rna.albany.edu/mods/). Although not all are essential for viability, a 
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Figure 1-1. Structure and modifications of tRNAs in Saccharomyces cerevisiae.  
Each nucleotide is represented as a circle and base pairing is indicated with horizontal or 
vertical lines. Blue circles are unmodified nucleotides, red circles are bases that are 
modified in some but not all tRNAs, white circles are nucleotides found in only certain 
tRNAs and may or may not be modified, and the green circles represent the CCA 
accepter sequence. Abbreviations used are according to the Modomics database 
(http://modomics.genesilico.pl). (Ψ) Pseudouridine; (Am) 2’-O-methyladenosine; (Cm) 
2’-O-methylcytidine; (m1G) 1-methylguanosine; (m2G) 2-methylguanosine; (ac4C) 4-
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acetylcytidine; (D) dihydrouridine; (Gm) 2’-O-methylguanosine; (m2,2G) N2, N2-
dimethylguanosine; (m3C) 3-methylcytidine; (I) inosine; (m5C) 5-methylcytidine; 
(mcm5U) 5-methoxycarbonylmethyluridine; (mcm5s2U) 5-methoxycarbonylmethyl-2-
thiouridine; (ncm5U) 5-carbamoylmethyluridine; (ncm5Um) 5-carbamoylmethyl- 2’-O-
methyluridine; (m1I) 1-methylinosine; (i6A) N6-isopentenyl adenosine; (yW) wybutosine; 
(t6A) N6-threonylcarbamoyladenosine; (Um) 2’-O-methyluridine; (m7G) 7-
methylguanosine; (rT) ribothymidine; (Ar(p)) 2’-O-ribosyladenosine (phosphate). The 
subscripted numbers associated with modification abbreviations indicate the nucleotide 
number relative to -1 position at the 5’ end. Anticodon bases are numbered 34, 35, 36, 
and the discriminator base is numbered 73. This figure was adapted from (63). 
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number of modifications are conserved in all forms of life (64). Modification of 
nucleotides in regions distal to the anticodon play a role in tRNA stability and prevent 
degradation by the rapid tRNA decay quality control pathway (65,66). Modifying the 
wobble position in the anticodon, and of other nucleotides in the anticodon loop, are 
important for tRNA function, decoding, and response to stress conditions (67-70). Loss 
of tRNA modification is also linked to human disease and causes temperature sensitivity 
in yeast (68,71,72).  
Despite the structural similarity across all tRNAs, an aaRS recognizes its cognate 
tRNA with a high degree of specificity (73). Aminoacyl-tRNA synthetases are divided 
into two classes based on structural differences. The class I aaRS catalytic domain 
contains a Rossmann fold and a five-stranded parallel β-sheet (74,75). Class I catalytic 
domains bind the minor groove side of the tRNA acceptor stem, and the 2’-OH group of 
A76 is ligated with an amino acid (21). Class II aaRSs are defined by a seven-stranded 
parallel β-sheet in the active site (76,77). Binding occurs on the major groove side of the 
tRNA acceptor stem (with the exception of alanyl-tRNA synthetase), and amino acids are 
attached to the 3’-OH group of A76 (with the exception of phenylalanyl-tRNA 
synthetase)(21). For both aaRS classes, aminoacylation occurs as a two-step reaction 
(78,79). First, an amino acid and ATP are bound and an aminoacyl adenylate is formed. 
Secondly, transfer of the amino acid and esterification of the 2’ or 3’-OH of nucleotide 
A76 forms an aminoacyl-tRNA and releases AMP. The rate-limiting step for class I 
aaRSs is the release of the tightly bound aminoacyl-tRNA product, which is mediated by 
the formation of a ternary structure with elongation factor EF-Tu (80). Conversely, 
aminoacylation by class II aaRSs is limited by the activation of amino acids in the 
presence of tRNAs (79,81,82). 
Aminoacyl-tRNAs are recruited to the ribosome by translation elongation factors 
for the incorporation of amino acids into a growing peptide chain. There are three tRNA 
binding sites in the ribosome, which include the aminoacyl (A), peptidyl (P), and exit (E) 
sites. To initiate peptide synthesis, eukaryotic initiation factor 2 (eIF2) bound to GTP 
recruits the initiator methionyl-tRNA to the P site of the small ribosome subunit. This 
leads to the assembly of the translation initiation complex (83) and enables mRNA 
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binding and scanning for a start codon (84). Next, the larger 60S ribosomal subunit is 
recruited to the initiation complex by the GTPase, eIF5B (IF2 in bacteria and aIF5B in 
archaea)(85). Upon binding, GTP hydrolysis and release of eIF5B promotes translation 
elongation (85,86).  
During elongation, EF-Tu coupled with GTP forms a ternary complex with an 
aminoacyl-tRNA and pairs the tRNA anticodon with the mRNA codon in the ribosome A 
site. GTP hydrolysis releases EF-Tu when complementary base pairing and the required 
tRNA-ribosomal interactions are met (87). Upon release of EF-Tu, the aminoacyl-tRNA 
is properly positioned for the peptidyltransferase reaction. The peptide bound to the 
tRNA in the P site is transferred to the amino acid of the tRNA in the A site. The 
translocase, EF-G (eEF2 in eukaryotes), bound to GTP stimulates the translocation of 
peptidyl-tRNAs from the A site to the P site after peptidyltranferase activity (87). The 
peptidyl-tRNA is moved to the P site, the deacylated tRNA to the E site, and the free A 
site can accommodate an aminoacyl-tRNA to continue elongation of the peptide (87). 
During termination of translation, the binding of a release factor in the ribosome A site 
when a stop codon is encountered signals the hydrolysis of the ester bond that links the P 
site bound tRNA to the full-length polypeptide (88,89).  
1.2 Protein Folding and Molecular Chaperones 
Peptide folding into a stable three-dimensional structure is needed for protein function. 
While some proteins fold spontaneously in an unassisted manner, others require 
molecular chaperones to overcome kinetic barriers and reach their native state (90). A 
chaperone is any molecule that interacts with a protein only to assist in folding, 
unfolding, or complex assembly (91). Without the help of chaperones, proteins can adopt 
misfolded conformations with propensity to form toxic aggregates within the cell (92). 
Chaperones are also involved in targeting irreversible misfolded proteins for degradation 
by ATP-dependent proteases, to eliminate their toxic affects within the cell. For these 
reasons, cells invest a great deal of energy in protein folding and express a high number 
of chaperone molecules for managing the proteome. 
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 Protein folding is driven by hydrogen bonds, ionic and covalent interactions, 
dipole interactions, van der Waals forces, and hydrophobic interactions (93). The 
sequence and composition of amino acids within a peptide determines the structure that 
will be formed (94). The folding of an unfolded peptide to its native state is not often a 
linear process (95). Figure 1-2 depicts the folding landscape that a typical protein may 
have to traverse to form a stable native structure. Most peptides adopt partially folded 
intermediates or transition states containing non-native interactions and have higher free 
energy states compared to their native structure (95,96). This is due to the vast number of 
weak interactions that must be met to achieve the native state but cannot all be satisfied 
simultaneously during folding. Characterizing the folding landscape and the diversity of 
folded intermediates has been improved in studies using innovative techniques involving 
nuclear magnetic resonance (NMR), Förster resonance energy transfer (FRET) and 
fluorescence correlation spectroscopy (FCS) (97-100).  
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Figure 1-2. The folding energy landscape.  
Unfolded peptides with high potential energy progress down the folding landscape and 
adopt various folding intermediates before reaching a stable native state. Chaperones 
assist partially folded or misfolded peptides in overcoming kinetic barriers to reach native 
state. The green (left) side represents folded states driven by intramolecular interactions 
that are stabilized during folding. Aggregates, oligomers, and fibrils can form due to 
intermolecular interactions between partially folded proteins (red). This figure was 
adapted from (90). 
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As a peptide is synthesized in eukaryotes, folding into a tertiary structure can 
commence as a co-translational process. This is true for multi-domain containing proteins 
and is a way to avoid the formation of unproductive intermediates and accelerate protein 
folding (12,101,102). Ribosome-associated chaperones bind protein domains, specifically 
hydrophobic residues, as they exit the ribosome. These chaperones include Trigger Factor 
(TF) in prokaryotes, ribosome-associated complex (RAC) in eukaryotes, and nascent-
chain-associated complex (NAC) in archaea and eukaryotes (103). TF binds hydrophobic 
residues of newly synthesized peptides in an ATP-independent manner and prevents the 
misfolding of highly aggregation prone motifs (104,105). RAC consists of Hsp70 
chaperones Ssb1/2p, Ssz1p, and the Hsp40 chaperone Zuotin (Zuo), all of which 
cooperate in binding of nascent peptide chains (106). NAC is present at 1:1 stoichiometry 
with ribosomes and is a general co-translational chaperone that binds nascent peptides 
and prevents their misfolding. Moreover, NAC interacts with the signal recognition 
particle (SRP), thereby mediating protein sorting (107,108).  
The Hsp70 chaperones are present in bacteria and eukaryotes and function in the 
cytosolic network of chaperones, along with the co-chaperone Hsp40 and nucleotide 
exchange factors (NEFs) (109,110). Together the system binds newly synthesized 
peptides, both co- and post-translationally, and acts early in protein folding. Structurally, 
Hsp70 contains an N-terminal nucleotide-binding domain (NBD), a C-terminal substrate-
binding domain (SBD), and a linker domain that loosely connects the SBD and NBD 
(111-113). When ATP is bound in the NBD, Hsp70 takes on an open conformation and 
the SBD can interact with hydrophobic residues of peptides recruited by Hsp40. 
Hydrolysis of ATP is stimulated by the binding of Hsp40 and causes the alpha-helical lid 
of the SBD to close over top of the bound peptide. An open conformation and release of 
the substrate is triggered by the binding of NEFs to the NBD and exchange of ADP for 
ATP (111-114). Thus, the Hsp70-Hsp40 chaperone system functions in cycles of 
substrate binding and release in an ATP-regulated manner.  
To complete maturation of client proteins, Hsp70 transfers folded intermediates to 
Hsp90. Hsp90 forms a highly flexible homodimeric structure in both bacteria and 
eukaryotes (115-117). The N-terminal domain contains an ATPase and its activity 
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regulates folding reaction cycles, similar to Hsp70. Substrate binding is accomplished by 
the middle domain, which also regulates ATP hydrolysis. The C-terminal domain 
functions as the dimer interface and in co-chaperone binding. It contains a fold that forms 
a four-helix bundle upon dimerization and interacts with co-chaperones via an MEEVD 
motif at the extreme C-terminus (118,119). When bound to ATP, the N-terminal domains 
of each Hsp90 dimer interact to form a closed conformation (116). ATP hydrolysis can 
cause the N-terminal domains to dissociate for release of the client protein (115; for a 
schematic of the ATPase cycle of Hsp90 see Young et al. (119)).  
Hsp90 interacts with a range of co-chaperones that recruit client proteins, regulate 
ATP hydrolysis, and remodel Hsp90 (for a list and descriptions of Hsp90 co-chaperones 
see Table 4-1). Sti1 physically interacts with both Hsp70 and Hsp90, mediating Hsp70 
client protein transfer. Sti1 contains three TPR (tetratricopeptide repeat) domains, one of 
which interacts with the C-terminus of Hsp90, and the other two interacting with the C-
terminal domain of Hsp70 (120). In addition to linking Hsp70 and Hsp90, Sti1 interacts 
with the middle and N-terminal domain of Hsp90 to stabilize the open conformation 
(15,121). Similarly, Cdc37 interacts with the N-terminal and middle domains of Hsp90, 
stabilizes the open conformation and inhibits ATP hydrolysis (122). The co-chaperone 
Aha1 displaces Sti1, promotes the N-terminally dimerized closed conformation, and 
activates ATP hydrolysis. Aha1 is subsequently displaced by p23, which inhibits ATP 
hydrolysis by interacting at the interface of the Hsp90 N-terminal domains. This 
interaction induces a tightly closed conformation of Hsp90 and may be a way to prolong 
the closed state for protein activation (17,116).  
Having a variety of Hsp90 co-chaperones not only regulates the folding cycle but 
also provides specificity in client protein recruitment. The tethering between Hsp70 and 
Hsp90 via Sti1 ensures that Hsp70 specific client proteins are delivered to Hsp90 to 
complete folding. Cdc37 specifically targets protein kinases to Hsp90 and is an important 
mechanism for regulating protein kinase activity (122,123). In plants, the function of 
nucleotide binding leucine-rich repeat receptors (NLRs) depends on recruitment to 
Hsp90, which is mediated by assembly of an Hsp90 complex containing the co-
chaperones Sgt1 and Rar1 (124).  
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The R2TP complex associates with Hsp90 and is involved in the assembly of 
RNA polymerase II (18), stabilizing PIKK protein complexes (125,126), and the 
biogenesis of box C/D small nucleolar ribonucleoproteins (snoRNPs) (127-129). In yeast, 
the R2TP complex was identified by screening for physical and genetic interactions with 
Hsp90 (130). The subunits of the complex are conserved from yeast to mammals and 
consist of Tah1/RPAP3 (yeast/mammals), Rvb1/RUVBL1, Rvb2/RUVBL2, and 
Pih1/PIH1D1 (130). The Tah1 TPR domain interacts with the C-terminal MEEVD motif 
of Hsp90, physically linking the two complexes. The Rvb1 and Rvb2 are a part of the 
AAA+ ATPase family (ATPases associated with a variety of cellular activities), and 
when incubated together form hexameric ring structures in yeast and humans (131,132). 
The Rvb1/2 ring, while also playing an important role in chromatin remodeling 
complexes (133,134), associates with the N-terminal region of Pih1 as part of the R2TP 
complex (135). The Tah1 C-terminal domain binds to an intrinsically disordered region 
in the C-terminus of Pih1. This interaction prevents Pih1 degradation and increases its 
stability (129,136,137), and is therefore a critical aspect of R2TP complex assembly.  
1.3 Regulation of PIKK proteins by the Hsp90-R2TP-TTT 
complex 
Pih1 tethers the TTT complex to the R2TP, and indirectly to Hsp90 (136). The PIH 
domain of Pih1 contains a phosphopeptide binding site, which interacts with a motif of 
Tel2 containing CK2-phosphorylated serine residues. Tel2 is a member of the TTT 
complex, and its interaction with Pih1 is required for the stability of PIKK proteins 
(125,136). Based on crystal structures and biochemical data, Pal et al. (136) created a 
model for the assembly of an Hsp90-R2TP-TTT complex, functioning in the recruitment 
of PIKK proteins (depicted in Figure 1-3). 
       The TTT complex consists of Tel2, Tti1, and Tti2, which are all found in yeast 
and mammals. Tel2 (telomere maintenance 2) was initially identified in a screen for 
mutant alleles that affect the maintenance of telomere length (138). It was subsequently 
annotated with functions in circadian rhythm, lifespan, and DNA damage and S-phase 
checkpoints (139-142). In a screen for interactors with Tor1 and Tor2, Hayashi et al.  
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Figure 1-3. Associations of the Hsp90, R2TP, and TTT complexes in yeast. 
The R2TP complex associates with Hsp90 through an interaction between the TPR 
domain of Tah1 and the C-terminal MEEVD motif of Hsp90. Tah1 interacts with Hsp90 
as a dimer, however, it is unknown whether the R2TP and TTT complexes can associate 
in duplicate. The PIH domain of Pih1 binds to Tel2 phosphoserines, linking the TTT 
complex and PIKKs to the R2TP complex and Hsp90. Whether the PIKKs make direct 
contact with either the Rvb proteins or Hsp90 remains to be determined. This figure was 
adapted from (136). 
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(143) detected Tel2 and subsequently identified uncharacterized proteins which they 
termed Tel two-interacting proteins 1 and 2 (Tti1 and Tti2) (143). In a different study, to 
define a proteome interaction network involved in chromatin regulation, all three TTT 
components were found in association with Tra1, Asa1, Rvb1, and Rvb2, in a complex 
termed ASTRA (ASsembly of Tel, Rvb and Atm-like kinase) (144). Moreover, Tti1, Tti2 
and Tel2 are all required in the DNA damage response, for PIKK stability and complex 
assembly, and for chromosome stability (126,145-147).  
The PIKK proteins are a family of serine-threonine kinases that includes TOR 
(target of rapamycin), TRRAP (transformation/transcription domain associated protein), 
SMG1 (suppressor with morphogenetic effect on genitalia-1), ATM (ataxia telangiectasia 
mutated), ATR (ATM- and Rad3-related), and DNA-PKcs (DNA-dependent protein 
kinase catalytic subunit). Functions for each PIKK member include nutrient and growth 
signaling (TOR), transcriptional regulation (TRRAP), regulating nonsense mediated 
mRNA decay (SMG1), and the DNA damage response and repair (ATM, ATR, and 
DNA-PKcs) (148-152). The PIKKs all have similar domain architectures. Starting from 
the N-terminus there are alpha-helical HEAT (Huntington, EF3A, ATM, TOR) repeats 
that make up the FAT (FRAP-ATM- and TRRAP) domain, followed by a kinase domain 
that resembles that of the PI3K (phosphatidylinositol-3-kinase) family, and a FATC 
(FRAP-ATM-TRRAP C-terminal) domain at the extreme C-terminus (152-154).  
It is likely that the TTT complex functions as an Hsp90 co-chaperone in the 
recruitment of PIKK proteins for their maturation. The TTT members have been 
implicated in pathways related to PIKK functions, and their depletion results in decreased 
expression and stability of the PIKKs, and affects PIKK complex assembly (145,155-
157). Rather than having individual functions, the TTT members seem to regulate the 
PIKKs as a complex since impairing the Tel2 interaction with Tti1-Tti2 disrupts PIKK 
stability and function (126). In support of a co-chaperone role for the TTT complex, Tel2 
binds newly synthesized PIKK peptides and is found in complex with Tti1, Tti2 and 
Hsp90 (126). It is still unclear how Hsp90 interacts with the PIKKs, however, inhibition 
of Hsp90 ATPase activity reduces PIKK stability (126). The recruitment of the PIKKs to 
Hsp90 also involves the R2TP complex. Phosphorylation of Tel2 serine residues 487 and 
  
16 
491 by CK2 is required for interaction of Tel2 with Pih1, and regulates PIKK stability 
and activity (125,136,158,159). Taken together, the evidence to date supports a model 
where the PIKK proteins are recruited to the Hsp90 system by a series of protein-protein 
interactions involving the TTT and R2TP complexes. 
1.4 Proteome Perturbations  
Maintaining the integrity of the proteome extends beyond protein folding. The stability 
and function of proteins can be affected by errors during translation, stress conditions, or 
defects in protein biosynthesis, and can cause toxicity within the cell. Cells have evolved 
to deal with misfolded protein and invest a great deal of energy to ensure proteins are 
synthesized correctly. These include upregulation of chaperones, targeting proteins for 
degradation, storage of toxic aggregates, and editing functions of the translation 
machinery. The pathways that control these processes are all linked to one another by a 
network of interactions that maintain proteostasis (13).  
 Translation is considered a high fidelity process that ensures faithful peptide 
synthesis corresponding to the codons of an mRNA. However, incorporation of an amino 
acid not specified by a codon, referred to as mistranslation, is more prevalent than 
expected and occurs at an approximate frequency between 10-3 and 10-4 (160). This 
frequency can be significantly increased for rare codons and when a tRNA is in low 
abundance (1). Mutations in an aaRS or within tRNA molecules can also increase 
mistranslation, but surprisingly, sequence variations are commonly found within 
eukaryotic species (10,161). Translational errors include amino acid substitutions, 
translational frameshifts, and read-through of stop codons (162-165). While 
mistranslation occurs more frequently than initially predicted, it is kept at tolerable levels 
by aaRS editing mechanisms that ensure the formation of cognate aminoacyl-tRNA 
species (21).  
A distinct aaRS is expressed for each canonical amino acid, with the exception of 
asparaginyl- and glutaminyl-tRNA synthetases in most bacteria and archaea. In these 
organisms, via an indirect pathway, glutamine and asparagine are biosynthesized on their 
cognate tRNAs from seemingly mis-aminoacyl-tRNA precursors charged with aspartic or 
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glutamic acid (reviewed in (166,167)). Misacylation, or mischarging, occurs when 
aminoacylation involves a non-cognate amino acid and/or tRNA substrate. Such errors 
are more frequent with near-cognate substrates, as demonstrated by the increased rate of 
misactivation of valine by E. coli isoleucyl-tRNA synthetase (168). In some cases, errors 
can be circumvented prior to translation by pre- and post-transfer hydrolytic editing. Pre-
transfer editing involves the hydrolysis of a non-cognate aminoacyl adenylate, resulting 
in the release of the amino acid from the active site of an aaRS (169,170). Post-transfer 
hydrolysis of an amino acid from a misacylated tRNA can be accomplished by one of ten 
aaRSs containing an editing domain, or by a trans-editing enzyme (21,171). 
It should also be recognized that independent of tRNA misacylation, mis-
incorporation of amino acids occurring at the ribosome during mRNA decoding is not 
uncommon. Variation in cellular concentration of different tRNAs correlates with codon 
decoding times (172). Delayed decoding of a codon by a low abundance tRNA provides 
an opportunity for codon misreading with near-cognate aminoacyl-tRNA species, as 
demonstrated by the two-fold reduction in the misreading of Arg codons upon 
overexpressing the low abundant tRNAArg in E. coli (1). Despite mechanisms that 
discriminate between aminoacyl-tRNAs at the ribosome, mistranslation by near-cognate 
aminoacyl-tRNAs at codons decoded by low abundance tRNAs can be as high as 3.7 x 
10-3 (1). 
 Identity elements of a tRNA are positive determinants for aminoacylation by a 
specific aaRS and consist of single nucleotides, nucleotide pairs, and structural motifs 
(173). Since the anticodon of a tRNA links an amino acid to the genetic code, many of 
the identity elements fall within the anticodon (174). However, identity sets are also 
found within the acceptor stem near the 3’-end CCA (175), which largely influences 
catalytic turnover rather than binding affinity. For example, variation of the G3:U70 
identity pair in tRNAAla causes the 3’-end CCA sequence to be orientated away from the 
catalytic site while bound to AlaRS, resulting in a 100-fold decrease in kcat while having 
no significant effect on binding affinity (176). Mutations in tRNAs can cause a switch in 
identity and allow for aminoacylation by a non-cognate aaRS. Introduction of the 
G3:U70 base pair into tRNACys, tRNAPhe, and tRNALys, is sufficient to confer charging 
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with alanine (177-180). Thus, mutation of a single nucleotide pair can be the only 
requirement for changing tRNA identity, causing ambiguous decoding and an increase in 
mistranslation. 
Mutations causing a change in the anticodon can switch the identity of a tRNA 
(181,182), and have been documented during the evolution of various organisms (183-
186). These identity switches would typically not be detrimental to the proteome since 
the anticodon would still link the correct amino acid with its codon, and tRNA genes are 
often redundant. However, changing the anticodon without switching tRNA identity, and 
thus aminoacylation, can cause ambiguous decoding, and in some cases, codon 
reassignment. Examples of this have been identified in nature. A bioinformatic analysis 
has identified selenocysteine tRNA species from microbial genomes that have anticodon 
sequences to recognize all stop codons, as well as ten sense codons (187). In Candida 
albicans a tRNASerCAG variant decodes Leu CTG codon as serine (188,189). Such 
anticodon switches can lead to detrimental effects on the proteome. Initially, expression 
of the tRNASerCAG anticodon variant causes mistranslation at levels that lead to significant 
fitness costs. However, if ambiguous decoding or codon reassignment offers an 
advantage, cells will adapt to the added proteome stress. Adaptation to such stress 
includes upregulation of genes involved in translation and the ubiquitin-proteasome 
system in order to increase protein synthesis and protein turnover (2). Mistranslation 
levels are also manipulated by altering cytoplasmic tRNA levels through upregulating 
pathways involved in tRNA surveillance and degradation (2).  
While mistranslation has been commonly viewed as harmful translational errors, 
it can be an adaptive response. In some species, aaRS editing activity has been lost during 
evolution or is dispensable without significant effects on growth (11,190). E. coli can 
accommodate a proteome consisting of ~10% mistranslated proteins without affecting 
growth (11). This suggests that cells have efficient mechanisms to manage low levels of 
mistranslation to maintain optimal growth and fitness. Interestingly, E. coli, S. cerevisiae, 
and HeLa cells increase mis-aminoacylation by methionyl-tRNA synthetase (MetRS) 
under oxidative stress (3,191,192). The increase in methionine residues incorporated 
during translation protects cells against toxic oxygen species.  
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In addition to mistranslation, there are numerous other factors that cause protein 
misfolding and proteome instability. These include mutations, environmental stress 
conditions, and changes in cell metabolism. Destabilizing mutations leading to protein 
aggregation are a hallmark of neurodegenerative disease such as Alzheimer, 
Huntington’s, and Parkinson’s Disease (193,194). Increases in misfolded proteins 
correlates with the increase in mutation rates of cancer cells, and coincides with the 
overexpression of heat shock proteins (195). Environmental stress conditions that affect 
protein stability consist of increased temperatures, osmotic stress, and exposure to 
different chemicals such as mutagens, oxidants, and electrophiles (196-199). Moreover, 
reactive oxygen species accumulation can change the cell environment and disrupt 
disulfide bonds, metal binding sites, react with aldehydes, and add oxidative species to 
amino acid side chains (200-202). Metabolic fluctuations that cause protein stress are 
related to a change in nutrient intake, an increase in reactive oxygen species (ROS), or 
mitochondrial disregulation (203,204). 
1.5 Protein Quality Control 
In addition to their function in protein folding, chaperones and co-chaperones are 
important for targeting misfolded proteins to the proteasome. The ubiquitin-proteasome 
system, in general terms, involves tagging misfolded proteins with ubiquitin for targeting 
to the 26S proteasome (205). In some cases, chaperones and co-chaperones recruit 
ubiquitin-conjugating enzymes and E3 ubiquitin ligases to misfolded peptides. For 
example, the mammals co-chaperone CHIP (carboxy terminus of Hsp70-interacting 
protein) is an E3 ubiquitin ligase that interacts with the C-terminus of both Hsp70 and 
Hsp90 via TPR repeats (206,207). CHIP contains a U-box domain that binds the 
ubiquitin-conjugating enzyme UbcH5, mediating ubiquitin ligase activity (206). 
Mammalian BAG-1 links Hsp70/Hsc70 to the proteasome. Induction of BAG-1 increases 
association of Hsp70/Hsc70 with the proteasome and is targeted by an N-terminal 
ubiquitin-like domain (208). Tethering Hsp70/Hsc70 to the proteasome may facilitate the 
transfer of ubiquitinated clients for their degradation.  
Overexpression of heat shock proteins reduces toxicity caused by protein 
aggregates associated with human disease (209). Extracting misfolded proteins from 
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aggregates and mediating their refolding is also accomplished by chaperones classified as 
disaggregases. The AAA+ ATPase Hsp104 in yeast forms hexameric ring structures that 
remove denatured proteins from aggregates by threading peptides through the ring 
channel lined with aromatic residues (210,211). The extracted proteins undergo refolding 
or are targeted to the proteasome; however, the decision to do so is not fully understood.  
 Autophagy is a eukaryotic cellular response that delivers protein aggregates, 
organelles, as well as invading bacteria and viruses to the lysosome for degradation (212-
216). The autophagy-lysosome response functions by the formation of a double 
membraned autophagosome, recognition and encapsulation of cytoplasmic targets, and 
fusion with the lysosome where protease digestion occurs (212). It is tightly linked to the 
ubiquitin-proteasome system and when one is impaired the other is upregulated for 
compensation (217). Autophagy also works in parallel with the endoplasmic reticulum 
associated degradation (ERAD) pathway. The ERAD pathway exports misfolded 
peptides from the ER to the cytoplasm for degradation by the proteasome. Autophagy is 
required for the elimination of higher molecular weight aggregates that cannot be 
managed by ERAD. For example, the autophagy-lysosome pathway is required to 
eliminate procollagen aggregates that form in the ER, since knock-down of autophagy-
related genes leads to procollagen aggregate accumulation (218).  
 Aggresomes are compartments that sequester and store misfolded proteins or 
aggregates when the ubiquitin-proteasome system is overburdened (219,220). 
Aggresomes are encompassed by an intermediate filament protein, vimentin, and co-
localize with centrosomal proteins where misfolded proteins are trafficked by 
microtubules (221,222). Studies indicate a beneficial role for aggresomes. Sequestration 
of toxic huntingtin proteins to aggresomes improves neuronal cell survival (223). 
Moreover, inhibition of aggresome formation increases the cellular toxicity caused by a 
mutant androgen receptor aggregate, normally trafficked to the aggresome (224). It is 
proposed that in yeast and mammals, aggregates can be deposited either near the nuclear 
membrane, termed the juxtanuclear quality-control (JUNQ) compartment, or next to the 
vacuole (or lysosome), known as the insoluble protein deposit (IPOD) (225). The JUNQ 
compartment typically contains either ubiquitinated proteins destined for the proteasome, 
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or soluble misfolded proteins that can be refolded by chaperones. Conversely, IPOD 
contains insoluble, irreversible misfolded proteins, such as huntingtin or prions, and 
associates with autophagy-related proteins (225,226).  
 Protein misfolding is pervasive to all organisms and its management by 
degradation, folding, and storage systems is essential for disease prevention and viability. 
Native conformations of proteins are destabilized by mistranslation, mutations, and 
conditions of stress. Fortunately, cells have evolved mechanisms to maintain the integrity 
of the proteome by controlled folding and refolding of peptides, disrupting and degrading 
toxic aggregates or misfolded proteins, and by directing toxic species to distinct 
compartments for isolation from cell constituents.  
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Chapter 2  
2 Saccharomyces cerevisiae Tti2 regulates PIKK proteins 
and stress response 
2.1 Introduction 
The biosynthesis and regulation of phosphatidylinositol 3-kinase-related kinase (PIKK) 
proteins is crucial for cells to grow, proliferate, and respond to stress conditions. The 
PIKK family of proteins includes ATM/Te11 (mammalian/yeast), ATR/Mec1, 
mTOR/Tor1, Tor2, TRRAP/Tra1, and the mammalian proteins DNA-dependent protein 
kinase (DNA-PKcs) and SMG1. Each has important roles in cell signaling during stress 
(1) and regulate one or more critical functions such as cell growth and nutrient response 
(mTOR), DNA damage response (ATM, ATR and DNA-PKcs), and the regulation of 
gene expression (TRRAP and SMG1) (2-5). The PIKK proteins are large, and share 
extensive N-terminal helical regions and a C-terminal domain that resembles the 
phosphatidylinositol-3-kinases (6). Perhaps due to this common structure, biosynthesis 
and maintenance of the PIKKs are regulated by a common set of proteins. This first 
became apparent when Takai et al. (7) demonstrated that Tel2 was required to maintain 
the steady state level of ATM, ATR, DNA-PKcs, SMG1, mTOR, and TRRAP. In 
subsequent work Takai et al. (8) demonstrated that Tel2 interacts with newly synthesized 
proteins, suggesting that it executes co-translational chaperone activity. TEL2 was also 
identified in a screen for genes involved in the DNA damage response, likely as a result 
of its regulation of ATM and ATR (9). In the same screen Hurov et al. (9) identified the 
genes encoding Tti1 (Tel2 interactor) and Tti2. The three proteins were found to mutually 
associate and co-elute in molecular weight fractions corresponding to a complex they 
termed the TTT complex. The TTT complex associates with a number of molecular 
chaperones including Hsp90, Hsp70, Hsp40 and the R2TP/prefoldin-like complex (8,10). 
The TTT complex is thus considered a co-chaperone, yet the role of each member of the 
complex, its substrate specificity and its mechanism of action are unknown.  
 We identified tti2 as a genetic suppressor of a tra1 allele, which alters the C-
terminal phenylalanine to alanine (11). This allele reduces the stability and nuclear 
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localization of Tra1, resulting in reduced growth particularly under stress conditions. 
Two alleles of tti2 (Phe328 to Ser and Ile336 to Phe) suppress the tra1-F3744A mutation. 
Consistent with a role for Tti2 as a co-chaperone, tti2 suppression of tra1-F3744A 
reduces its degradation, and enhances the stability and nuclear localization of Tra1-
F3744A (11). The tti2 alleles did not, however, suppress the growth defects of a mec1 
allele with a C-terminal Trp to Ala mutation, suggesting specific interactions between 
Tti2 and Tra1.  
 In S. cerevisiae TTI2 encodes an essential protein of 421 amino acid residues. 
Like Tel2 (8), Tti2 is predicted to be primarily helical, and localizes to both the nucleus 
and cytoplasm (11). Further emphasizing the importance of Tti2 are findings that it is 
implicated in human brain development. A missense mutation that converts I436 to N 
within human Tti2 causes an autosomal recessive disorder defined by microcephaly, short 
stature, behavioural problems, skeletal abnormalities, and facial dismorphic features (12). 
Furthermore, A P367L missense mutation in TTI2 has been linked to intellectual 
disability (13). Individuals with a Tti2 defect show characteristics similar to individuals 
who are unable to respond to DNA damage, possibly due to inhibition of ATR function 
(12).  
 Our goal is to use a molecular genetic approach to define the role of Tti2, 
characterize its structure/function relationships, as well as its relationship with Tel2 and 
Tti1. We therefore began this study with a screen for tti2 alleles that would identify 
features required for the function of the protein. Surprisingly, we identified an allele with 
an ochre mutation at codon 276.  As C-terminal truncations of Tti2 do not support 
viability, this result suggested that low levels of Tti2 potentially obtained by read-through 
of the ochre mutation were sufficient for viability. To further characterize the effect of 
depleting Tti2, we placed it under control of the GAL10 promoter and analyzed the 
properties of the protein and strain in raffinose and glucose-containing media. We 
demonstrate that low levels of Tti2 are sufficient for viability in non-stress conditions. 
Depleting Tti2 does, however, result in temperature sensitivity and impairs the ability of 
cells to respond to certain conditions of stress related to PIKK function. We show that the 
steady state levels of Mec1, Tra1 and Tor1 decrease when Tti2 levels are depleted, with 
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Mec1 and Tra1 being more affected. A significant proportion of both Tra1 and Mec1 
mislocalize to foci within the cytosol when Tti2 is expressed at low levels, which does 
not appear to result from protein aggregation. Furthermore, overexpressing Hsp90, a 
molecular chaperone involved in PIKK complex assembly (8,10), results in synthetic 
lethality in cells depleted of Tti2. Tti2 is not induced by heat shock, but its absence 
induces expression of Hsp42. Taken together, these results support a specialized role for 
Tti2 in PIKK complex assembly, rather than acting as a general chaperone in protein 
folding. 
2.2 Materials and Methods 
2.2.1 Yeast strains and Growth Conditions 
Yeast strains were grown in YP (Yeast Peptone) media or synthetic dropout media 
supplemented with required nitrogenous bases and amino acids. Strains containing 
YCplac111-GAL10-TTI2 as the sole source of TTI2 were grown in YP or synthetic 
dropout media containing 2% galactose except as otherwise indicated. 
            All strains in this study (Table S 2-1) are derivatives of the wild type yeast strains 
BY4741, BY4742, and BY4743 (14). The tti2 disruption strain CY6032 was generated in 
the diploid BY4743 strain by integrating a TTI2-Tn10luk-MET5 cassette (described in 
DNA constructs). This strain was subsequently transformed with YCplac111-DED1-TTI2 
(LEU2 centromeric plasmid), sporulated, and URA3/LEU2 haploids selected to give rise 
to the MATa strain CY6049.  The URA3 was then eliminated by counter-selection with 5-
fluoroorotic acid (5-FOA; Toronto Research Chemicals Inc.) YCplac33-DED1-TTI2 
(URA3 centromeric plasmid) was transformed into CY6049 and YCplac111-DED1-TTI2 
lost after repeated growth on leucine containing plates to generate CY6070. This strain 
was subsequently transformed with YCplac111-DED1-TTI2, YCplac111-DED1-tti2L187P, 
and YCplac111-DED1-tti2Q276TAA, then plated on 5-FOA to lose YCplac33-DED1-TTI2 
and generate strains CY6857, CY6872, and CY6874, respectively. The related MATα 
strain CY6963 was obtained by sporulation after crossing BY4742 with CY6070. 
CY6971 and CY6991 were made by transforming CY6070 with YCplac111-GAL10-TTI2 
and YEplac181-GAL10-TTI2, respectively, and in each strain the DED1-TTI2 URA3 
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plasmid was lost by plasmid shuffling on 5-FOA. To generate CY6973, the plasmid copy 
of LEU2 was disrupted with URA3 by integrating pLU12 (15) digested with HpaI and 
SalI. CY7000 is a diploid strain containing a disruption of both genomic copies of TTI2 
made by mating CY6971 with CY6963, and subsequently losing the URA3 on 5-FOA.   
            CY7086 expressing C-terminal Myc9-tagged Tti2 from its endogenous promoter 
was constructed by transforming BY4742 with the SphI-SacI fragment of pCB2890 and 
selecting for growth on medium lacking histidine. Integration of the Myc9-tag was 
confirmed by Western blot. To generate CY7172, pCB2911 was transformed into 
CY6971, repeatedly grown on leucine containing plates depleted of uracil to lose 
YCplac111-GAL10-TTI2, then checked for leucine auxotrophy.   
            Flag5-tagged TRA1 (CY5919) and Flag5-tagged MEC1 (CY6194) strains have 
been previously described (11,16). CY6999 and CY7030 were made by integration of the 
Flag5-tagged TRA1 and MEC1 containing cassette into CY6971 (11,16). CY6415 
containing a Flag5-tagged TOR1 allele was made by integration of a URA3-containing 
cassette (described below) into BY4743 and CY7000.  
            Strains expressing eGFP-TRA1 (CY5998 and CY7193) were made by integrating 
an SphI-XbaI fragment of pCB2301 (as described in (11)). Similarly, eGFP-MEC1 
strains (CY6306 and CY7189) were made by integrating an SphI-EcoRI fragment of 
pCB2395 (16).  
            CY6857 and CY6872 were transformed with a two micron URA3-containing 
plasmid expressing htt25Q from the GAL1 promoter (described in (17)) to generate 
CY7236 and CY7238, or htt103Q expressed from the GAL1 promoter to create CY7237 
and CY7239. For an empty vector control, YCplac33 was transformed into CY6872, 
resulting in CY7241.  
            Two micron LEU2 plasmids containing CDC37, HSP82, AHA1, or HSC82 
expressed from the GPD promoter were transformed into CY6070 to generate strains 
CY7370, CY7371, CY7372, and CY7373, respectively and into CY6973 to create strains 
CY7374, CY7375, CY7376, and CY7377, respectively. Two micron URA3 plasmids 
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expressing either HSP42, HSP26, or HSP104 (described in (18)) were transformed into 
CY6857 to generate CY7323, CY7247, and CY7248, respectively, and into CY6971 to 
produce CY7324, CY7251, and CY7252, respectively. YCplac33 was transformed into 
CY6857 and CY6971 to give rise to empty vector control strains CY7245 and CY7249, 
respectively.  
2.2.2 DNA molecules 
The tti2 disruption cassette in pCB2312 was created in three steps. First, genomic DNA 
was used to PCR amplify a SalI-BamHI fragment at the 3’ end of TTI2 extending into 
noncoding sequence using primers 6085-3 and 6085-4 (see Table S 2-2 for a listing of 
oligonucleotides), which was cloned into pTZ18r.  A 5’ fragment of TTI2 extending into 
MET5 fragment was amplified using primers 6085-1 and 6085-2 and inserted as a 
BamHI-EcoRI into the above plasmid. Tn10luk (19) was then inserted into the BamHI 
site of this molecule. Digestion with SalI and EcoRI allowed insertion into yeast with 
selection for Ura+ transformants. 
            pCB2134 and pCB2319 express Myc9-tagged TTI2 from the DED1 promoter in 
the LEU2 and URA3 centromeric plasmids YCplac111 and YCplac33, respectively (11). 
The GAL10 promoter was substituted into pCB2134 after cloning a PCR product using 
oligonucleotides 2764-1 and 2764-2 as a PstI-HindIII fragment to generate pCB2844 
(YCplac111-GAL10-TTI2). GAL10-TTI2 from pCB2844 was inserted as a PstI-SacI 
fragment into YEplac181 to give pCB2862.  
            The PHO5-lacZ and STRE-lacZ fusion constructs in YCp87 have been previously 
described (20,21). The HSE-lacZ plasmid has been described by Duennwald & Lindquist 
(22). 
pCB2890, the molecule to integrate a C-terminal Myc9-tag into Tti2 was 
constructed in a cassette using a base oligonucleotide synthesized by Life Technologies 
Inc. (see Supporting Information for sequence, Figure S 2-1). This molecule was cloned 
as a SphI-SacI fragment into pTZ19r lacking a HindIII site. The SphI site is at base pair 
1076 relative to the TTI2 translational start, followed by the TTI2 coding sequence to the 
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C-terminus, with the Myc9-tag from YCPlac111-DED1-TTI2 cloned as a HindIII-NotI 
fragment in front of the translational stop codon. The molecule contains a BamHI site 
downstream of the translational stop into which HIS3 was cloned, followed by additional 
downstream sequence and a SacI site to allow integration into yeast as a SphI-SacI 
fragment. The TTI2 promoter was PCR amplified using primers TD0569 and TD0570 
and genomic DNA as template, cloned into YCplac33 as a SalI-HindIII fragment in a 
triple ligation with TTI2 from pCB2134 as a SalI-SacI fragment to generate pCB2911.  
pCB2425, which contains a cassette to integrate Flag5 -tagged TOR1 as an SphI-
EcoRI fragment was adapted from pCB2134 used previously to tag TRA1 (11). TOR1-
specific sequences were added to this molecule as SphI-HindIII and NotI-SalI fragments 
after PCR with oligonucleotides 6496-1 and 6496, and 6496-3 and 6496-4. Digestion 
with SphI and SalI allows insertion into at TOR1 after selection for Ura+ transformants.  
CDC37, HSP82, HSC82, and AHA1 were amplified by PCR (refer to Table S 2-2 
for oligonucleotide sequences) using genomic DNA as template and cloned into 
Gateway® GAL1 two micron destination vectors as described in Alberti et al. (23). 
The plasmids used for overexpressing Hsp26 and Hsp104 from the 
glyceraldehyde-3-phosphate dehydrogenase (GPD) promoter have been previously 
described (18). HSP42 along with its promoter (500bp sequence upstream of translation 
start site) was cloned by PCR using primer TK7578 and TK7579 and genomic DNA as 
template. The PCR product was ligated into a URA3 two micron plasmid (YEplac195) as 
a NotI-SacI fragment.  
2.2.3 Screening for defective tti2 alleles 
To generate strains CY6872 and CY6874, a library of randomly mutagenized TTI2 alleles 
was constructed by PCR using Taq polymerase and primers 5693-1 and 5693-2, and 
inserting into YCplac111-DED1-TTI2 as a NotI-SacI fragment. The randomly mutated 
alleles were transformed into CY6070, and TTI2 on the URA3 plasmid was shuffled out 
by plating on 5-FOA. These strains were patched onto a YPD plate and screened for slow 
growth on a YPD plate containing 6% ethanol or when grown at 37°C. Plasmids were 
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recovered (24) and transformed back into CY6070 to confirm the phenotype. Alleles 
resulting in slow growth were sequenced to identify mutations.  
2.2.4 Growth assays 
Stress sensitivity assays were performed at 30°C or 37°C on YP plates containing 2% 
raffinose or glucose and either 6% ethanol, 1 nM rapamycin (LC Laboratories), 0.1 M 
hydroxyurea (Sigma-Aldrich), 8 μg/ml Calcofluor white (Sigma-Aldrich), 10 mM 
caffeine (Sigma-Aldrich) or 1 M sodium chloride (EMD Chemicals Inc.). Strains were 
grown to stationary phase, their optical density at 600 nm normalized, and spotted in ten-
fold serial dilutions onto each plate. Growth curves were performed in YP media with 
either 2% glucose, 2% galactose, or 2% raffinose as the carbon source after growth of a 
starter culture in YP containing 2% raffinose.   
2.2.5 Western blotting 
Yeast strains were grown to mid-logarithmic phase then lysed with glass beads to harvest 
protein.  Western blotting was performed using PVDF membranes and anti-Flag (M2; 
Sigma-Aldrich) and anti-Myc (9E10; Sigma-Aldrich) monoclonal antibodies as 
previously described (20,21). Anti-Hsp42 polyclonal antibody was kindly provided by 
Johannes Buchner (Technische Universität München) and was used as previously 
described (25).   
2.2.6 Half-life of Tti2 
Yeast strains CY6971 and BY4742 were grown to stationary phase in YP medium 
containing galactose, diluted 1:100 in the same media, then grown to an optical density of 
2.0 before adding 35 µg/ml of cycloheximide. 108 cells were harvested before adding 
cycloheximide, and at two, four, six, and eight hours thereafter.  Protein was extracted as 
described in von der Haar (26) in the presence of protease inhibitors (working 
concentrations: 10 M phenylmethylsulfonyl fluoride, 5 g/ml pepstatin, 10 M 
benzamidine, 500 g/ml trypsin inhibitor, and 5 g/ml leupeptin), and the lysates were 
separated by SDS-PAGE and Western blotted with anti-Myc antibody.  The bottom 
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quarter of the gel was stained with Coomassie Brilliant Blue and shown as a control for 
equal loading. 
2.2.7 β-galactosidase assays 
LacZ reporter plasmids were assayed in strains CY6070 and CY6973. For the PHO5-
lacZ reporter, strains were grown to stationary phase, washed three-times with sterile 
water, diluted 20-fold in YPD medium depleted of phosphate, and grown for eight hours. 
Cell densities were normalized and β-galactosidase units were determined using o-
nitrophenol-β-D-galactosidase as substrate as described in Mutiu et al. (21). Strains 
containing the STRE-lacZ reporter were diluted 1:20 from stationary culture and grown in 
medium containing 2% glucose and 6% ethanol for eight hours prior to the assay. When 
assaying the heat shock element, strains were grown to mid-logarithmic phase in YPD 
then heat shocked at 42°C for 30 minutes. Strains containing PGK-lacZ were grown to 
stationary phase in medium with raffinose as the sole carbon source, then diluted 1:20 in 
YPD and grown for eight hours.  
2.2.8 Fluorescence microscopy 
Yeast strains CY5998, CY7193, CY6306, and CY7189 were grown to stationary phase in 
minimal medium lacking uracil, diluted 1:20 and grown to an optical density of 0.8 at 
600 nm. Cells were concentrated 10-fold and 33258 Hoechst bisbenzimidazole dye 
(Sigma-Aldrich) was added to each culture at 1.0 µg/ml one hour prior to imaging. Cells 
were washed twice in one ml of sterile water and imaged using a Zeiss Axioskop 2 
microscope driven by Image J 1.41 software (National Institutes of Health) and a Scion 
CFW Monochrome CCD Firewire camera (Scion, Frederick MD) with bright field, DAPI 
and GFP filter sets. Image J 1.48 software was used for quantifying GFP signal 
intensities. For each cell counted, the elliptical tool was used to trace each cell on bright 
field images and the measure function was used to calculate signal intensity per unit area 
from GFP images. The nucleus was defined as the top 10% of pixels with the highest 
intensity values within the outlined cell from images taken with the DAPI filter and was 
determined using the threshold function. This area was outlined using the magic wand 
tool and the traced area was used to measure GFP signal intensity in the nucleus. 
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Background noise was subtracted from the whole cell and nuclear intensity values and 
was measured in the area adjacent to the cell. Percent intensity in the nucleus was 
calculated by dividing the background subtracted intensity values of the nucleus by the 
background-subtracted values of the whole cell. Percent nuclear intensity calculations 
represent an average of individual cell ratios (nuclear GFP intensity: whole cell GFP 
intensity) taken across 20 cells for each strain. 
2.2.9 Semi Denaturing Detergent-Agarose Gel Electrophoresis 
(SDD-AGE) 
Aggregation of Mec1 was analyzed using SDD-AGE as described in Kryndushkin et al. 
(27) with the following modifications. Yeast strains CY6194 and CY7030 were grown to 
stationary phase in minimal medium lacking uracil and containing 2% raffinose. BY4742 
was grown in YPD to stationary phase. All strains were diluted 1:20 in YPD and grown 
to mid-logarithmic phase. Protein was extracted from cells by glass bead lysis in buffer 
containing 100 mM Tris pH 7.5, 200 mM NaCl, 1.0 mM EDTA, 5% glycerol, 1.0 mM 
DTT, and protease inhibitors (working concentrations: 10 M phenylmethylsulfonyl 
fluoride, 5 g/ml pepstatin, 10 M benzamidine, 500 g/ml trypsin inhibitor, and 5 g/ml 
leupeptin). Protein lysates were separated on a 1.8% agarose gel then transferred to 
PVDF overnight by capillary transfer in Tris buffered saline pH 7.5. The PVDF 
membrane was Western blotted using anti-Flag primary and mouse secondary antibodies 
as described previously (20,21). Ponceau S (Sigma-Aldrich) was used to stain the 
membrane after capillary transfer to document equal loading.  
2.3 Results 
2.3.1 Identification of stress-sensitive tti2 alleles 
To initiate studies into the structure/function relationships of Tti2 we selected for 
randomly created mutations that confer slow-growth under stress conditions. A library 
containing random mutations in TTI2 generated by PCR with Taq polymerase was 
transformed into CY6070, a strain with the genomic copy of TTI2 deleted and with TTI2 
on a URA3-containing plasmid. After plasmid shuffling on 5-fluroorotic acid, we 
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screened colonies for slow growth on YPD plates containing 6% ethanol and/or when 
grown at 37º. Two strains were identified. The plasmids from each strain were then 
sequenced and the phenotype confirmed after retransformation. One tti2 allele contained 
a mutation converting leucine 187 to proline; the second allele, tti2Q276TAA, contained an 
ochre mutation at codon 276. As shown in Figure 2-1, the L187P mutation causes a slight 
reduction in growth on YPD at 30º, and more severely reduced growth on medium 
containing 6% ethanol, and at 37º.  The tti2Q276TAA allele resulted in slow growth under 
each condition with severely reduced growth on medium containing the cell wall binding 
compound Calcofluor white and at 37º.   
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Figure 2-1. Selection of randomly created tti2 mutations causing slow growth. 
CY6070 (TTI2), CY6872 (tti2L187P), and CY6874 (tti2Q276TAA) were grown to saturation in 
YPD medium then spotted in 10-fold serial dilutions onto YPD, YPD containing 6% 
ethanol or 8 μg/ml Calcofluor white and grown at 30º, and on YPD grown at 37º.  
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2.3.2 Low levels of Tti2 support viability but cause slow growth 
As the tti2 alleles were Myc9-tagged we were able to examine their expression by 
Western blotting (Figure 2-2a). Tti2L187P is expressed at a level approximately two-fold 
less than the wild type protein. tti2Q276TAA is expressed at a reduced level, and as expected 
is truncated. The ability of tti2Q276TAA to support viability may indicate that the C-terminal 
sequence of Tti2 is not essential for function, or that the ochre mutation is read-through 
(or skipped) at a low frequency, which is sufficient to support viability. To test if the C-
terminus of Tti2 is essential we used plasmid shuffling to examine whether C-terminal 
truncations to residue 356 and 321 support viability. As shown in Figure 2-2b, neither 
truncation allele supports viability. We therefore conclude that C-terminal sequences are 
essential, and hypothesize that tti2Q276TAA supports viability due to a low level of read-
through of the ochre mutation.  
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Figure 2-2. Characterization of Tti2 mutations. 
A. Yeast strains CY6872 (lanes 1, 2, and 3), CY6070 (lanes 5, 6, and 7), CY6874 (lanes 
9, 10, and 11), and BY4742 (lane 13), were grown to stationary phase in minimal 
medium, diluted 1:20 in YPD and grown for 8 hours at 30º.  Protein was harvested by 
grinding with glass beads and the indicated amount of lysate separated by SDS-PAGE 
(8%) and Western blotted with anti-Myc antibody. B. CY6070 was transformed with 
plasmids containing full length TTI2, or derivatives with C-terminal deletions to residues 
350 (Δ351-421) or 325 (Δ326-421). Individual transformants were grown in YPD and 
spotted serially on a minimal plate containing 5-FOA. C.  Strains CY6070 (DED1-TTI2) 
and CY6971 (GAL10-TTI2) were grown to stationary phase, then spotted in 10-fold serial 
dilutions onto YP plates containing 2% galactose, raffinose, or glucose, and grown for 
three days at 30º. 
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To test the effect of reducing TTI2 expression, we placed it under the control of 
the GAL10 promoter on a LEU2 centromeric plasmid in a strain lacking the genomic 
copy (CY6971). Comparisons were made between TTI2 expressed from the DED1, the 
promoter of a constitutively expressed RNA helicase, and the GAL10 promoter. When 
grown on galactose-containing medium GAL10-TTI2 supported growth at a rate 
comparable to DED1-TTI2 (Figure 2-2c). To test for growth on raffinose and glucose-
containing plates, conditions that repress GAL10 transcription, cells were first grown in 
liquid culture containing the respective carbon source. Similar to what was observed with 
tti2Q276TAA, GAL10-TTI2 supported viability but showed reduced growth when cells were 
grown with these carbon sources. These results were reproduced in liquid media where 
growth of the GAL10-TTI2 strain in glucose and raffinose decreased the doubling time of 
cells in logarithmic phase by approximately three and 1.5-fold (relative to DED1-TTI2), 
respectively (Table 2-1).  
 
Table 2-1. Doubling times (hours) of strains during logarithmic growth phase in YP 
media containing the indicated carbon sources. 
Strain Galactose Raffinose Glucose 
CY6070 (DED1-TTI2) 2.0 +/- 0.1 2.8 +/- 0.1 1.50 +/- 0.01 
CY6973 (GAL10-TTI2) 2.5 +/- 0.1 4.1 +/- 0.1 4.4 +/- 0.4 
  
To ensure that the observed doubling times were not influenced by excess Tti2 
remaining in the cells from their prior growth in galactose, we determined the protein’s 
half-life. The tti2 disruption strain containing GAL10-TTI2 (CY6971) was grown to mid-
logarithmic phase with galactose as the carbon source and translation was blocked with 
cycloheximide. Tti2 levels decreased approximately two-fold after six hours (Figure 2-
3a; compare lanes 2 and 7). We conclude that by growing cells in raffinose or glucose 
containing media over two days, we can deplete the cellular levels of Tti2 and assess the 
effect on growth.  
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Figure 2-3. Depleting Tti2 below endogenous levels supports viability. 
A. Yeast strains CY6971 and BY4742 were grown to saturation in YP medium 
containing galactose then diluted 1:100 in the same media and grown for 16 hours to an 
optical density of 2.0 at 600 nm. 108 cells were then harvested before blocking translation 
and two, four, six, and eight hours after adding 35 µg/ml of cycloheximide. For each time 
point, cell pellets were washed with lysis buffer then immediately stored at -80º.  Total 
protein was extracted from each cell pellet using an optimized extraction protocol (von 
der Haar, 2007) and in the presence of protease inhibitors. 1.0 µl of lysate was loaded per 
time point and separated by SDS-PAGE. Tti2 was detected by Western blotting with anti-
Myc antibody and the bottom of the gel was stained with Coomassie Brilliant Blue for a 
loading control. B. GAL10-TTI2 expression in glucose-containing medium. Yeast strain 
CY6070 (lanes 1, 2, and 3), CY6971 (lanes 5 and 8), and BY4742 (no tag control; lane 4) 
were grown to stationary phase in glucose-containing YP, diluted 1:20 in fresh medium 
and grown for 8 hours before harvesting. Protein was extracted with glass beads and the 
indicated amounts separated by SDS-PAGE and Western blotted with an anti-Myc 
antibody to detect tagged Tti2. Lane numbers are listed between the blot and the bottom 
of the gel, which was stained with Coomassie Brilliant Blue for a loading control (CBB). 
Lane 6 was left open to separate galactose control lanes. C. CY7086 (genomically 
encoded C-terminal Myc9-tagged TTI2, WT-TTI2; lanes 1, 2, 3, and 7), CY6971 (GAL10-
TTI2; lanes 4, 5, 6, and 8), and BY4742 (no tag; lane 9) were grown to saturation in YP 
media containing either raffinose or galactose, then diluted 1:20 in the same media and 
grown for 8 hours. Protein was extracted by bead lysis and the indicated amounts 
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separated by SDS-PAGE and Western blotted as described above. The bottom portion of 
the gel was stained with Coomassie Brilliant Blue. D. CY6971, CY7172 (YCplac33-
TTI2-TTI2), and BY4742 were grown to stationary in media depleted of leucine and 
containing either raffinose or galactose, diluted 1:20 in the same media, and grown for 
eight hours before harvesting. Protein extraction and Western blotting was performed as 
in (B). 
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We then examined the steady state expression of Tti2 in different media by 
Western blotting. The amount of Tti2 was similar when expressed from the GAL10 or 
DED1 promoter when cells were grown in galactose-containing medium (Figure S 2-2a). 
In contrast, Tti2 was not detected in 100 µg of protein extract when the GAL10-TTI2 
allele was expressed in glucose (Figure 2-3b; lane 5) or raffinose media (Figure S 2-2b; 
lane 5). In these same conditions DED1-TTI2 expression was detected in one microgram 
of extract (Figure 2-3b and Figure S 2-2b; lane 2). To provide an indication of the relative 
expression of GAL10-TTI2 in raffinose and glucose media we engineered the constructs 
in the two micron plasmid YEplac181. The level of expression from the two micron 
plasmid supported robust growth on glucose-containing plates (Figure S 2-3a). GAL10 
expressed Tti2 from the two micron plasmid was detected in raffinose and glucose-
containing media with the expression in raffinose being approximately five-fold higher 
than in glucose (Figure S 2-3b; compare lanes 4 and 7), a fold-change consistent with 
what we routinely observe with LacZ-fusions to the GAL10 promoter. 
Two approaches were taken to demonstrate that depleting Tti2 using the GAL10 
promoter results in expression below endogenous levels. First, the expression of an 
integrated C-terminally Myc9-tagged tti2 allele was compared to GAL10-TTI2 expression 
from a centromeric plasmid in raffinose containing medium. Again, Tti2 expressed from 
the GAL10 promoter was not detected with 100 μg of protein loaded (Figure 2-3c, lane 
4). In comparison the endogenous allele allowed detection at 10 μg (lane 2), suggesting a 
minimum difference of 10-fold in raffinose and by extrapolation 50-fold in glucose 
medium. Second, we analyzed Tti2 expression regulated by the TTI2 promoter on a 
centromeric plasmid. Tti2 was detected when expressed from its promoter at 37.5 µg of 
protein extract (Figure 2-3d, lane 3), while expression from the GAL10 promoter in 
raffinose was undetectable in 150 µg of protein loaded (lane 4). Taken together, these 
results indicate that expression of Tti2 below endogenous levels supports viability but 
lead to slow growth. 
2.3.3 Depleting Tti2 levels causes sensitivity to stress conditions 
Strains containing YCplac111-GAL10-TTI2 were analyzed to determine whether 
depleting Tti2 would affect growth under stress conditions, possibly by regulating PIKK 
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expression. Serial dilutions of the GAL10-TTI2 and DED1-TTI2 containing strains were 
spotted onto plates with raffinose as the carbon source, and also on raffinose containing 
either hydroxyurea (ribonucleotide reductase inhibitor), ethanol, Calcofluor white (cell 
wall integrity), rapamycin (mTOR inhibitor), caffeine, and sodium chloride (osmotic 
stress) (Figure 2-4a). Growth at 37°C was also examined. Slow growth was observed in 
all of these stress conditions. For conditions that had more moderate effects on growth we 
repeated the assay on plates with glucose as the carbon source. In each case (ethanol, 
Calcofluor white, and rapamycin) this resulted in a more severe growth defect (Figure 2-
4b). The pattern resembled that seen for the tti2Q276TAA allele, however the GAL10-TTI2 
strain was more sensitive to rapamycin and slightly less sensitive to Calcofluor white. 
Taken together, these results indicate that low levels of Tti2 cause stress sensitivity to 
conditions that perturb pathways regulated by PIKK proteins, including the DNA damage 
response, cell wall integrity pathway, nutrient limitation, and osmoregulation.  
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Figure 2-4. Stress sensitive phenotypes caused by reduced expression of TTI2. 
A. CY6070 (DED1-TTI2), CY6971 (GAL10-TTI2), and mec2-1 (included as a control for 
sensitivity to hydroxyurea; (28)), were grown to stationary phase in YP medium 
containing raffinose then 10-fold serial dilutions spotted onto YP plates containing 
raffinose or with raffinose and either 0.1 M hydroxyurea, 6% ethanol, 8 μg/ml Calcofluor 
white, 1.0 nM rapamycin, or 1 M NaCl and grown for 3 days at 30º or 37º. B. CY6070, 
CY6971 and CY6874 (tti2Q276TAA) were grown to stationary phase in YPD medium then 
10-fold serial dilutions spotted onto YPD plates, or YPD with either 6% ethanol, 8 μg/ml 
Calcofluor white, 1.0 nM rapamycin, or 10 mM caffeine and grown at 30º for 3 days. 
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2.3.4 Depleting Tti2 reduces PIKK steady state levels 
The nature of the stress-related growth defects following reduced levels of Tti2 suggested 
that PIKK proteins are affected. We previously found that reduced levels of Tra1 alter the 
expression of genes involved in stress response (20). To address whether Tra1 was 
affected by depleting Tti2, we analyzed transcription regulated by a stress response 
element (STRE), a heat shock element (HSE) and the PHO5 promoter. Tti2 levels were 
depleted in the GAL10-TTI2 strain by growing in medium containing glucose and β-
galactosidase activity was compared to that of the DED1-TTI2 containing strain. The 
STRE promoter was activated by growth in medium containing 6% ethanol. The PHO5 
promoter was activated by growth in phosphate-depleted medium, and the heat shock 
element by growth at 42º. Activity of the PGK promoter was analyzed under steady state 
conditions and used as a negative control. As shown in Figure 2-5, expression decreased 
approximately three-fold in the GAL10-TTI2 strain for each promoter except PGK, 
suggesting that Tti2 is required for transcription at Tra1-regulated promoters.  
 
 
 
  
60 
 
 
Figure 2-5. Low levels of Tti2 affect expression of Tra1-regulated promoters. 
Yeast strains CY6070 (DED1-TTI2) and CY6973 (GAL10-TTI2) were transformed with 
either a PHO5-lacZ fusion, the stress response element (STRE)-regulated lacZ fusion, the 
heat shock element (HSE)-regulated lacZ fusion, or PGK-lacZ on a LEU2 centromeric 
plasmid. For the PHO5 promoter, strains were grown to stationary phase in raffinose 
medium depleted of leucine, cells were washed three times with water before being 
diluted 1:20 in YPD medium depleted of phosphate and grown for 8 hours. Cell densities 
were normalized and β-galactosidase activity determined. The β-galactosidase units are 
the average of three replicates, with the standard deviation shown by error bars. Average 
enzyme units are compared as the percentage of GAL10-TTI2 to the DED1-TTI2 strain. 
Strains containing STRE-lacZ fusions were grown to stationary phase in raffinose 
medium depleted of leucine, diluted 1:20 in YPD media containing 6% ethanol and 
grown for 16 hours. HSE-lacZ expression was analysed in strains grown to stationary 
phase in raffinose medium depleted of leucine, diluted 1:20 in YPD media, grown for 8 
hours then heat shocked at 42º for 30 minutes. PGK-lacZ was analyzed after growing 
cells to stationary phase in raffinose medium depleted of leucine, diluting 1:20 in YPD 
and growing for 8 hours. 
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To directly test if reduced levels of Tti2 alter the expression of PIKK proteins, we 
examined the levels of Flag5-Tra1, Mec1 and Tor1 in cells containing GAL10-TTI2, 
comparing to a strain expressing TTI2 from the DED1 promoter. Tra1 expression was 
similar for cells grown in galactose (Figure 2-6a, lanes 7 and 8), but reduced 
approximately eight-fold for cells grown in glucose (for example compare lanes 3 and 6 
in Figure 2-6a). Mec1 expression (Figure 2-6b) was similarly reduced in the GAL10-TTI2 
strain when cells were grown in glucose (densitometry indicated an 8.9-fold change). 
Tor1 expression was affected to a somewhat lesser extent compared to Tra1 and Mec1 
after depleting Tti2, having an approximate 2.5-fold decrease in levels (Figure 2-6c).  
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Figure 2-6. Expression of Tra1, Mec1, and Tor1 are reduced when Tti2 is depleted. 
A. Yeast strains CY5919 (Flag5-TRA1 TTI2; lanes 1, 2, 3, and 7), CY6999 (Flag5-TRA1 
tti2::Tn10luk GAL10-TTI2; lanes 4, 5, 6, and 8) and BY4742 (wild type no tag; lane 9) 
were grown to stationary phase in media containing glucose or galactose (indicated above 
each blot), diluted 1:20 and grown for 8 hours before extracting protein by bead lysis. 
The indicated amount of protein (in micrograms) was separated by SDS-PAGE.  Anti-
Flag (M2) antibody was used to Western blot the top portion of each gel and the bottom 
was stained with Coomassie Brilliant Blue (CBB). B. Protein lysates from strains 
CY6194 (Flag5-MEC1 TTI2; lanes 1, 2, 3, and 7), CY7030 (Flag5-MEC1 tti2::Tn10luk 
GAL10-TTI2; lanes 4, 5, 6, and 8), and BY4742 (wild type no tag; lane 9) were prepared 
and Western blotted as described in (A).  C. Protein lysates from strains CY6415 (Flag5-
TOR1/TOR1 TTI2/TTI2; lanes 1, 2, 3 and 7), CY7035 (Flag5-TOR1/TOR1 tti2::Tn10luk/ 
tti2::Tn10luk GAL10-TTI2; lanes 4, 5, 6, and 8), and BY4742 (wild type no tag; lane 9) 
were prepared and Western blotted as described in (A). 
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2.3.5 Mislocalization of Tra1 and Mec1 in the absence of Tti2 
Tra1 and Mec1 normally localize to the nucleus, however when the stability of each 
protein is compromised by mutations or truncations at the C-terminus, mislocalization to 
the cytoplasm occurs (11,16). Since the absence of Tti2 may affect the stability or folding 
of PIKKs, we determined if depleting Tti2 levels causes mislocalization of Tra1 and 
Mec1. We integrated an eGFP tag at the N-terminus of Tra1 and Mec1 into a wild type 
strain and in a strain expressing TTI2 from the GAL10 promoter. Upon depleting Tti2 
levels, both Tra1 and Mec1 mislocalized to foci outside the nucleus. eGFP signal was 
also dispersed throughout the cytoplasm (Figure 2-7). When grown in minimal medium 
containing glucose, 38% of the fluorescent signal was localized to the nucleus in the 
eGFP-Tra1 strain expressing abundant Tti2, whereas 18% was nuclear when depleting 
Tti2. For eGFP-Mec1, 26% of the signal intensity was detected in the nucleus in wild 
type cells compared to 14% when Tti2 levels were depleted. These results indicate that 
low levels of Tti2 cause mislocalization of Tra1 and Mec1 into foci and other areas 
throughout the cytoplasm.  
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Figure 2-7. Localization of Tra1 and Mec1 upon depleting Tti2. 
Strains CY5998 (eGFP-TRA1 WT-TTI2), CY7193 (eGFP-TRA1 GAL10-TTI2), CY6306 
(eGFP-MEC1 WT-TTI2), and CY7189 (eGFP-MEC1 GAL10-TTI2) were grown to 
stationary phase in synthetic complete medium containing raffinose, diluted 1:20 in 
synthetic complete medium containing glucose and grown to mid-logarithmic phase and 
stained with Hoechst stain. Cells were harvested and washed twice in sterile water then 
imaged using fluorescence microscopy. 
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We then examined if the cytoplasmic foci of eGFP-Mec1 seen upon depleting 
Tti2 resulted from the formation of Mec1 aggregates within the cell. To detect protein 
aggregation, we performed Semi-Denaturing Detergent-Agarose Gel Electrophoresis 
(SDD-AGE), comparing the migration of Flag-tagged Mec1 from strains having either 
wild type or depleted levels of Tti2. The same molecular weight product for Flag-Mec1 
was detected for both strains indicating no change in protein aggregation (Figure S 2-4). 
A protein product of a Huntingtin's disease allele was used as a positive control for 
aggregation under the same semi-denaturing conditions. 
2.3.6 Overexpressing Hsp90 chaperones and co-chaperones is 
lethal when Tti2 is depleted 
Tti2, along with Tel2 and Tti1, share interactions with Hsp90 and inhibiting Hsp90 
prevents the association of Tel2 with PIKK proteins (8). We tested if Hsp90 
overexpression could rescue slow growth caused by Tti2 depletion, possibly through an 
increase in the recruitment of Tti2 to PIKK peptides. We expressed Hsp90 chaperones 
Hsp82 and Hsc82, and co-chaperones Cdc37 and Aha1, from multicopy plasmids in tti2 
disruption strains containing either DED1-TTI2 or GAL10-TTI2. Interestingly, when Tti2 
was depleted by growing the GAL10-TTI2 cells in glucose-containing medium, 
overexpression of each chaperone or co-chaperone resulted in synthetic lethality (Figure 
2-8). This effect depended on depleting Tti2 levels as the GAL10-TTI2 strains were viable 
on galactose-containing plates (Figure 2-8). Together with the results from Takai et al. 
(8), these findings suggest that altered stoichiometry of protein interactions between 
Hsp90 chaperones, Hsp90 co-chaperones, and TTT complex members is detrimental to 
the cell, possibly through an effect on PIKK assembly.  
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Figure 2-8. Overexpression of Hsp90 chaperones and co-chaperones results in 
synthetic lethality in strains depleted for Tti2. 
Yeast strains CY7245 (DED1-TTI2), CY7249 (GAL10-TTI2), CY7370 (DED1-TTI2 
GPD-CDC37), CY7371 (DED1-TTI2 GPD-HSP82), CY7372 (DED1-TTI2 GPD-AHA1), 
CY7373 (DED1-TTI2 GPD-HSC82), CY7374 (GAL10-TTI2 GPD-CDC37), CY7375 
(GAL10-TTI2 GPD-HSP82), CY7376 (GAL10-TTI2 GPD-AHA1), CY7377 (GAL10-TTI2 
GPD-HSC82) were grown to stationary phase in minimal medium containing 2% 
raffinose and lacking leucine. Cell densities were normalized then cells spotted in ten-
fold serial dilutions onto both YPD and YP-galactose plates and grown at 30º for two 
days.  
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2.3.7 Tti2 is required for stress responses 
Considering Tti2's proposed role as a co-chaperone, and that depleted or mutant Tti2 
strains grow slowly at 37º, we hypothesized that Tti2 plays a role in responding to protein 
stress and managing misfolded proteins. To test this, we examined if exon 1 of the human 
Huntingtin gene containing a 103 residue polyQ (polyglutamine) sequence caused 
synthetic slow growth when expressed in the Tti2L187P-containing strain. The 103 residue 
polyQ sequence caused slow growth in both wild-type TTI2 and tti2-L187P strains when 
expressed from the GAL10 promoter on a two micron (Figure 2-9a) or centromeric 
plasmid (Figure S 2-5), whereas a 25 residue polyQ sequence did not. Growth was more 
severely compromised in the tti2L187P background, suggesting a role for Tti2 in 
responding to protein stress. To determine whether reduced Tti2 function induces a heat 
shock response, we analyzed the expression of the heat inducible Hsp42 (25) in strains 
containing DED1-TTI2 or GAL10-TTI2 when grown at 30º in glucose containing 
medium. Steady state levels of Hsp42 were increased 3.8 fold when Tti2 was depleted 
(Figure 2-9b; average signal intensity was calculated using lanes 1, 3, and 5 for DED1-
TTI2, and lanes 2, 4, and 6 for GAL10-TTI2). However, as shown in Figure 2-9c Tti2 is 
not heat inducible, with the expression of endogenous Tti2 slightly decreased after 
shifting yeast strain CY7086 (WT-TTI2-MYC9) from 30º to 42º for 30 minutes, conditions 
in which Hsp42 was induced (Figure 2-9d). These results suggest that Tti2 does not play 
a general role in the heat shock response, however depleting Tti2 results in protein stress. 
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Figure 2-9. Tti2 is required for stress response. 
A. Yeast strains CY7245 (DED1-TTI2 YCplac33), CY7236 (DED1-TTI2 GAL1-htt25Q), 
CY7237 (DED1-tti2L187P GAL1-htt25Q), CY7238 (DED1-TTI2 GAL1-htt103Q), CY7239 
(DED1- tti2L187P GAL1-htt103Q), and CY7241 (DED1- tti2L187P YCplac33) were grown 
to stationary phase in minimal medium containing 2% galactose and lacking uracil. Cell 
densities were normalized then cells were spotted in 10-fold serial dilutions onto a YP 
plate containing galactose and grown at 32°C for two days. B. CY6070, C6973, and a 
Δhsp42 strain were grown to stationary phase in YP medium containing raffinose, diluted 
1:20 in YPD, grown for eight hours at 30º then harvested. Protein was extracted by bead 
lysis and 10 µg of protein loaded for each sample. Western blotting was performed with 
anti-Hsp42 antibody. Lane 7 was left blank to avoid overflow into the Δhsp42 lane and 
the bottom of the gel was stained with CBB for a loading control. C. Yeast strain 
CY7086 (WT-TTI2) and BY4742 (no tag control) were grown to stationary phase in 
YPD, diluted 1:20, grown for eight hours then heat shocked at 42º for 30 minutes.  
Protein extraction and Western blotting were done as described in (B), except with anti-
Myc antibodies. The bottom of the gel was stained with Coomassie Brilliant Blue (CBB) 
and shown for a loading control.  D. The same CY7086 cell lysate from (C) was 
separated a second time by SDS-PAGE. Protein lysates were then Western blotted with 
anti-Hsp42 antibody. Protein extract from a Δhsp42 strain (Cashikar et al. 2005) was used 
as a negative control. 
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As Hsp42 levels increase in the Tti2-depleted strain, we examined whether its 
overexpression, or overexpression of Hsp26 or Hsp104, could suppress slow growth and 
stress sensitivity caused by low levels of Tti2. Each of these heat shock proteins has been 
characterized for their role as molecular chaperones that bind unfolded or misfolded 
proteins, preventing or disrupting aggregation and mediating protein reactivation (25,29-
31). Hsp26, Hsp42, and Hsp104 were expressed from multicopy plasmids in tti2 
disruption strains containing either DED1-TTI2 or GAL10-TTI2. Their overexpression did 
not result in the synthetic slow growth observed with overexpression of the Hsp90 
chaperones and co-chaperones, but also did not suppress slow growth caused by 
depleting Tti2 on any of the conditions tested (Calcofluor white, hydroxyurea, ethanol, 
and growth at 37º) (Figure S 2-6).  
 
 
 
 
  
 
 
 
 
 
 
 
 
  
70 
2.4 Discussion 
Tti2 was initially characterized through its interaction with Tel2 and Tti1 in mammalian 
cells and S. pombe (8,10,32). The studies in mammalian cells identified a role for Tel2 in 
the cellular level of PIKK proteins. The association of Tel2 with nascent PIKK peptides, 
and interactions of Tti2, Tel2 and Tti1 with chaperones and co-chaperones including, 
Hsp70, Hsp90, Hsp40, and R2TP subunits (8,10), suggested they were involved in the 
biosynthesis of members of the PIKK protein family. In S. cerevisiae mutation of tel2 
results in shortened telomeres (33), a telomere position effect (34) and defects in DNA 
repair (35). This is likely due to reduced levels of Tel1 (35), an effect also observed with 
mutation of tti2 (36). The effect of individual S. cerevisiae TTT proteins on cellular 
phenotypes and on the PIKK family members has not been well characterized. This is 
likely in part because gene knockouts are inviable and the limited availability of 
conditional alleles.  
 Our screen for alleles of tti2 that resulted in growth defects identified two alleles, 
tti2L187P and tti2Q276TAA. We have found that with more extensive mutagenesis, additional 
alleles can be obtained with multiple mutations.  The protein is predicted to be rich in 
alpha helices, and L187 is found within a predicted helix. The proline mutation may 
destabilize this helix leading to partial loss of function. We have also analyzed numerous 
N and C-terminal truncations of Tti2 and find that only short truncations at the C-
terminus are viable. We were therefore initially surprised to see that the tti2Q276TAA allele 
supported viability. Although we do not see full-length protein by Western blotting some 
read through is likely because ochre mutations are read through by tRNAGln (37,38). Such 
read through is enhanced if the context of the stop codon is not optimal (39). This has 
been observed previously for nonsense mutations (40), and for native stop codons and 
may be a regulated event (41).        
 The GAL10-expressed TTI2 allele confirmed that low level expression of Tti2 is 
sufficient for viability. Further characterization revealed that the reduced expression leads 
to slow growth in many stress conditions. Many of these phenotypes are shared with 
mutations of PIKK encoding genes (e.g. sensitivity to rapamycin, Calcofluor white, 
ethanol, hydroxyurea, and caffeine; see Table 2-2 for a list of the phenotypes examined). 
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In addition, the expression of Tra1-regulated genes decreases upon Tti2 depletion. This 
further suggests that Tra1 is affected by depleting Tti2 as we have found hypomorphic 
alleles of TRA1 have these same characteristics (20). Indeed, the protein levels of 
epitope-tagged versions of Tra1, Mec1 and Tor1 were reduced in response to Tti2 
depletion, with Tra1 and Mec1 steady state levels being decreased approximately 8-fold. 
Together with the result of Stirling et al. (36) that Tel1 is reduced in a conditional tti2 
strain, our findings suggest that Tti2 is required for the expression of all of the PIKK 
proteins. The ability of Tti2 to influence the PIKK proteins places it at a strategic position 
to regulate cell function. The PIKK proteins are themselves regulators of gene 
expression, chromosomal stability, DNA damage response and protein metabolism. 
Factors that influence Tti2 will thus have a profound effect on cell survival. 
 
Table 2-2. Growth phenotypes of the GAL10-TTI2 strain (CY6971) under stress 
conditions. 
Condition Galactose Raffinose Glucose 
6% ethanol ++ ++ + 
8 µg/ml Calcofluor white ++ + +/- 
0.1 M hydroxyurea ++ +/- +/- 
37°C ++ +/- +/- 
1 M NaCl ++ + + 
1 nM rapamycin ++ ++ +/- 
10 mM caffeine ++ + + 
(++) wild type growth, (+) slow growth, (+/-) severe slow growth 
 
Our results support a role for Tti2 in protein biosynthesis, though perhaps more 
complex than acting exclusively in protein folding. As expected for a co-chaperone, Tra1, 
Mec1 and to a lesser extent Tor1 levels are diminished upon Tti2 depletion. Nuclear 
localization of Tra1 and Mec1 is reduced and cytoplasmic foci apparent; potentially 
suggesting that Tti2 has a role in protein trafficking. The nature of the Mec1 and Tra1 
foci is unclear but they do not appear to result from aggregation. Consistent with Tti2 
being required for proteostasis, its depletion induces expression of Hsp42, and the stress 
sensitive tti2L187P allele causes synthetic slow growth with overexpression of the 
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Huntingtin gene PolyQ repeat sequences.  
The TTT complex is associated functionally with Hsp90 and its co-chaperones. 
Takai et al. (8) demonstrated that the maturation of PIKK complexes is disrupted by 
depleting Tel2 or by inhibiting Hsp90. Furthermore, Tel2 links the R2TP/prefoldin like 
complex with Hsp90 and the PIKKs (8,10,42). Tti2 shares Hsp90 and R2TP interactions 
with Tel2, and the binding of Tel2 with Tti1-Tti2 is important for PIKK levels (8,9,36). 
These findings suggest that the toxicity we observe when Hsp90 or its co-chaperones are 
overexpressed in strains depleted for Tti2, is due to a role for Tti2 with Tel2 and Tti1 in 
mediating the association of PIKK proteins with Hsp90 and R2TP/prefoldin. We favor 
the idea that the toxicity is caused by Hsp90 or the co-chaperones sequestering the low 
level of Tti2 into nonproductive complexes, though we cannot exclude that Tti2 normally 
functions to negatively inhibit what are detrimental effects of the Hsp90 chaperones.  
The finding that cells can survive in exceedingly low levels of Tti2 does suggest 
however that Tti2 may have a specialized role. This agrees with the limited number of 
Tti2 client proteins identified to date (only the PIKK proteins), the finding that Tti2 is not 
a heat shock protein, its relatively low cellular abundance (estimated to be up to 100-fold 
less than most of the heat shock proteins with the exception of Hsp42; Ghaemmaghami et 
al. (43); refer to Table 2-3), and that overexpressing Hsp26, Hsp42 or Hsp104 fails to 
compensate for Tti2 depletion.  
The nature of tti2 alleles that suppress slow growth due to mutations in Tra1’s 
FATC domain also suggests that the role for Tti2 in Tra1 biosynthesis is more complex. 
The C-terminal FATC domain of the PIKK proteins is integral to the kinase domain (44). 
Substitution of the terminal phenylalanine of Tra1 to alanine reduces both the level of the 
protein and its nuclear localization, particularly under stress. We described two alleles of 
tti2 that almost completely reverse this effect (11). The suppressing alleles are partially 
dominant, but since we have subsequently found numerous other suppressing alleles, 
many with multiple mutations, we believe that suppression is due to a loss of Tti2 
function. If as predicted, partial loss of a Tti2 function restores the stability and 
localization of defective Tra1 derivatives, Tti2 would seem to have a role outside of 
  
73 
protein folding. In this regard, the relationship between Tti2, Tel2, and Tti1 needs further 
investigation. Interestingly, our random selections for suppressors of tra1F3744A have 
identified numerous alleles of tti2, but not alleles of tel2 or tti1. 
Table 2-3. Relative cellular abundance of TTT members to other heat shock 
proteins and the R2TP components (43). 
Protein Molecules/Cell 
Tel2 638 
Tti1 721 
Tti2 1470 
Ssa1 (Hsp70) 269000 
Hsp82 445000 
Hsc82 132000 
Hsp104 32800 
Hsp26 19300 
Hsp42 1470 
Tah1 1660 
Pih1 2610 
Rvb1 11600 
Rvb2 3030 
 
The possibility that the PIKK proteins are the only known clients of the TTT 
complex has implications with regard to the function of the TTT complex. It also may 
further define the significance of the PIKK proteins, which may warrant their exclusive 
regulation by the TTT complex. What targets the PIKK proteins for regulation by Tti2 is 
unclear? Our earlier study highlighted a genetic interaction between the C-terminal 
FATC domain of Tra1 and Tti2 (11). The FATC domain is shared amongst the PIKK 
proteins, but is not likely to be solely responsible because suppression is not allele 
specific, and similar mutations in mec1 are not suppressed (11). To further address if 
there are additional clients of the TTT complex, we have analyzed two-dimensional gels 
before and after Tti2 depletion. Of the ~500 proteins visible, we could detect none with a 
change in expression comparable to the Tra1 and Mec1.  
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2.6 Supporting Information 
2.6.1 Tables 
Table S 2-1. Yeast strains used in this study. 
Strain Genotype 
Plasmid (plasmid-promoter-
gene) 
Reference 
BY4741 
MATa his3∆0 leu2∆0 
∆met15 ura3∆0 
 (14) 
BY4742 
MATα his3∆0 leu2∆0 
lys2∆0 ura3∆0 
 (14) 
BY4743 
MATa/α his3∆1/his3∆1 
leu2∆0/leu2∆0 LYS2/lys2∆0 
met15∆0/MET15 
ura3∆0/ura3∆0 
 (14) 
CY1217 
MATa his3∆0 leu2∆0 
∆met15 ura3∆0 
∆ire1::kanMX 
 (45) 
CY5857 mec2-1  (28) 
CY5919 
MATa his3∆0 leu2∆0 
ura3∆0 URA3-Flag5-TRA1 
 (11) 
CY5998 
Isogenic to BY4742 except 
URA3-eGFP-TRA1 
 (11) 
CY6032 
Isogenic to BY4743 except 
tti2∆-met5∆::Tn10luk 
 This work 
CY6049 
MATa his3∆0 leu2∆0  
met5∆0 ura3∆0  tti2∆-
met5∆::Tn10luk 
YCplac111-DED1-TTI2 This work 
CY6070 
MATa his3∆0 leu2∆0  
met5∆0 ura3∆0  tti2∆-
met5∆::Tn10luk 
YCplac33-DED1-TTI2 This work 
CY6194 
MATa his3∆0 leu2∆0 
ura3∆0 URA3-Flag5-MEC1 
 (16) 
CY6306 
MATa ura3∆0 his3∆0 
leu2∆0 URA3-eGFP-MEC1 
 (16) 
CY6415 
Isogenic to BY4743 except 
TOR1/URA3-Flag5-TOR1 
 This work 
CY6857 Isogenic to CY6070 YCplac111-DED1-TTI2 This work 
CY6872 Isogenic to CY6070 YCplac111-DED1-tti2L187P This work 
CY6874 Isogenic to CY6070 YCplac111-DED1-tti2Q276TAA This work 
CY6963 
MATα his3∆0 leu2∆0 
ura3∆0 tti2Δ-
YCplac33-DED1-TTI2 This work 
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met5Δ::Tn10luk 
CY6971 Isogenic to CY6070 YCplac111-GAL10-TTI2 This work 
CY6973 Isogenic to CY6070 
YCplac111-GAL10-TTI2-
leu2Δ0::URA3 
This work 
CY6991 Isogenic to CY6070 YEplac181-GAL10-TTI2 This work 
CY6999 
Isogenic to CY6971 except 
URA3-Flag5-TRA1 
YCplac111-GAL10-TTI2 This work 
CY7000 
Diploid of CY6971 and 
CY6963 
YCplac111-GAL10-TTI2 This work 
CY7030 
Isogenic to CY6971 except 
URA3-Flag5-MEC1 
YCplac111-GAL10-TTI2 This work 
CY7035 
Diploid of CY6963 x 
CY6965 with TOR1/URA3-
Flag5-TOR1 
YCplac111-GAL10-TTI2 This work 
CY7086 
Isogenic to BY4742 except 
TTI2-Myc9-HIS3 
 This work 
CY7172 Isogenic to CY6971 YCplac33-TTI2-TTI2 This work 
CY7189 
Isogenic to CY6971 except 
URA3-eGFP-MEC1 
YCplac111-GAL10-TTI2 This work 
CY7193 
Isogenic to CY6971 except 
URA3-eGFP-TRA1 
YCplac111-GAL10-TTI2 This work 
CY7236 Isogenic to CY6857 2µ URA3 GAL1-FLAG-htt25Q This work 
CY7237 Isogenic to CY6857 2µ URA3 GAL1-FLAG-htt25Q This work 
CY7238 Isogenic to CY6872 2µ URA3 GAL1-FLAG-htt103Q This work 
CY7239 Isogenic to CY6872 2µ URA3 GAL1-FLAG-htt103Q This work 
CY7241 Isogenic to CY6872 YCplac33 This work 
CY7245 Isogenic to CY6857 YCplac33 This work 
CY7247 Isogenic to CY6857 2µ URA3 GPD-HSP26 This work 
CY7248 Isogenic to CY6857 2µ URA3 GPD-HSP104 This work 
CY7249 Isogenic to CY6971 YCplac33 This work 
CY7251 Isogenic to CY6971 2µ URA3 GPD-HSP26 This work 
CY7252 Isogenic to CY6971 2µ URA3 GPD-HSP104 This work 
CY7323 Isogenic to CY6857 2µ URA3 HSP42-HSP42 This work 
CY7324 Isogenic to CY6971 2µ URA3 HSP42-HSP42 This work 
CY7370 Isogenic to CY6070 2µ LEU2 GPD-CDC37 This work 
CY7371 Isogenic to CY6070 2µ LEU2 GPD-HSP82 This work 
CY7372 Isogenic to CY6070 2µ LEU2 GPD-AHA1 This work 
CY7373 Isogenic to CY6070 2µ LEU2 GPD-HSC82 This work 
CY7374 Isogenic to CY6973 2µ LEU2 GPD-CDC37 This work 
CY7375 Isogenic to CY6973 2µ LEU2 GPD-HSP82 This work 
CY7376 Isogenic to CY6973 2µ LEU2 GPD-AHA1 This work 
CY7377 Isogenic to CY6973 2µ LEU2 GPD-HSC82 This work 
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Table S 2-2. Oligonucleotides used in this study. 
Name Sequence (5'-3') Description 
2764-1 AACTGCAGTAATACGCTTAACTGCTC GAL10 
promoter 
2764-2 CCCAAGCTTGACGTTAAAGTATAGAGGT GAL10 
promoter 
4213-1 GGCCGACTACAAGGACGACGATGACAAGGC Flag tag 
4213-2 GGCCGCCTTGTCATCGTCGTCCTTGTAGTC Flag tag 
5693-1 ATAAGAATGCGGCCGCAATGACGGCCGTAACTG
ATATC 
 
TTI2 
5693-2 ATACGAGCTCTGCATTTGTCTGTGTCTGTGT TTI2 
6085-1 CCTGTCACCATATGACGCGG TTI2 
6085-2 CAGGATCCACTACCTGCTCGATGTTCC TTI2 
6085-3 GGGGATCCGGAAACGATAAGCTGGTTGC TTI2 
6085-4 GGTTGGTCGACGGGATTCTTCAGCATAAAGGG TTI2 
6496-1 ACATGCATGCTACTAAAGCCTCATTTCCAA TOR1 
6496-2 CCCAAGCTTAAACAATCCCGCTGTTGT TOR1 
6496-3 ATAAGAATGCGGCCGCTATGGAACCGCATGAGG
AGC 
TOR1 
6496-4 ACGCGTCGACAATTCATGTTCCAAGGA TOR1 
TD0569 GCCAAGCTTATATTTTGTTATATGATTTTATTCTT
CACC 
TTI2 
promoter 
TD0570 TGGTAAAGCTTCACATACTTATAACTTGATGC TTI2 
promoter 
MD11 GGGGACAAGTTTGTACAAAAAAGCAGGCTATGG
CCATTGATTACTCTAAGTGG 
CDC37 
MD12 GGGGACCACTTTGTACAAGAAAGCTGGGTCTAG
TCAACAGTGTCGGCAGTATG 
CDC37 
MD13 GGGGACAAGTTTGTACAAAAAAGCAGGCTATGG
CTAGTGAAACTTTTGAATTTC 
HSP82 
MD14 GGGGACCACTTTGTACAAGAAAGCTGGGTCTAA
TCTACCTCTTCCATTTCGGT 
HSP82 
MD15 GGGGACAAGTTTGTACAAAAAAGCAGGCTATGG
TCGTGAATAACCCAAATAAC 
AHA1 
MD16 GGGGACCACTTTGTACAAGAAAGCTGGGTTTAT
AATACGGCACCAAAGCC 
AHA1 
MD17 GGGGACAAGTTTGTACAAAAAAGCAGGCTATGG
CTGGTGAAACTTTTGAA 
HSC82 
MD18 GGGGACCACTTTGTACAAGAAAGCTGGGTTTAA
TCAACTTCTTCCATCTCGG 
HSC82 
TK7578 AAGGAAAAAAGCGGCCGCTTCCAAATTTTTAAT
ATTTAGCTGGG 
HSP42 
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2.6.2 Figures 
 
 
Figure S 2-1. Sequence of oligonucleotide to integrate C-terminal TTI2 Myc9-tag. 
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Figure S 2-2. GAL10-TTI2 expression in galactose and raffinose containing media. 
A. GAL10-TTI2 expression in galactose-containing medium. Yeast strain CY6070 (lanes 
1, 2, and 3), CY6971 (lanes 5, 6, and 7), and BY4742 (no tag control; lane 4) were grown 
to stationary phase in galactose-containing YP, diluted 1:20 in fresh medium and grown 
for 8 hours before harvesting. Protein was extracted with glass beads and the indicated 
amounts separated by SDS-PAGE and Western blotted with anti-Myc antibody to detect 
tagged Tti2. Lane numbers are listed between the blot and the bottom of the gel, which 
was stained with Coomassie Brilliant Blue for a loading control (CBB). B. GAL10-TTI2 
in raffinose medium. Strains CY6070, CY6971 and BY4742 were prepared for Western 
blotting as in (A), with the exception that galactose was substituted by raffinose. 
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Figure S 2-3. Relative levels of constitutive and depleted Tti2 expression.  
A. CY6070, CY6971 (CEN GAL10-TTI2), and CY6991 (2µ GAL10-TTI2) were grown to 
stationary phase in YPD medium, cell densities were normalized, then spotted in 10-fold 
serial dilutions onto a YPD plate and grown for three days at 30º. B. Yeast strains 
CY6070 (lanes 1, 2, and 3), CY6991 (lanes 4-9), and BY4742 (no tag control; lane 10) 
were grown to stationary phase in YP media containing the indicated carbon source, 
diluted 1:20 in the same media, then grown for 8 hours.  Cells were lysed using glass 
beads and protein extracts separated by SDS-PAGE. Western blotting was then 
performed using an anti-Myc antibody. The bottom of the gel was stained with 
Coomassie Brilliant Blue and shown as a loading control. 
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Figure S 2-4. Depleting Tti2 does not result in aggregation of Mec1.  
Yeast strain CY6194, CY7030, and BY4742 were grown in raffinose containing medium 
then diluted 1:20 in YPD and grown for 8 hours. Protein was extracted by bead lysis and 
the indicated amounts separated on a 1.8% agarose gel containing 0.1% SDS. Protein was 
transferred onto a PVDF membrane by capillary transfer and Western blotted using an 
anti-Flag antibody (left). A W303 yeast strain expressing human huntinton exon I variant 
containing a 72 residue polyQ region was used as a positive control (described in 
Duennwald et al. 2006). The membrane was stained with Ponceau S prior to Western 
blotting and shown for a loading control (right). 
 
  
85 
 
 
Figure S 2-5. Synthetic slow growth due to exon 1 of the human Huntingtin gene 
containing a 103 residue polyQ sequence. 
The wild-type (CY6857) and tti2L187P (CY6872) strains were transformed with YCplac33 
or CEN-GAL1-htt103Q, and grown to stationary phase in minimal medium containing 
2% glucose and lacking uracil. Cell densities were normalized then cells spotted in 10-
fold serial dilutions onto a YP plate containing 2% galactose and grown at 30°C for two 
days. 
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Figure S 2-6. Overexpression of HSP26, HSP42, or HSP104 does not compensate for 
depleting Tti2. 
Strains CY7245 (DED1-TTI2 YCplac33), CY7249 (GAL10-TTI2 YCp33), CY7247 
(DED1-TTI2 2µ-GPD-HSP26), CY7251 (GAL10-TTI2 2µ-GPD-HSP26), CY7248 
(DED1-TTI2 2µ-GPD-HSP104), CY7252 (GAL10-TTI2 2µ-GPD-HSP104), CY7323 
(DED1-TTI2 2µ-HSP42-HSP42), and CY7324 (GAL10-TTI2 2µ-HSP42-HSP42) were 
grown to stationary phase in medium lacking uracil and containing raffinose. Cell 
densities were normalized and then 10-fold serial dilutions spotted onto YPD plates 
grown at either 30º or 37º, and onto YPD plates containing 6% ethanol, 8 µg/ml 
Calcofluor white, or 100 mM hydroxyurea. 
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Chapter 3 
3 Genetic selection for mistranslation rescues a defective 
co-chaperone in yeast 
3.1 Introduction 
Protein synthesis is a high fidelity process that ensures accurate production of the 
proteome as specified by the sequence of codons in protein coding genes. Overall error 
rates for translation indicate one in every ~5000 amino acids are mis-incorporated (1). 
Faithful interpretation of the genetic code requires that aminoacyl-tRNA synthetases 
(aaRSs) specifically recognize and ligate their cognate tRNAs with the appropriate amino 
acid (2). Accurate recognition is determined by specific nucleotides in the tRNA called 
identity elements that allow the aaRSs to discriminate between tRNA species (3,4). 
Altering identity nucleotides can cause loss of amino acid charging, reduced substrate 
affinity, or a decrease in turnover (5-8). Certain changes or modifications to identity 
nucleotides switch tRNA identity, causing mis-aminoacylation of a tRNA by a non-
cognate aaRS (9,10). Ten of the aaRSs have editing activities that prevent the formation 
of mis-aminoacylated tRNA species (11). While cells also have quality control 
mechanisms to cope with increased rates of mistranslation and protein mis-folding (12-
14), defects in the editing activity of aaRSs can result in cancer and neurodegeneration 
(15,16), and lead to a cardiac disease phenotype in mouse models (17).  
In an apparent contradiction, cells are able to tolerate large amounts of amino acid 
mis-incorporation with respect to the standard codon assignments (18). It is estimated 
that Escherichia coli tolerates a proteome with 10% of proteins made incorrectly by 
activating a compensatory heat shock response to eliminate mis-folded proteins (13). 
Under certain conditions tRNA mis-aminoacylation and the resulting mistranslation is an 
adaptive response (13,19-22). Despite the loss in translational fidelity, altering tRNA 
identity can allow cells to survive otherwise lethal mutations. Such mutant tRNAs are 
known to suppress missense, frameshift, and nonsense mutations (23-25).  
We identified a novel missense suppressor tRNAPro and elucidated a mechanism 
that induces yeast cells to mistranslate Pro codons. We selected suppressor mutations for 
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a stress-sensitive Leu (CTA) to Pro (CCA) substitution at residue 187 in the 
Saccharomyces cerevisiae co-chaperone Tti2.  Tti2 is involved in the folding and 
regulation of phosphatidylinositol 3-kinase related kinases (PIKKs) (26-29). The 
defective tti2 allele results in loss of function and an inability to grow under stress 
conditions. We demonstrate that Pro to Ala mistranslation in vivo restores wild-type like 
growth in the tti2L187P-containing suppressor strains, and that yeast cells tolerate this 
proline to alanine mis-incorporation. As suppression can also be engineered with 
tRNAProAGG, we have identified a general mechanism to direct proteome-wide missense 
Ala mutations at all Pro codons. 
3.2 Material and Methods 
3.2.1 Yeast strains and growth conditions 
Yeast strains were grown in Yeast Peptone media containing 2% glucose (YPD) or 
synthetic media supplemented with nitrogenous bases and amino acids as required. For 
spot plate assays, strains were grown to stationary phase, normalized to cell density, then 
spotted in 10-fold serial dilutions onto YPD plates or YPD plates containing 6% ethanol 
or 6 µM tunicamycin. Cells were grown at 30ºC unless otherwise indicated. For growth 
curves, strains were grown to stationary phase in selective media diluted 1:100 in YPD 
media and grown at 30ºC. Optical density measurements were taken every hour and 
average growth rates and doubling times were calculated using three biological replicates 
per strain.  
All strains used (Table S 3-1) were derived from either BY4741, BY4742, or 
BY4743 (30). The tti2 disruption strains CY6070 and CY6857 have been described (31). 
YCplac111-DED1-tti2Q276TAA and YCplac111-DED1-tti2L50P were transformed into 
CY6070, and YCplac33-DED1-TTI2 was lost by plating on 5-fluoroorotic acid to 
generate CY6874 and CY6944, respectively. CY6070 was crossed with BY4742, giving 
rise to the diploid strain CY6945. Haploid spore colonies of CY6945 were genotyped to 
identify MATa and MATα strains CY6963 and CY6965, respectively. YCplac111-DED1-
tti2L187P was transformed into CY6963 and YCplac33-DED1-TTI2 lost by plating on 5-
fluoroorotic acid to generate CY7020. YCplac111-DED1-tti2L187A was plasmid shuffled 
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into CY6963 to give CY7369. CY7093, CY7105, CY7106, and CY7108 were selected as 
spontaneous suppressors of the slow growth of CY7020 and contain tP(UGG)N1G3:U70, 
tP(UGG)N2G3:U70, SUF8G3:U70, and SUF9G3:U70, respectively. CY7222 was obtained after 
mating CY7108 with CY6965 and selecting a Leu+ ethanol resistant spore colony. To 
generate CY7243, YCplac33-DED1-TTI2 was transformed into CY7222 and the tti2L187P 
allele lost by repeated growth on media containing leucine. This strain was crossed to 
CY7093. The resulting diploid strain was sporulated and Ura+ strains CY7286 
containing SUF9G3:U70 and tP(UGG)N1G3:U70, CY7287 containing SUF9 and 
tP(UGG)N1, and CY7288 containing SUF9G3:U70 and tP(UGG)N1 were identified. 
CY7093 was transformed with YCplac33-DED1-TTI2 and YCplac111-DED1-TTI2L187P 
lost by repeated growth on media containing leucine to generate CY7355.  
Yeast strain CY7416 was purchased from GE Healthcare (described in (32)). The 
Sik1-RFP strain used for fluorescence microscopy was provided by Martin Duennwald 
and has been described (33). Yeast strains CY2423, CY7450, and CY1217 contain 
deletions of rpn4, atg8, and ire1, respectively. Each strain is derived from a spore colony 
of the yeast magic marker strain in the BY4743 diploid background (34).  
3.2.2 Plasmid constructs 
SUF9 (pCB2957) and SUF9G3:U70 (pCB2948) including 500bp of upstream sequence 
were amplified by PCR using primers TH4224 and TH4225 (Table S 3-2) and wild-type 
or CY7108 genomic DNA, respectively. SUF9 alleles were cloned as a HindIII fragment 
into YCplac33 and YCplac111. 
SUF2 was amplified by PCR using genomic DNA as template with primers 
UA9497 and UA9498, then ligated into YCplac33 as a BamHI/EcoRI fragment 
(pCB3015). To introduce the suppressor mutation into the 3'-end acceptor stem, 
YCplac33-SUF2 was used as template in a PCR with primers UA9498 and UB0181. This 
product was cloned as a SmaI/SalI fragment into YCplac33-SUF2 (pCB3028).  
A two-step PCR was used to remove the SUF9 intron and introduce the intron 
into SUF2. SUF9 was amplified using primer TH4224 with UF4196 and TH4225 with 
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UF4197. The PCR products were the template in a second round of PCR with primers 
TH4224 and TH4225. Primers UA9497 with UF4199 and UA9498 with UF4198 were 
used to amplify SUF2 in the first step, and primers UA9497 and UA9498 in the second 
step. SUF9 was cloned into YCplac33 as a HindIII fragment, SUF2 as a BamHI/EcoRI 
fragment.  
TTI2 (pCB2595) and tti2L187P (pCB2599) expressed from the DED1 promoter and 
containing TAP and Flag tags (35) were cloned in the URA3 two micron plasmid 
YCplac195 as NotI/SacI fragments. The tti2L187P  allele has been described (31). tti2L50P 
was isolated in an identical screen. tti2L187A was created by a two-step primer extension 
PCR. Using primers 5693-1 with TK7291, and 5693-2 with TK7290 in the first step and 
primers 5693-1 and 5693-2 in the second step. This product was cloned as a NotI/SacI 
fragment into YCplac111 (pCB3020).  
Yeast AlaRS gene (ALA1) was amplified by PCR with primers TI5697 and 
TI5698. The PCR product was digested with NcoI/EcoRI and EcoRI/SacI, and triple 
ligated into NcoI/SacI cut pPROEX
TM HTa (Invitrogen; pCB2975). 
eGFPD129P (CCA) was generated by QuikChange (Agilent) using eGFP expressed 
from the DED1 promoter on a URA3 centromeric plasmid (36) as template and 
oligonucleotides UD2159 and UD2160. SPT7 was subsequently cloned into this vector 
NotI/EcoRI from YCp88-myc9-SPT7 (35) giving eGFPD129P-SPT7 (pCB3057). Primers 
UF4570 and UF4571 were similarly used to create eGFPD129A-SPT7. 
      Centromeric URA3-containing plasmid expressing htt103Q from the GAL1 
promoter (described in (37)), as well as the URA3-containing plasmid expressing HSE-
eGFP, were kindly provided by Martin Duennwald. 
3.2.3 Selection of suppressor mutations of tti2L187P 
CY7020 was grown to stationary phase in YPD medium and approximately 106 cells 
from independent cultures plated onto each of ten YPD plates containing 6% ethanol. 
Colonies with restored growth were confirmed after growth under non-selective 
conditions. Suppressor strains where Western blotting indicated an increase in Tti2 
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expression or where plasmid shuffling indicated that the suppressor mutation was 
plasmid borne were eliminated. Four of ten colonies were taken for further 
characterization.  
3.2.4 Preparation of genomic DNA 
Yeast strains were grown in 25 ml YPD medium to stationary phase, harvested, washed 
in 10 ml of sterile water, and suspended in 5 ml of water containing 100 µl of β-
mercaptoethanol. After 15 minutes cells were harvested and cell pellets incubated at 37ºC 
for 1 hour in 5 ml of 1 M sorbitol, 100 mM sodium citrate (pH 5.8), 10 mM EDTA, and 1 
mg of lyticase. Cells were harvested and suspended in 1.2 ml of 150 mM NaCl, 100 mM 
EDTA, and 0.1% SDS. A half volume of buffered phenol was added and mixed gently 
for 30 minutes before adding a half volume of chloroform. The aqueous phase was 
collected and the extraction repeated. Nucleic acids were precipitated with two volumes 
of ethanol and incubating at -20ºC for 15 minutes. Precipitated nucleic acids were 
pelleted, washed with 80% ethanol, and suspended in 500 µl of Tris-EDTA buffer. 
RNase was added to 20 µg/ml and incubated at 37ºC for 1 hour. Nucleic acids were 
purified using phenol:chloroform:isoamyl alcohol (25:24:1), followed by 
chloroform:isoamyl alcohol (24:1) extraction and precipitated with 2.5 volumes of 95% 
ethanol. Genomic DNA was washed in 75% ethanol, air dried, then resuspended in 50 µl 
of H2O.  
3.2.5 Genomic sequencing and analysis 
Samples were processed at the London Regional Genomics Centre (http://www.lrgc.ca) 
using the Illumina MiSeq (Illumina, Inc.). High molecular weight DNA was quantified 
using the Qubit DNA HS reagent (Life Technologies) and 1 ng from each sample 
processed as per the Nextera XT DNA Library Preparation Guide (Illumina, PN: 
15031942 Rev. E). Briefly, samples were tagmented, amplified (via PCR with indexed 
primers to permit sample pooling), cleaned-up and equimolar pooled into one library. The 
pooled library was analyzed on an Agilent High Sensitivity DNA Bioanalyzer chip 
(Caliper Life Sciences) to assess size distribution. The quantity of the library was 
assessed via qPCR (Kapa Biosystems, Inc.). The library was sequenced on an Illumina 
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MiSeq using 2 x 150 paired end run. Approximately 18 million reads (150 bp paired end) 
that mapped to the S288c genome were obtained. Data analysis was performed using 
CLCbio Genomics Workbench, v8.1. Paired end reads (150 bp) were mapped to the 
Saccharomyces cerevisiae S288c reference genome using the local alignment tool and 
duplicate reads removed. The fixed ploidy variant detection tool was used with a ploidy 
of one, required variant probability of 90%, a minimum coverage of 10 reads, and a 
minimum read quality score of 20. All variants that were detected in the control strain, 
CY7020, were removed from the analysis of each suppressor strain using the compare 
sample variants tool. 
3.2.6 Preparation of tRNAs 
Oligonucleotides encoding a T7 promoter and yeast tRNA genes (SUF9-1 and SUF9-2 
for tRNAProUGG, SUF9G3:U70-1 and SUF9G3:U70-2 for tRNA
Pro
UGG (G3:U70), and 
tA(AGC)D-1 and tA(AGC)D-2 for tRNAAlaAGC) were obtained from Sigma-Aldrich. 
Complementary oligonucleotides for each tRNA gene were phosphorylated with 
polynucleotide kinase (Roche Inc) at 37ºC for 1 hour and hybridized in T4 DNA ligase 
buffer (New England Biolabs) by boiling for 5 minutes at 95ºC then gradual cooling to 
room temperature over 2 hours. Hybridized products were ligated into pTZ19r and 
verified by sequencing.  
Each tRNA gene was amplified in a 50 µl PCR reaction, using primers UA9593 
with UA9594 for SUF9, UA9595 with UA9596 for tA(AGC)D, and UA9597 with 
UA9598 for SUF9G3:U70 (Table S 3-2). PCR products were gel purified then used as 
template for in vitro transcription. Transcription reactions were carried out in 40 mM 
Hepes/KOH pH 8.0, 22 mM MgCl2, 5 mM dithiothreitol, 1 mM spermidine, 4 mM of 
each NTP, 30 nM T7 RNA polymerase and 10 µg of template DNA at 37ºC for 3 hours. 
RNA transcripts were isolated on a 12% polyacrylamide gel, extracted in 3 M sodium 
acetate and precipitated in an equal volume of isopropanol at -80ºC. tRNAs were folded 
by heating to 95ºC for 5 minutes, then gradually cooling to room temperature. MgCl2 (10 
mM) was added at 65ºC. For 3'-end labelling, 2 µg of folded tRNA was incubated at 37ºC 
for 1 hour with CCA adding enzyme and [α-32P] ATP (PerkinElmer) as described in (38). 
Labelled tRNAs were purified using BioSpin30 columns (Bio-Rad Laboratories, Inc.).  
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3.2.7 Protein purification 
Yeast strains expressing YEplac195-TAP-Flag-tti2L187P (URA3-containing two-micron 
plasmid) and either SUF9 or SUF9G3:U70 expressed from a LEU2 centromeric plasmid 
(YCplac111) were grown to stationary phase in minimal medium lacking uracil and 
leucine, diluted 1:1000 in YPD medium and grown to an OD600nm = 2.5. Cells were 
harvested and protein extracted by grinding cells in liquid nitrogen. Lysate was cleared 
by ultracentrifugation at 110000 x g for 1 hour. TAP-tagged Tti2 was purified using the 
two-step tandem affinity purification protocol as described in (39). 
Yeast strain Y258 over-expressing yeast Protein A-tagged ProRS (BG1805-
YHR020W, GE Healthcare) was grown for 48 hours in minimal media lacking uracil and 
containing 3% ethanol, 3% glycerol, and 0.05% glucose. Cells were diluted 1:25 into the 
same medium and grown for another 48 hours. 25 mL of cells were diluted into 500 mL 
of YP medium containing 2% galactose. At OD600nm = 3.0, cells were harvested by 
centrifugation. Cell pellets were lysed by grinding in liquid nitrogen. ProRS was purified 
by binding to IgG resin (Sigma-Aldrich) in buffer containing 10 mM Tris-HCl pH 8.0 
and 150 mM NaCl for 2 hours. The resin with bound protein was washed three times with 
4 ml of binding buffer and purified protein was cleaved from the resin with Protease 3C 
(a kind gift from Elton Zeqiraj in Dr. Frank Sicheri’s lab) in buffer containing 50 mM 
Tris-HCl (pH 7.0), 150 mM NaCl, 1 mM EDTA, and 1 mM dithiothreitol. This was 
dialyzed into the same buffer with 40% glycerol and stored at -20ºC. 
E. coli expressing pPROEX HTa-ALA1 was grown to stationary phase in 2 ml of 
LB medium containing 25 µg/ml chloramphenicol and 100 µg/ml ampicillin. Cells were 
diluted 1:1000 into 500 ml of the same LB medium and grown to an OD600nm = 0.6. 
Isopropyl β-D-1-thiogalactopyranoside was added to 1 mM and cells induced overnight 
at room temperature. Harvested cells were lysed in 25 mM Hepes pH 7.5, 100 mM NaCl, 
1 mM EDTA, and 0.5 mg/ml lysozyme. Histidine-tagged AlaRS was purified using 
TALON® resin (Clontech Laboratories, Inc.) as described by the manufacturer, and 
eluted with 100 mM imidazole. Purified protein was dialyzed overnight into 50 mM 
Hepes (pH 7.5), 300 mM NaCl, 40% glycerol and stored at -20ºC.   
  
94 
3.2.8 Aminoacylation assay 
Aminoacylation reactions were performed, as described in (40), with 3 µM tRNA, 300 
nM 32P-labelled tRNA, 10 mM amino acid, 5 mM ATP (pH 7.0), and either 1 µM ProRS, 
100 nM AlaRS, or 500 pM AlaRS. Two microlitres of each reaction was spotted onto 
polyethyleneimine-cellulose thin layer chromatography plates (EMD Millipore) and 
developed in 5% acetic acid and 100 mM ammonium acetate. TLC plates were exposed 
to phosphor screens and imaged using a Storm 860 Phosphorimager (GE Healthcare Life 
Sciences). Densitometry analysis of the image was done using ImageJ 1.49i. Enzyme 
activities were calculated across three technical replicates.  
3.2.9 Fluorescence microscopy and GFP reporter assay 
Yeast strains were grown to stationary phase in selectable media, diluted 1:20, and grown 
for 5 hours before harvesting. Cells were imaged using a Nikon eclipse Ti confocal 
microscope coupled with a Nikon DS-Qi1Mc camera head and using differential 
interface contrast (DIC), GFP, and RFP filters. Exposure time and gain settings were left 
constant across all GFP and RFP images. Cell measurements were taken using Image J 
1.50i with the following protocol. The DIC, GFP, and RFP images for each field of view 
were merged by selecting Image-> Color -> Merge Channels and assigning each image to 
a different channel. RFP-Sik1 was used to identify the nucleus which was circled with the 
oval selection tool for each cell. The intensity of the GFP signal was calculated using the 
measure tool. Background intensity was calculated from an open area adjacent to the cell. 
Integrated density values were divided by the area of the oval selection and the 
background integrated density values subtracted from each cell measurement. An average 
and median value of integrated density per unit area was calculated across 150 cells per 
strain. R version 3.2.0 along with ggplot2 (41) was used to generate the box plot. 
      For the HSE-eGFP reporter assay, yeast strain BY4742 containing HSE-eGFP 
and SUF9 or HSE-eGFP and SUF9G3:U70 were grown to stationary phase in medium 
lacking leucine and uracil, diluted 1:100 in the same medium, and grown for six hours at 
30ºC. BY4742 containing HSE-eGFP was heat shocked at 42ºC for one hour and used to 
determine the heat shock induced eGFP signal intensity. All cell densities were 
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normalized by optical density at 600 nm prior to measuring fluorescence. Fluorescence 
was measured with a BioTek Synergy H1 microplate reader at an emission wavelength of 
528nm using Gen5 2.08 software. A BY4742 strain lacking HSE-eGFP, and containing 
either SUF9 or SUF9G3:U70, was used to subtract background fluorescence from each 
respective experimental strain. The average signal intensity was calculated across three 
technical and three biological replicates for each strain.  
3.2.10 Mass spectrometry 
Sample preparation was performed at the Functional Proteomics Facility (University of 
Western Ontario, http://www.uwo.ca/biochem/fpf/). TAP-Tti2 was tandem affinity 
purified from BY4742 expressing either SUF9 or SUF9G3:U70. Tti2 was picked from a 
10% polyacrylamide gel stained with Coomassie Brilliant Blue using the Ettan™ Spot 
Picker robotic system. Gel pieces were destained in 50 mM ammonium bicarbonate and 
50% acetonitrile, reduced in 10 mM dithiothreitol (DTT), alkylated using 55 mM 
iodoacetamide (IAA), and digested with trypsin (prepared in 50 mM ammonium 
bicarbonate, pH 8). The Waters MassPREP Station (PerkinElmer) was used for in-gel 
digestion. Peptides were extracted in 1% formic acid and 2% acetonitrile, then 
lyophilized.  
      Nano liquid chromatography-coupled tandem mass spectrometry (nano LC–
MS/MS) analysis of the digested protein was performed with approximately 250 ng of 
peptides on column. The peptide mixture was separated by C18 reverse-phase 
chromatography on an ACQUITY MClass Peptide BEH column (length, 25 cm; inner 
diameter (i.d.), 75 μm; particle size, 1.7 μm, Waters Inc.) using a trapping column 
(ACQUITY MClass Trap, Symmetry C18, length, 2 cm; i.d., 180 μm; particle size, 5 μm, 
Waters Inc.) and a mobile phase gradient from 5 to 40% (v/v) ACN, 0.1% (v/v) FA in 90 
min with a flow rate of 300 nL/min on an MClass UHPLC (nano) chromatography 
system (Waters Inc.). Peptides were ionized utilizing a nanospray Flex ion source 
(Thermo Fisher Scientific) into an Orbitrap Elite Velos Pro mass spectrometer (Thermo 
Fisher Scientific) via fused silica emitter tip. FT and IT injection waveforms were 
enabled, 1 microscan was acquired for all scan types. FT master scan preview was 
enabled, as was charge state screening; singly charged ions were rejected in DDA 
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analysis. The mass spectrometer was calibrated internally with the m/z of 445.120024. 
Peptide ions were fragmented using Collision Induced Dissociation (CID). The overall 
acquisition was an FT/IT/CID Top 15, DDA targeted scheme using dynamic exclusion in 
positive ion mode. The targeted ions were the +2 and +3 charged states of the peptide of 
interest, GVLLAQTLLNHTFmNETNDSK, where m is oxidized Methionine and A 
represents the substituted amino acid. 
      Data files (raw format, Thermo Scientific) were searched against the Uniprot, 
Yeast database (6729 sequences), with the Peaks algorithm (v.7.5, Bioinformatics 
Solutions Inc.) using the Spider node for homology search (single point mutation). For 
database search, the enzyme was set to trypsin, tolerating three missed cleavages and one 
non-specific cleavage end. The parent mass tolerance was set to 20 ppm, and the MS/MS 
fragment mass tolerance, to 0.8 Da. Cysteine carbamidomethylation was set as a fixed 
modification, and oxidation of methionine and deamidation of Asparagine/Glutamine 
were tolerated as a variable modification. Global false discovery rate (FDR) was set to 
1% with minimum 1 unique peptides required for protein identification. All acquired 
mass spectra are available upon request.  
3.2.11 Western blotting 
Yeast strains were grown to mid-logarithmic phase then lysed with glass beads. Western 
blotting was performed with anti-GFP antibodies (Sigma) kindly provided by Patrick 
Lajoie (University of Western Ontario), and anti-Myc antibodies (Sigma), and used as 
previously described (31). 
3.3 Results 
3.3.1 Identifying second site suppressor mutations for tti2L187P 
Tti2 is an Hsp90 co-chaperone required for the folding and stability of PIKK family 
proteins including Tra1, Mec1, Tel1, and Tor1 (27-29). We identified tti2L187P and 
tti2Q276TAA (31), and subsequently tti2L50P in random screens for alleles of TTI2 that cause 
stress sensitive growth. As our goal was to identify specific functions of Tti2 and its 
interactions, we undertook a genetic approach selecting for second-site suppressors of the 
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slow growth caused by the tti2L187P allele. CY7020 (tti2L187P) was grown to stationary 
phase and approximately 106 cells plated without mutagenesis onto each of ten YPD 
plates containing 6% ethanol. Spontaneous suppressor strains were colony purified then 
examined for expression of Tti2L187P by Western blotting. Strains with a near wild-type 
level of expression of Tti2L187P were further characterized. Suppression was observed in 
each of four independent strains, CY7093, CY7105, CY7106 and CY7108 (Figure 3-1a), 
where 2:2 segregation indicated that single mutations were responsible (not shown). 
Whole genome sequencing was performed to reveal potential causative mutations in each 
strain, comparing to the parent CY7020. Interestingly, all of the strains had a cytosine to 
thymine point mutation at nucleotide 100 in different tRNAProUGG (proline tRNA 
molecule with UGG anticodon) genes (Table 3-1).  
 
Table 3-1. Suppressor tRNAPro mutations identified by next generation sequencing. 
tRNA gene 
names 
(anticodon in 
subscript) 
Chromosome: 
Position of 
Mutation 
Mutation 
Type 
Reference 
Nucleotide 
Variant 
Nucleotide 
Reads 
with 
Variant 
Total 
Number 
of Reads 
tP(UGG)N1UGG XIV:547193 SNV C T 24 24 
tP(UGG)N2UGG XIV:568214 SNV C T 68 69 
SUF8UGG VIII:388896 SNV C T 43 43 
SUF9UGG VI:101475 SNV C T 67 67 
 
The CY7108 strain containing SUF9G3:U70 and tti2L187P was characterized in 
further detail. To verify that the SUF9G3:U70 mutation was responsible for suppression, its 
linkage with the suppressor phenotype was analyzed.  CY7108 was mated with the tti2-
disrupted strain CY6965, which contains TTI2 on a Ura3+ centromeric plasmid. The 
diploid was sporulated to allow independent assortment. The resulting spore colonies 
were plated on 5-FOA to eliminate the wild-type copy of TTI2 and select for strains 
containing tti2L187P. Each spore colony was then examined for growth on medium 
containing ethanol to determine if there was suppression or a stress sensitive phenotype. 
We sequenced the SUF9 allele of 10 spore colonies, including four without and six with 
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the suppressor phenotype. In each case, SUF9G3:U70 was linked to suppression whereas 
slow growth was associated with the wild-type SUF9 allele, thus indicating that 
SUF9G3:U70 was responsible for suppression. 
      We then introduced SUF9 or SUF9G3:U70 from a centromeric plasmid into the 
tti2L187P strain (CY7020) to determine if the mutant allele was sufficient for suppression. 
The plasmid expressing SUF9G3:U70 suppressed slow growth of the tti2L187P strain on an 
ethanol stress plate (Figure 3-1b). The SUF9G3:U70 allele did not suppress tti2Q276TAA or 
tti2L50P (CUC to CCC), indicating that suppression is allele specific and thus SUF9G3:U70 
acts directly by mistranslating P187 (Figure 3-1c). These results suggest that the G3:U70 
mutation in tRNAProUGG is directly responsible for the suppression of tti2L187P in each of 
the four sequenced suppressor strains. 
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Figure 3-1. Suppression of tti2L187P by tRNAProUGG (G3:U70) alleles. 
A) Yeast strains CY7020 (tti2L187P), CY7093 (tti2L187P tP(UGG)N1G3:U70), CY7105 
(tti2L187P tP(UGG)N2G3:U70), CY7106 (tti2L187P SUF8G3:U70), CY7108 (tti2L187P 
SUF9G3:U70) were grown to stationary phase in YPD media. Cell densities were 
normalized then spotted in 10-fold serial dilutions onto YPD plates and grown at either 
30°C or 37°C and onto a YPD plate containing 6% ethanol and grown at 30°C. B) Strain 
CY6963 containing YCplac33-DED1-TTI2 (TTI2), and CY7020 (tti2L187P) containing 
either YCplac33 (-), YCplac33-SUF9 (G3:C70), or YCplac33-SUF9G3:U70 (G3:U70) were 
grown to stationary phase in medium lacking uracil, then spotted in 10-fold serial 
dilutions onto a YPD plate and a YPD plate containing 6% ethanol and grown at 30°C. 
C) Strains CY7020 (tti2L187P), CY6944 (tti2L50P), and CY6874 (tti2Q276TAA), each 
containing either YCplac33-SUF9 (G3:C70) or YCplac33-SUF9G3:U70 (G3:U70), were 
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grown to stationary phase in medium lacking uracil, then spotted in 10-fold serial 
dilutions onto a YPD plate and a YPD plate containing 6% ethanol and grown at 30°C. 
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3.3.2 Suppression is due to alanine substitution for proline during 
translation of tti2L187P 
The suppressor mutation in the tRNAProUGG genes results in a G3:C70 to G3:U70 base 
pair change in the tRNA acceptor stem (Figure 3-2a). The G3:U70 pair is the major 
identity element for alanyl-tRNA synthetase (AlaRS) (42,43). Introducing this base pair 
confers alanine accepting identity to tRNACys and tRNAPhe in E. coli (44). We predicted 
that the G3:U70 base pair in tRNAProUGG (C70U) results in aminoacylation with alanine 
and subsequent mis-incorporation of alanine into Tti2L187P. Consistent with this model an 
allele of TTI2 encoding an Ala in place of the wild-type Leu (tti2L187A) grows at near 
wild-type levels under stress conditions (Figure 3-2b). 
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Figure 3-2. tRNA secondary structures and stress resistance of tti2L187A. 
A) Secondary structures of tRNAProUGG, tRNA
Pro
UGG (G3:U70), and tRNA
Ala
AGC. Each 
anticodon and the suppressor mutation position are in bold font and the discriminator 
base is highlighted in orange. B) Yeast strains CY6857 containing YCplac111-DED1-
TTI2 (TTI2), CY7369 containing YCplac111-DED1-tti2L187A (tti2L187A), and CY7020 
containing YCplac111-DED1-tti2L187P (tti2L187P) were grown to stationary phase in YPD 
medium. Cell densities were normalized before spotting in 10-fold serial dilutions onto 
YPD plates and grown at either 30°C or 37°C and onto a YPD plate containing 6% 
ethanol and grown at 30°C.       
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We performed in vitro aminoacylation assays to determine the amino acid 
accepting activity of tRNAProUGG, tRNA
Pro
UGG (G3:U70), and tRNA
Ala
AGC with purified 
yeast AlaRS and prolyl-tRNA synthetase (ProRS). AlaRS charges both tRNAAlaAGC and 
mutant tRNAProUGG (G3:U70) with alanine (Figure 3-3a and Figure S 3-1a). 
Aminoacylation of tRNAProUGG with alanine by AlaRS was not detected (Figure S 3-1a). 
Ala-tRNAAlaAGC formation proceeds at an initial rate of 144 ±15 pmol/min per pmol of 
AlaRS as compared to 0.6 ± 0.01 pmol/min for Ala-tRNAProUGG (G3:U70), an 
approximate 230-fold decrease in apparent catalytic rate. As expected tRNAProUGG was 
aminoacylated with proline using ProRS (Figure 3-3b and Figure S 3-1b), however, we 
did not detect the formation of Pro-tRNAProUGG (G3:U70) with ProRS (Fig S 3-1b). 
ProRS showed overall less activity compared to AlaRS, with tRNAProUGG being 
aminoacylated at an initial rate of 12 ± 2 fmol/min per pmol of ProRS. Though it is 
difficult to compare reactions using the different enzymes, AlaRS produced Ala-
tRNAProUGG (G3:U70) with a greater than 50-fold increase in specific activity compared 
to cognate Pro-tRNAProUGG production by ProRS. Together the in vitro experiments show 
that mutant tRNAProUGG (G3:U70) is aminoacylated with alanine but not proline. This 
provides a mechanistic basis for CCA mistranslation as Ala and indicates that production 
of the mis-translating Ala-tRNAProUGG (G3:U70) species in the cell is at a level such that 
Ala-tRNAPro competes with Pro-tRNAPro for insertion at CCA codons. 
  
104 
 
Figure 3-3. tRNA aminoacylation assays. 
A) Measurements of alanine aminoacylated tRNAAlaAGC and tRNA
Pro
UGG (G3:U70) by 
AlaRS at 0, 2, 10, 20, and 40-minute time points. Each measurement represents an 
average across three technical replicates and the error bars indicate one standard 
deviation. B) Proline aminoacylation measurements of tRNAProUGG at 0, 2, 10, 20, 40, 
and 80-minute time points. Measurements represent an average across three technical 
replicates with one standard deviation indicated by the error bar. 
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      To test if suppression affected Tti2 L187P expression, we analysed the steady state 
level of Tti2L187P with or without SUF9G3:U70 (Fig S2). Tti2L187P was elevated 1.1-fold in 
CY7108 (SUF9G3:U70) as compared to the CY7020 strain (SUF9). Though slight this 
increase is consistent with an alanine for proline substitution stabilizing the mistranslated 
protein. To confirm if alanine was incorporated into Tti2L187P in vivo, we purified TAP-
tagged Tti2L187P from yeast expressing SUF9G3:U70. The purified proteins were digested 
with trypsin and peptides containing alanine substitutions identified by electrospray mass 
spectrometry. Tti2 peptides were detected containing proline or alanine at residue 187 
(Table 3-2).  A proline to alanine substitution was also detected at Pro245 (CCA codon) 
in Tti2 peptide V242-K252. Interestingly, two alanine substitutions were detected at CCT 
codons at Pro280 and Pro327 (Table 3-2). For each peptide containing amino acid 
substitutions the wild type peptide was also detected, indicating ambiguous decoding for 
each Pro codon. 
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Table 3-2. Alanine substitutions at Pro codons detected by mass spectrometry. 
Mutated 
or wild 
type (wt) 
residue 
Peptide 
Sequenc
e 
Range 
Mis-
translated 
Codon 
Score¶ 
Mass 
(Da) 
# 
Spectrum 
P187A* 
 
L187P 
 
L187P* 
GVLLAQTLLNH
TFM*NETNDSK 
183-203 CCA 35.62 
2361.16
3 
2 
GVLLPQTLLNH
TFMNETNDSK 
183-203 CCA 47.4 
2371.18
4 
7 
GVLLPQTLLNH
TFM*NETNDSK 
183-203 CCA 32.76 
2387.17
9 
3 
P245A 
P245 (wt) 
VVFATIQSLYK 242-252 
CCA 
47.48 
1267.71
8 
7 
VVFPTIQSLYK 242-252 
CCA 
48.06 
1293.73
3 
315 
P280A* 
P280 (wt) 
P280 
(wt)* 
FM*SEIILQNIIA
R 
269-281 
CCT 
25.14 
1562.84
9 
4 
FMSEIILQNIIPR 269-281 CCT 57.35 1572.87 15 
FM*SEIILQNIIP
R 
269-281 
CCT 
60.24 
1588.86
5 
54 
P327A 
P327 (wt) 
NAFYTTFPK 326-334 
CCT 
35.16 
1087.53
4 
7 
NPFYTTFPK 326-334 
CCT 
46.72 
1113.54
9 
45 
* peptides with oxidized methionine resulting in an added mass of 15.99 Daltons.  
¶ score value was calculated as the negative log (10) of the p-value of the matched 
peptide. Peptides were considered significant if the false discovery rate of the peptide-
spectrum match was less than 1% and the peptide score value was >15.5. 
_ underlined amino acids represent the position mistranslated or mutated.  
 
      To estimate the frequency of alanine incorporation at Pro codons by tRNAProUGG 
(G3:U70), we engineered an eGFP reporter protein where mistranslation could be 
visualized. eGFP was constructed with an Asp to Pro mutation at residue 129 
(eGFPD129P), a position where proline, but not alanine, disrupts the beta-barrel structure of 
GFP and eliminates fluorescence. Comparisons were made to a functional eGFPD129A 
molecule. To localize the GFP signal intensity to the nucleus we fused each GFP 
molecule to Spt7 (45). The nucleus was identified with RFP-tagged Sik1 (33). eGFPD129P-
Spt7 or eGFPD129A-Spt7 were expressed in strains containing either SUF9 or SUF9G3:U70. 
Fluorescence of eGFPD129P is significantly enhanced in the presence of SUF9G3:U70 but 
not wild-type SUF9 (Figure 3-4, Figure S 3-3). Calculating the signal across 150 cells 
from each strain, we estimate a ~ four-fold increase (p= 0.008) in the average eGFPD129P  
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Figure 3-4. GFP reporter links fluorescence to mistranslation. 
A yeast strain containing Sik1-RFP strain was transformed with either YCplac111-SUF9 
(SUF9) or YCplac111-SUF9G3:U70 (SUF9G3:U70), and either YCplac33-eGFPD129P-SPT7 
(eGFPD129P) or YCplac33-eGFPD129A-SPT7 (eGFPD129A). Transformants were grown to 
stationary phase in medium lacking uracil and leucine, diluted 1:20 and grown for 5 
hours before harvesting cells for imaging. Exposure time for GFP and RFP images was 1 
second and the gain was kept constant. Contrast was adjusted uniformly across all GFP 
images shown.  
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fluorescence in the SUF9G3:U70 strain compared to the SUF9 strain (Figure S 3-3). To 
approximate the frequency of alanine incorporation, we compared the signals of 
eGFPD129P with eGFPD129A. In the SUF9G3:U70 strain, eGFPD129P signal intensity averaged 
8.9% of the eGFPD129A signal, whereas it was 2.8% in the wild-type SUF9 strain. The 
difference of these percentages suggests that mistranslation of proline CCA codons by 
tRNAProUGG (G3:U70) occurs at a frequency of approximately 6%. Expression of intact 
eGFPD129P-Spt7 was confirmed by Western blot (Figure S4), and consistent to what was 
observed with Tti2L187P, SUF9G3:U70 slightly increased the level of eGFPD129P-Spt7 (1.4-
fold). 
3.3.3 Suppression of tti2L50P by SUF2G3:U70 
In our screen for defective alleles of TTI2 we also identified tti2L50P, which contains a 
non-synonymous mutation that alters a CUC to a CCC Pro codon and results in slow 
growth under stress conditions. SUF2 encodes tRNAProAGG, which decodes the CCC 
codon (46). To examine if the mutant G3:U70 base pair would alter the specificity of a 
second tRNA, we incorporated the appropriate cytosine to thymine point mutation 
(Figure 3-5a) into a plasmid copy of SUF2 and assessed whether it could suppress 
tti2L50P. SUF2G3:U70 suppresses the stress sensitivity caused by tti2L50P in media 
containing 6% ethanol (Figure 3-5b). This result suggests that tRNAProAGG molecules 
containing the G3:U70 pair can also be mischarged, likely with alanine, at an efficiency 
sufficient for suppression of tti2L50P. 
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Figure 3-5. Suppression of tti2L50P by SUF2G3:U70. 
A) Secondary structure of tRNAProAGG showing the suppressor tRNA base pair change 
(G3:U70) and anticodon in bold font and the discriminator base in orange. B) Yeast 
strains CY6963 (TTI2), and CY6944 (tti2L50P) containing either YCplac33 (-), YCplac33-
SUF2 (SUF2), or YCplac33-SUF2G3:U70 (SUF2G3:U70) were grown to stationary phase in 
medium lacking uracil. Cell densities were normalized and cells spotted in 10-fold serial 
dilutions onto a YPD plate or on a YPD plate containing 6% ethanol and grown at 30°C. 
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3.3.4 Impact of introns in tRNAPro (G3:U70) genes on suppression 
of tti2 alleles 
Many of the yeast tRNAs including all of the nuclear encoded tP(UGG) alleles contain 
introns. Having a screen in which plasmid encoded tP(UGG)G3:U70 is required for growth 
provided a mechanism to evaluate the role of the intron in SUF9. We engineered a 
mischarging SUF9 allele lacking the intron (Figure S 3-5). The intronless G3:U70 allele, 
an intron containing G3:U70 allele, and the wild-type SUF9 allele encoded on 
centromeric plasmids were transformed into CY7020 (tti2L187P). The transformed strains 
were then analyzed for growth on plates containing ethanol. The intronless and intron 
containing G3:U70 alleles similarly suppressed tti2L187P (Figure 3-6a). 
      We also performed the inverse experiment, inserting an intron into the otherwise 
intronless SUF2G3:U70 allele (Figure S 3-5). The intron-containing SUF2G3:U70 had a 
slightly reduced ability to suppress slow growth caused by tti2L50P (Figure 3-6b). This 
result suggests that the intron in tP(UGG) genes partially reduces tRNA maturation or 
activity.   
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Figure 3-6. Suppression of tti2 alleles by intron-containing (+) and intronless (-) 
tP(UGG) and tP(AGG) alleles. 
A) CY7020 (tti2L187P) containing either YCplac33-SUF9 (G3:C70), YCplac33-
SUF9G3:U70 (G3:U70), or YCplac33-SUF9G3:U70 (G3:U70) lacking (-) the intron sequence 
(Δ37-67), were grown to stationary phase in medium lacking uracil, cell densities were 
normalized and spotted in ten-fold serial dilutions onto a YPD plate and a YPD plate 
containing 6% ethanol. B) Yeast strain CY6944 (tti2L50P) containing either YCplac33-
SUF2 (G3:C70), YCplac33-SUF2G3:U70 (G3:U70), or YCplac33-SUF2G3:U70 with the 
intron (G3:U70 +) was grown and plated as described above onto a YPD plate and a YPD 
plate containing 6% ethanol. 
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3.3.5 Cellular response to mistranslation 
There are 10 copies of tRNAProUGG annotated in S288c derivatives of S. cerevisiae (47).  
As tRNAProUGG (G3:U70) results in the mis-incorporation of alanine for proline, we 
examined the effect of increasing the copy number of this tRNA on cell growth. Strains 
were constructed that contained SUF9G3:U70 (CY7288), tP(UGG)N1G3:U70 (CY7355), or 
both tP(UGG)N1G3:U70 and SUF9G3:U70 (CY7286) in a background containing wild-type 
TTI2. A single copy of tP(UGG)G3:U70, either tP(UGG)N1G3:U70 or SUF9G3:U70, results in 
minimal change in growth at 30ºC in rich medium or in medium containing 6% ethanol. 
A reduction in growth was observed for cells grown in 6 µM tunicamycin or under heat 
stress at 37ºC (Figure 3-7). The presence of two copies of the mis-translating tRNA 
(tP(UGG)N1G3:U70 and SUF9G3:U70) slightly reduced growth at 30ºC, and exacerbated the 
growth defect in the stress conditions (Figure 3-7). In liquid culture, the doubling time 
during exponential growth increased relative to the wild-type strain by 6 ± 2 % and 15 ± 
3 % in single copy (SUF9G3:U70) and double copy (tP(UGG)N1G3:U70 SUF9G3:U70) strains, 
respectively (growth curves shown in Figure S 3-6). These relatively minor effects on cell 
growth suggest that the cells have compensation mechanisms to cope with some level of 
mis-incorporation of alanine at Pro codons (48,49). 
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Figure 3-7. Growth of suppressor tRNA strains under conditions of stress. 
CY7287 (SUF9 tP(UGG)N1), CY7288 (SUF9G3:U70 tP(UGG)N1), CY7355 (SUF9 
tP(UGG)N1G3:U70), and CY7286 (SUF9G3:U70 tP(UGG)N1G3:U70) were grown to stationary 
phase in YPD medium. After normalizing for cell densities cells were spotted in 10-fold 
serial dilutions onto YPD plates and grown at either 30°C or 37°C, and onto YPD plates 
containing either 6% ethanol or 6 µM tunicamycin and grown at 30°C. 
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We further analyzed the effect of mistranslation on the cellular response to protein 
stress. Normally cells compensate for mistranslation through induction of the heat shock 
response (13), therefore, we compared the fluorescent signal intensity resulting from 
expression of eGFP fused to a heat shock element in strains containing SUF9 or 
SUF9G3:U70. A wild type strain grown at 30°C then shifted to 42°C for one hour shows a 
5.8-fold increase in eGFP signal intensity after heat shock (Figure 3-8a). When 
comparing strains containing SUF9 or SUF9G3:U70 grown at 30°C, we detected a 3.4-fold 
increase in eGFP signal intensity caused by SUF9G3:U70 (Figure 3-8a). This result 
suggests that cells compensate for low levels of mistranslation by partially inducing the 
heat shock response.       
      We investigated synthetic interactions between SUF9G3:U70 and deletions of genes 
involved in autophagy (ATG8), the unfolded protein response (IRE1), or proteasome 
regulation (RPN4). SUF9G3:U70 was expressed from a URA3 centromeric plasmid that was 
transformed into each deletion strain (atg8Δ0, ire1Δ0, rpn4Δ0) and the wild-type yeast 
strain BY4741. Transformants were spotted on agar plates lacking uracil (Figure 3-8b). 
Expression of SUF9G3:U70 in the atg8Δ0 and ire1Δ0 modestly reduced growth, at a level 
similar to the wild-type strain. Synthetic slow growth was observed upon expressing the 
mis-translating tRNA in the rpn4Δ0 strain. This observation suggests a role for the 
proteasome in managing cellular stress caused by mistranslation.  
           We next tested if mistranslation caused by tRNAProUGG (G3:U70) might induce 
protein quality control pathways that could alleviate or exacerbate the growth defects 
associated with a disease-causing allele. The human huntingtin gene contains extensive 
CAG repeats encoding a toxic polyglutamine tract protein that causes an autosomal-
dominant neurodegenerative disorder, known as Huntington’s disease (reviewed in (50)). 
We analyzed the consequence of SUF9G3:U70 expression in yeast cells containing human 
huntingtin exon 1 with a 103 residue polyQ tract (htt103Q). The htt103Q exon was 
expressed from a galactose inducible promoter on a centromeric plasmid. Wild-type 
SUF9 or SUF9G3:U70 was expressed from a centromeric plasmid in these strains. 
Induction of htt103Q in galactose-containing medium reduced cell growth (Figure S 3-7). 
Expression of SUF9G3:U70 did not change the toxicity resulting from expression of 
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htt103Q. The tRNA-induced mistranslation was unable to rescue the growth defect, but 
did not further inhibit growth. The data suggest that mistranslation caused by SUF9G3:U70 
is tolerated in strains containing toxic protein aggregates. 
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Figure 3-8. Effects of mistranslation on the heat shock response and proteostasis. 
A) Yeast strain BY4742 containing HSE-eGFP and SUF9 or HSE-eGFP and SUF9G3:U70 
were grown to stationary phase in medium lacking leucine and uracil, diluted 1:100 and 
grown for six hours at 30°C. Cell densities were normalized and fluorescence was 
measured at an emission wavelength of 528nm. BY4742 containing HSE-eGFP and 
SUF9 was heat shocked for one hour at 42°C, cell densities were normalized to the cell 
densities measured from 30°C growth, and fluorescence was measured at an emission 
wavelength of 528nm. A BY4742 strain lacking HSE-eGFP, and containing either SUF9 
or SUF9G3:U70, was used to subtract background fluorescence from each respective 
experimental strain. All calculations were done using three biological replicates and three 
technical replicates for each strain. Error bars indicate one standard deviation. B) Yeast 
strains BY4741 (-), CY1217 (ire1), CY2423 (rpn4), and CY7450 (atg8) expressing either 
YCplac33-SUF9 (SUF9) or YCplac33-SUF9G3:U70 (SUF9G3:U70) were grown to stationary 
phase in medium lacking uracil. Cell densities were normalized and cells spotted in 10-
fold serial dilutions onto a minimal medium plate lacking uracil and grown at 30°C.  
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3.4 Discussion 
The tti2L187P allele provided an efficient system to select for mistranslation and to identify 
suppressor tRNA mutations. The L187P mutation has a profound effect on cell growth in 
stress conditions (31). The structure of Tti2 is unknown, but L187 is situated in a 
predicted alpha helix, which is likely disrupted by the Pro mutation.  In addition, a low 
level of Tti2 is sufficient to support viability (31). We surmise that the low level of Tti2 
required to support normal growth is related to the ability of the L187P to select for 
mistranslation in yeast. The amount of mistranslation required to restore Tti2 function 
can thus be at a level that is low enough to not compromise viability yet high enough to 
provide a sufficient amount of Tti2 for normal growth under stress conditions. 
3.4.1 A single nucleotide mutation disrupts the genetic code 
The anticipated high fidelity of protein synthesis and the interpretation of the genetic 
code itself can be disrupted by a single nucleotide mutation. Our genetic screen for 
suppressors of tti2L187P identified four alleles of tP(UGG) with a mutation converting 
C70U that restored growth in stress conditions. This point mutation changes a G3:C70 
base pair in the acceptor stem of tRNAProUGG to a G3:U70 wobble base pair. We 
hypothesized that tRNAProUGG (G3:U70) is charged with alanine based on several 
previous findings. Introducing a single G:U pair in the acceptor stem can be the sole 
determinant for charging a tRNA molecule with alanine in Escherichia coli (44,51). 
Missense suppressors containing C70U in tRNALys have been identified in E. coli (24), 
and are likely charged with either glycine or alanine (52). Finally, the introduction of 
G3:U70 into a mini RNA helix derived from tRNATyr permits charging with alanine (53).   
      Crystal structures (54) revealed that AlaRS interacts with the minor and major 
grooves of the acceptor stem of tRNAAla such that the G3:U70 identity element is 
required for orientation of the 3'-CCA into the active site of AlaRS. Similarity in the 
acceptor stems of tRNAAla and tRNAPro (Fig 2A), and the extensive interactions between 
acceptor stem nucleotides and residues of the AlaRS tRNA recognition domain, are 
plausible reasons for why tRNAPro containing the G3:U70 pair acts as an efficient 
substrate for aminoacylation by AlaRS (54). 
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      We have shown that single spontaneous mutations can give rise to tRNA 
molecules with switched identity, mischarging alanine for proline. Similar results in E. 
coli (44) have led to the idea that tRNA identity elements are part of a ‘second genetic 
code’ that is non-degenerate and more deterministic than the classic view of the code 
based on accurate pairing of codon and anti-codon (55). Moreover, genetic diversity 
found in tRNA genes and the discovery of codon reassignments that can be of selective 
advantage is consistent with an evolving genetic code, contrary to Crick's “frozen 
accident” hypothesis (56-60). In Candida albicans, serine is incorporated into 97% of 
Leu CUG codons, suggesting a naturally evolved CUG codon reassignment from Leu to 
Ser (61). Alterations to the standard genetic code are also found in yeast mitochondrial 
organelles, bacteria, archaea, and viruses (62,63). These findings, along with the 
identification of pyrrolysine and selenocysteine as natural expansions of the genetic code, 
suggest that the genetic code continues to evolve (64-66). 
3.4.2 Life with mistranslation 
A priori, ambiguous decoding or mistranslation should be harmful to the cell due to 
effects on proteome stability. We examined cells expressing suppressor tRNAProUGG 
(G3:U70) to determine how mistranslation of Pro codons with alanine affects growth and 
response to protein stress. We found only mild reductions in the growth rates of yeast 
expressing one or two copies of the mistranslating tRNAProUGG (G3:U70) alleles, and a 
partial induction of the heat shock response caused by SUF9G3:U70 expression. These 
results suggest that yeast tolerate a significant amount of proline to alanine mis-
incorporations. This is likely because cells have several ways to reduce the toxicity of 
mis-folded proteins, including the ubiquitin-proteasome system, autophagy, induction of 
the heat shock response and upregulation of molecular chaperones, and organization of 
aggregates into inclusion bodies (67,68). The synthetic slow growth upon expressing 
SUF9G3:U70 in a strain deleted for the proteasome regulator Rpn4 suggests that the 
ubiquitin-proteasome system is compensating for increased mistranslation arising from 
Ala-tRNAProUGG (G3:U70). The lack of a genetic interaction between SUF9G3:U70 and 
ATG8 may indicate that low levels of Pro mistranslation does not cause larger toxic 
aggregates that require autophagosomes for removal. 
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Yeast cells overburdened by tRNASerCAG mistranslation can adapt when grown for 
over 250 generations (69). Adaptation is mediated through large genome rearrangements 
that cause accelerated protein synthesis and protein degradation, and increase glucose 
uptake to meet energy demands (69). As a consequence of such adaptations, the extent of 
toxic protein aggregates within the cells is reduced. Additional studies will be required to 
address whether yeast compensate and adapt to Pro mistranslation by tRNAProUGG 
(G3:U70) over multiple generations. 
     It is difficult to estimate the extent to which Ala-tRNAProUGG (G3:U70) is 
incorporated into proteins, and it is likely that the rate of mis-incorporation may differ at 
different Pro codons or based on mRNA sequence context.  As there are 10 tP(UGG) 
genes in the genome, the mutant tRNA may represent roughly 10% of the tRNAProUGG 
pool. The relative amounts of charging of the mutant tRNA with alanine as compared to 
the wild-type with proline is more difficult to estimate because the reactions involve two 
different aaRSs. Measurements of initial rates actually suggest that tRNAProUGG (G3:U70) 
is charged more efficiently with alanine than wild-type tRNAProUGG with proline. In vivo 
comparisons are further complicated by variations in the amino acid pools and stabilities 
of the products, though the expression of AlaRS and ProRS is similar (70) and editing or 
deacylation of mis-charged Ala-tRNAPro is negligible in S. cerevisiae (62). Evaluation of 
the concentration of the final protein products (e.g., Tti2L187A) in cells is also complicated 
by the potential instability of the Tti2L187P protein.  Considering this, we estimated the 
frequency of Ala-tRNAProUGG incorporation into proteins using a GFP reporter assay 
whereby signal intensity of a eGFPD129P mutant is restored by mistranslation of the CCA 
Pro codon with alanine. We calculated an approximate 6% increase in eGFPD129P signal 
intensity as a result of SUF9G3:U70 expression. This rate of mistranslation agrees with our 
estimate that ~10% of the tRNAProUGG pool is mischarged with alanine. The ratio of Tti2 
peptides containing proline to alanine substitutions from our mass spectrometry data is 
also consistent with a rate of mistranslation between 5-10%.  
     Johansson et al. (49) found that a strain deleted for all of the tRNAProAGG genes is 
viable and does not show slow growth. This led them to hypothesize that tRNAProUGG 
molecules can decode all Pro codons. Our finding that SUF9G3:U70 (tP(UGG)) does not 
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suppress the L50P mutation, a CCC codon, which is suppressed by SUF2G3:U70 
(tP(AGG)), suggests that Ala-tRNAProUGG molecules do not efficiently decode CCC. 
Consistent with this, in a strain expressing SUF9G3:U70 we detected only proline residues 
at both CCC codons in Tti2 by mass spectrometry, while alanine incorporations at two of 
the three CCT codons were identified (Table 2). The tRNAProUGG species in S. cerevisiae 
contains 5-carbamoylmethyluridine (ncm5U) as the only modification at U34 (71). 
Uridine modifications do not have bond angles required for pairing with C in the 
ribosome A site (72), however, it is predicted that unmodified uridine can base pair with 
any nucleoside at the wobble position (72). Therefore, it is possible that uridine in the 
tRNAProUGG anticodon undergoes frequent modification and is unable to decode CCC at 
the level of efficiency required for suppression of tti2L50P. 
3.4.3 Intron splicing in a mistranslating tRNA 
Introns are found in the tRNAs of organisms across all kingdoms of life where they play 
a role in transcriptional regulation, tRNA modification, and prevention of viral genome 
integration (reviewed in (73)). In S. cerevisiae, 61 of the 295 tRNA genes contain introns. 
Removing the intron from SUF9G3:U70 had no effect on suppression of tti2L187P, 
suggesting that the intron does not play an essential role in tP(UGG) function. 
Interestingly, introducing an intron into the tP(AGG) allele SUF2G3:U70 partially reduced 
its ability to suppress. These results are consistent with those of Winey et al. (74) who 
found that removing the intron from a frameshift suppressor allele of SUF8 improved its 
translation efficiency. In the case of both the intronless SUF2 and SUF8, the increased 
activity may be due to increased levels of the tRNA by removing the need of a potentially 
inefficient splicing step (74). In this regard, the intron may play a role in regulating the 
abundance of mature tRNA. 
3.5 Conclusion 
Our study prompts further evaluation of the idea that a ‘frozen’ genetic code is a 
prerequisite for life. Rather we demonstrate that mistranslation can arise via a single 
nucleotide mutation as a route to circumvent lethal mutations in the genome. The tRNAs 
we have identified are relatively efficient at missense suppression and these tRNAs will 
  
121 
continue to be useful tools for genetic analyses and synthetic biology applications (e.g. 
(75)). The spontaneous nature of the selection process and the limited consequences of 
the genetic code change on growth suggest that tRNA alleles resulting in mis-
aminoacylation may become fixed in a population where they confer advantage and may 
be more common than previously assumed. Otherwise deleterious mutations in coding 
regions may become phenotypically neutral due to the cell’s ability to reinterpret the 
meaning of codons leading to ambiguous decoding and mistranslation.  
3.6 Bibliography 
1. Loftfield, R.B. and Vanderjagt, D. (1972) The frequency of errors in protein 
biosynthesis. Biochem J, 128, 1353-1356. 
2. Ibba, M. and Söll, D. (2000) Aminoacyl-tRNA synthesis. Annu Rev Biochem, 69, 
617-650. 
3. Giegé, R., Sissler, M. and Florentz, C. (1998) Universal rules and idiosyncratic 
features in tRNA identity. Nucleic Acids Res, 26, 5017-5035. 
4. Beuning, P.J. and Musier-Forsyth, K. (1999) Transfer RNA recognition by 
aminoacyl-tRNA synthetases. Biopolymers, 52, 1-28. 
5. Park, S.J., Hou, Y.M. and Schimmel, P. (1989) A single base pair affects binding 
and catalytic parameters in the molecular recognition of a transfer RNA. 
Biochemistry, 28, 2740-2746. 
6. Ibba, M., Hong, K.W., Sherman, J.M., Sever, S. and Söll, D. (1996) Interactions 
between tRNA identity nucleotides and their recognition sites in glutaminyl-
tRNA synthetase determine the cognate amino acid affinity of the enzyme. Proc 
Natl Acad Sci U S A, 93, 6953-6958. 
7. Aldinger, C.A., Leisinger, A.K. and Igloi, G.L. (2012) The influence of identity 
elements on the aminoacylation of tRNA(Arg) by plant and Escherichia coli 
arginyl-tRNA synthetases. FEBS J, 279, 3622-3638. 
8. Yuan, J., Gogakos, T., Babina, A.M., Söll, D. and Randau, L. (2011) Change of 
tRNA identity leads to a divergent orthogonal histidyl-tRNA synthetase/tRNAHis 
pair. Nucleic Acids Res, 39, 2286-2293. 
9. Muramatsu, T., Nishikawa, K., Nemoto, F., Kuchino, Y., Nishimura, S., 
Miyazawa, T. and Yokoyama, S. (1988) Codon and Amino-Acid Specificities of a 
Transfer-Rna Are Both Converted by a Single Post-Transcriptional Modification. 
Nature, 336, 179-181. 
  
122 
10. Perret, V., Garcia, A., Grosjean, H., Ebel, J.P., Florentz, C. and Giege, R. (1990) 
Relaxation of a transfer RNA specificity by removal of modified nucleotides. 
Nature, 344, 787-789. 
11. Perona, J.J. and Gruic-Sovulj, I. (2014) Synthetic and editing mechanisms of 
aminoacyl-tRNA synthetases. Top Curr Chem, 344, 1-41. 
12. Reynolds, N.M., Lazazzera, B.A. and Ibba, M. (2010) Cellular mechanisms that 
control mistranslation. Nat Rev Microbiol, 8, 849-856. 
13. Ruan, B., Palioura, S., Sabina, J., Marvin-Guy, L., Kochhar, S., Larossa, R.A. and 
Söll, D. (2008) Quality control despite mistranslation caused by an ambiguous 
genetic code. Proc Natl Acad Sci U S A, 105, 16502-16507. 
14. Liu, Z., Vargas-Rodriguez, O., Goto, Y., Novoa, E.M., Ribas de Pouplana, L., 
Suga, H. and Musier-Forsyth, K. (2015) Homologous trans-editing factors with 
broad tRNA specificity prevent mistranslation caused by serine/threonine 
misactivation. Proc Natl Acad Sci U S A, 112, 6027-6032. 
15. Schimmel, P. (2008) Development of tRNA synthetases and connection to genetic 
code and disease. Protein Sci, 17, 1643-1652. 
16. Lee, J.W., Beebe, K., Nangle, L.A., Jang, J., Longo-Guess, C.M., Cook, S.A., 
Davisson, M.T., Sundberg, J.P., Schimmel, P. and Ackerman, S.L. (2006) 
Editing-defective tRNA synthetase causes protein misfolding and 
neurodegeneration. Nature, 443, 50-55. 
17. Liu, Y., Satz, J.S., Vo, M.N., Nangle, L.A., Schimmel, P. and Ackerman, S.L. 
(2014) Deficiencies in tRNA synthetase editing activity cause 
cardioproteinopathy. Proc Natl Acad Sci U S A, 111, 17570-17575. 
18. Ribas de Pouplana, L., Santos, M.A., Zhu, J.H., Farabaugh, P.J. and Javid, B. 
(2014) Protein mistranslation: friend or foe? Trends Biochem Sci, 39, 355-362. 
19. Pezo, V., Metzgar, D., Hendrickson, T.L., Waas, W.F., Hazebrouck, S., Doring, 
V., Marliere, P., Schimmel, P. and De Crecy-Lagard, V. (2004) Artificially 
ambiguous genetic code confers growth yield advantage. Proc Natl Acad Sci U S 
A, 101, 8593-8597. 
20. Netzer, N., Goodenbour, J.M., David, A., Dittmar, K.A., Jones, R.B., Schneider, 
J.R., Boone, D., Eves, E.M., Rosner, M.R., Gibbs, J.S. et al. (2009) Innate 
immune and chemically triggered oxidative stress modifies translational fidelity. 
Nature, 462, 522-526. 
21. Reynolds, N.M., Ling, J., Roy, H., Banerjee, R., Repasky, S.E., Hamel, P. and 
Ibba, M. (2010) Cell-specific differences in the requirements for translation 
quality control. Proc Natl Acad Sci U S A, 107, 4063-4068. 
  
123 
22. Schwartz, M.H. and Pan, T. (2016) Temperature dependent mistranslation in a 
hyperthermophile adapts proteins to lower temperatures. Nucleic Acids Res, 44, 
294-303. 
23. Qian, Q., Li, J.N., Zhao, H., Hagervall, T.G., Farabaugh, P.J. and Bjork, G.R. 
(1998) A new model for phenotypic suppression of frameshift mutations by 
mutant tRNAs. Mol Cell, 1, 471-482. 
24. Prather, N.E., Murgola, E.J. and Mims, B.H. (1984) Nucleotide substitution in the 
amino acid acceptor stem of lysine transfer RNA causes missense suppression. J 
Mol Biol, 172, 177-184. 
25. Singaravelan, B., Roshini, B.R. and Munavar, M.H. (2010) Evidence that the 
supE44 mutation of Escherichia coli is an amber suppressor allele of glnX and 
that it also suppresses ochre and opal nonsense mutations. J Bacteriol, 192, 6039-
6044. 
26. Hoffmann, K.S., Duennwald, M.L., Karagiannis, J., Genereaux, J., McCarton, 
A.S. and Brandl, C.J. (2016) Saccharomyces cerevisiae Tti2 Regulates PIKK 
Proteins and Stress Response. G3 (Bethesda). 
27. Hurov, K.E., Cotta-Ramusino, C. and Elledge, S.J. (2010) A genetic screen 
identifies the Triple T complex required for DNA damage signaling and ATM and 
ATR stability. Genes Dev, 24, 1939-1950. 
28. Takai, H., Xie, Y., de Lange, T. and Pavletich, N.P. (2010) Tel2 structure and 
function in the Hsp90-dependent maturation of mTOR and ATR complexes. 
Genes Dev, 24, 2019-2030. 
29. Stirling, P.C., Bloom, M.S., Solanki-Patil, T., Smith, S., Sipahimalani, P., Li, Z., 
Kofoed, M., Ben-Aroya, S., Myung, K. and Hieter, P. (2011) The complete 
spectrum of yeast chromosome instability genes identifies candidate CIN cancer 
genes and functional roles for ASTRA complex components. PLoS Genet, 7, 
e1002057. 
30. Winzeler, E.A. and Davis, R.W. (1997) Functional analysis of the yeast genome. 
Curr Opin Genet Dev, 7, 771-776. 
31. Hoffman, K.S., Duennwald, M.L., Karagiannis, J., Genereaux, J., McCarton, A.S. 
and Brandl, C.J. (2016) Saccharomyces cerevisiae Tti2 Regulates PIKK Proteins 
and Stress Response. G3 (Bethesda), 6, 1649-1659. 
32. Gelperin, D.M., White, M.A., Wilkinson, M.L., Kon, Y., Kung, L.A., Wise, K.J., 
Lopez-Hoyo, N., Jiang, L., Piccirillo, S., Yu, H. et al. (2005) Biochemical and 
genetic analysis of the yeast proteome with a movable ORF collection. Genes 
Dev, 19, 2816-2826. 
  
124 
33. Huh, W.K., Falvo, J.V., Gerke, L.C., Carroll, A.S., Howson, R.W., Weissman, 
J.S. and O'Shea, E.K. (2003) Global analysis of protein localization in budding 
yeast. Nature, 425, 686-691. 
34. Tong, A.H., Evangelista, M., Parsons, A.B., Xu, H., Bader, G.D., Page, N., 
Robinson, M., Raghibizadeh, S., Hogue, C.W., Bussey, H. et al. (2001) 
Systematic genetic analysis with ordered arrays of yeast deletion mutants. 
Science, 294, 2364-2368. 
35. Hoke, S.M., Liang, G., Mutiu, A.I., Genereaux, J. and Brandl, C.J. (2007) C-
terminal processing of yeast Spt7 occurs in the absence of functional SAGA 
complex. BMC Biochem, 8, 16. 
36. Hoke, S.M., Guzzo, J., Andrews, B. and Brandl, C.J. (2008) Systematic genetic 
array analysis links the Saccharomyces cerevisiae SAGA/SLIK and NuA4 
component Tra1 to multiple cellular processes. BMC Genet, 9, 46. 
37. Duennwald, M.L., Jagadish, S., Muchowski, P.J. and Lindquist, S. (2006) 
Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl 
Acad Sci U S A, 103, 11045-11050. 
38. Oshikane, H., Sheppard, K., Fukai, S., Nakamura, Y., Ishitani, R., Numata, T., 
Sherrer, R.L., Feng, L., Schmitt, E., Panvert, M. et al. (2006) Structural basis of 
RNA-dependent recruitment of glutamine to the genetic code. Science, 312, 1950-
1954. 
39. Gregan, J., Riedel, C.G., Petronczki, M., Cipak, L., Rumpf, C., Poser, I., 
Buchholz, F., Mechtler, K. and Nasmyth, K. (2007) Tandem affinity purification 
of functional TAP-tagged proteins from human cells. Nat Protoc, 2, 1145-1151. 
40. O'Donoghue, P., Sheppard, K., Nureki, O. and Soll, D. (2011) Rational design of 
an evolutionary precursor of glutaminyl-tRNA synthetase. Proc Natl Acad Sci U S 
A, 108, 20485-20490. 
41. Ginestet, C. (2011) ggplot2: Elegant Graphics for Data Analysis. J R Stat Soc a 
Stat, 174, 245-245. 
42. Imura, N., Weiss, G.B. and Chambers, R.W. (1969) Reconstitution of alanine 
acceptor activity from fragments of yeast tRNA-Ala II. Nature, 222, 1147-1148. 
43. Hou, Y.M. and Schimmel, P. (1989) Evidence that a major determinant for the 
identity of a transfer RNA is conserved in evolution. Biochemistry, 28, 6800-
6804. 
44. Hou, Y.M. and Schimmel, P. (1988) A simple structural feature is a major 
determinant of the identity of a transfer RNA. Nature, 333, 140-145. 
  
125 
45. Gansheroff, L.J., Dollard, C., Tan, P. and Winston, F. (1995) The Saccharomyces 
cerevisiae SPT7 gene encodes a very acidic protein important for transcription in 
vivo. Genetics, 139, 523-536. 
46. Hani, J. and Feldmann, H. (1998) tRNA genes and retroelements in the yeast 
genome. Nucleic Acids Res, 26, 689-696. 
47. Chan, P.P. and Lowe, T.M. (2009) GtRNAdb: a database of transfer RNA genes 
detected in genomic sequence. Nucleic Acids Res, 37, D93-97. 
48. Bonitz, S.G., Berlani, R., Coruzzi, G., Li, M., Macino, G., Nobrega, F.G., 
Nobrega, M.P., Thalenfeld, B.E. and Tzagoloff, A. (1980) Codon recognition 
rules in yeast mitochondria. Proc Natl Acad Sci U S A, 77, 3167-3170. 
49. Johansson, M.J., Esberg, A., Huang, B., Bjork, G.R. and Bystrom, A.S. (2008) 
Eukaryotic wobble uridine modifications promote a functionally redundant 
decoding system. Mol Cell Biol, 28, 3301-3312. 
50. Ross, C.A. and Tabrizi, S.J. (2011) Huntington's disease: from molecular 
pathogenesis to clinical treatment. Lancet Neurol, 10, 83-98. 
51. McClain, W.H. and Foss, K. (1988) Changing the identity of a tRNA by 
introducing a G-U wobble pair near the 3' acceptor end. Science, 240, 793-796. 
52. Murgola, E.J. and Pagel, F.T. (1983) Suppressors of lysine codons may be 
misacylated lysine tRNAs. J Bacteriol, 156, 917-919. 
53. Francklyn, C. and Schimmel, P. (1989) Aminoacylation of RNA minihelices with 
alanine. Nature, 337, 478-481. 
54. Naganuma, M., Sekine, S., Chong, Y.E., Guo, M., Yang, X.L., Gamper, H., Hou, 
Y.M., Schimmel, P. and Yokoyama, S. (2014) The selective tRNA 
aminoacylation mechanism based on a single G*U pair. Nature, 510, 507-511. 
55. de Duve, C. (1988) Transfer RNAs: the second genetic code. Nature, 333, 117-
118. 
56. Crick, F.H. (1968) The origin of the genetic code. J Mol Biol, 38, 367-379. 
57. Santos, M.A.S., Cheesman, C., Costa, V., Moradas-Ferreira, P. and Tuite, M.F. 
(1999) Selective advantages created by codon ambiguity allowed for the evolution 
of an alternative genetic code in Candida spp. Mol Microbiol, 31, 937-947. 
58. Santos, M.A., Moura, G., Massey, S.E. and Tuite, M.F. (2004) Driving change: 
the evolution of alternative genetic codes. Trends Genet, 20, 95-102. 
59. Goodenbour, J.M. and Pan, T. (2006) Diversity of tRNA genes in eukaryotes. 
Nucleic Acids Res, 34, 6137-6146. 
  
126 
60. Parisien, M., Wang, X.Y. and Pan, T. (2013) Diversity of human tRNA genes 
from the 1000-genomes project. Rna Biol, 10, 1853-1867. 
61. Bezerra, A.R., Simoes, J., Lee, W., Rung, J., Weil, T., Gut, I.G., Gut, M., Bayes, 
M., Rizzetto, L., Cavalieri, D. et al. (2013) Reversion of a fungal genetic code 
alteration links proteome instability with genomic and phenotypic diversification. 
Proc Natl Acad Sci U S A, 110, 11079-11084. 
62. Ling, J.Q., O'Donoghue, P. and Soll, D. (2015) Genetic code flexibility in 
microorganisms: novel mechanisms and impact on physiology. Nat Rev 
Microbiol, 13, 707-721. 
63. Ambrogelly, A., Palioura, S. and Soll, D. (2007) Natural expansion of the genetic 
code. Nat Chem Biol, 3, 29-35. 
64. Soll, D. (1988) Genetic-Code - Enter a New Amino-Acid. Nature, 331, 662-663. 
65. Hao, B., Gong, W.M., Ferguson, T.K., James, C.M., Krzycki, J.A. and Chan, 
M.K. (2002) A new UAG-encoded residue in the structure of a methanogen 
methyltransferase. Science, 296, 1462-1466. 
66. Srinivasan, G., James, C.M. and Krzycki, J.A. (2002) Pyrrolysine encoded by 
UAG in Archaea: Charging of a UAG-decoding specialized tRNA. Science, 296, 
1459-1462. 
67. Chen, B., Retzlaff, M., Roos, T. and Frydman, J. (2011) Cellular Strategies of 
Protein Quality Control. Cold Spring Harb Perspect Biol, 3, a004374. 
68. Ciechanover, A. and Kwon, Y.T. (2015) Degradation of misfolded proteins in 
neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med, 47. 
69. Kalapis, D., Bezerra, A.R., Farkas, Z., Horvath, P., Bodi, Z., Daraba, A., 
Szamecz, B., Gut, I., Bayes, M., Santos, M.A. et al. (2015) Evolution of 
Robustness to Protein Mistranslation by Accelerated Protein Turnover. PLoS Biol, 
13, e1002291. 
70. Kulak, N.A., Pichler, G., Paron, I., Nagaraj, N. and Mann, M. (2014) Minimal, 
encapsulated proteomic-sample processing applied to copy-number estimation in 
eukaryotic cells. Nat Methods, 11, 319-324. 
71. Keith, G., Desgres, J., Pochart, P., Heyman, T., Kuo, K.C. and Gehrke, C.W. 
(1990) Eukaryotic tRNAs(Pro): primary structure of the anticodon loop; presence 
of 5-carbamoylmethyluridine or inosine as the first nucleoside of the anticodon. 
Biochim Biophys Acta, 1049, 255-260. 
72. Lim, V.I. (1994) Analysis of Action of Wobble Nucleoside Modifications on 
Codon-Anticodon Pairing within the Ribosome. J Mol Biol, 240, 8-19. 
  
127 
73. Yoshihisa, T. (2014) Handling tRNA introns, archaeal way and eukaryotic way. 
Front Genet, 5, 213. 
74. Winey, M., Mendenhall, M.D., Cummins, C.M., Culbertson, M.R. and Knapp, G. 
(1986) Splicing of a yeast proline tRNA containing a novel suppressor mutation 
in the anticodon stem. J Mol Biol, 192, 49-63. 
75. Brandon, H.E., Friedt, J.R., Glaister, G.D., Kharey, S.K., Smith, D.D., Stinson, 
Z.K. and Wieden, H.J. (2015) Introducing a class of standardized and 
interchangeable parts utilizing programmed ribosomal frameshifts for synthetic 
biology applications. Translation (Austin), 3, e1112458. 
 
3.7  Supporting Information 
3.7.1 Tables 
Table S 3-1. Yeast strains used in this study. 
Strain Relevant Genotype Plasmid Reference 
BY4741 
MATa his3∆1 leu2∆0 ∆met15 
ura3∆0 
 (30) 
BY4742 
MATα his3∆1 leu2∆0 lys2∆0 
ura3∆0 
 (30) 
BY4743 
MATa/α his3∆1/his3∆1 
leu2∆0/leu2∆0 LYS2/lys2∆0 
met15∆0/MET15 ura3∆0/ura3∆0 
 (30) 
CY1217 
MATa his3∆1 leu2∆0 ura3∆0 
ire1Δ0::kanMX 
 (34) 
CY2423 
MATa his3∆1 leu2∆0 ura3∆0 
rpn4∆0::kanMX 
 (34) 
CY6070 
MATa his3∆1 leu2∆0 met5∆0 
ura3∆0 tti2∆-met5∆::Tn10luk 
YCplac33-DED1-TTI2 (26) 
CY6874 Isogenic to CY6070 
YCplac111-DED1- 
tti2Q276TAA 
(26) 
CY6944 Isogenic to CY6070 
YCplac111-DED1- 
tti2L50P 
This study 
CY6945 
MATa/α his3∆1/his3∆1 
leu2∆0/leu2∆0 ura3∆0/ ura3∆0 
TTI2/tti2∆-met5∆-mTn10luk 
YCplac33-DED1-TTI2 This study 
CY6963 MATα his3∆1 leu2∆0 lys2∆0 YCplac33-DED1-TTI2 This study 
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met15∆0 ura3∆0 tti2∆-met5∆-
mTn10luk 
CY6965 
MATa his3∆1 leu2∆0 lys2∆0 
met15∆0 ura3∆0 tti2∆-met5∆-
mTn10luk 
YCplac33-DED1-TTI2 This study 
CY7020 Isogenic to CY6963 
YCplac111-DED1-
tti2L187P 
This study 
CY7093 
Isogenic to CY6963 except 
tP(UGG)N1G3:U70 
YCplac111-DED1-
tti2L187P 
This study 
CY7105 
Isogenic to CY6963 except 
tP(UGG)N2G3:U70 
YCplac111-DED1-
tti2L187P 
This study 
CY7106 
Isogenic to CY6963 except 
SUF8G3:U70 
YCplac111-DED1-
tti2L187P 
This study 
CY7108 
Isogenic to CY6963 except 
SUF9G3:U70 
YCplac111-DED1-
tti2L187P 
This study 
CY7222 
MATa his3∆1 leu2∆0 ura3∆0 
tti2∆-met5∆-mTn10luk 
SUF9G3:U70 
YCplac111-DED1-
tti2L187P 
This study 
CY7243 Isogenic to CY7222 YCplac33-DED1-TTI2 This study 
CY7286 
MATα his3∆1 leu2∆0 ura3∆0 
tti2∆-met5∆-mTn10luk 
tP(UGG)N1G3:U70 SUF9G3:U69 
YCplac33-DED1-TTI2 This study 
CY7287 
MATa his3∆1 leu2∆0 ura3∆0 
tti2∆-met5∆-mTn10luk 
tP(UGG)N1 SUF9 
YCplac33-DED1-TTI2 This study 
CY7288 
MATa his3∆1 leu2∆0 ura3∆0 
tti2∆-met5∆-mTn10luk 
tP(UGG)N1 SUF9G3:U70 
YCplac33-DED1-TTI2 This study 
CY7355 Isogenic to CY7093 YCplac33-DED1-TTI2 This study 
CY7416 
MATa ∆pep4-3 ∆his4-580 ∆ura3-
52 ∆leu2-3 
BG1805-GAL1-
YHR020W 
(32) 
CY7450 
MATa his3∆1 leu2∆0 ura3∆0 
atg8∆0::kanMX 
 (34) 
 
Table S 3-2. Oligonucleotides used in this study. 
Name Sequence Description 
5693-1 ATAAGAATGCGGCCGCAATGACGGCCGTAAC TTI2 
  
129 
TGATATC 
5693-2 ATACGAGCTCTGCATTTGTCTGTGTCTGTGT TTI2 
TH4224 ATGAAGCTTCCGGTAGTCCTGGTGAGCAAAA
G 
SUF9 
TH4225 ATGAAGCTTGGGTCTGCCATGCTCATCCTACT SUF9 
TK7290 GTTCTGCTCGCGCAGACGCTATTAAA tti2L187A 
TK7291 TAGCGTCTGCGCGAGCAGAACA tti2L187A 
UA9497 CGTGAATTCGTCCTTGGTAGCATGGGTCAAG SUF2 
UA9498 CATGGATCCGAAGCGCTTCCTCCAAT SUF2 
UB0181 GGGAGGTCCCGGGTTCGAGTCCCGGCTCGTC
CCACATTGTTT 
SUF2G3:U70 
TI5697 CCACCATGGCGATCGGTGATAAGCAAAAATG
G 
ALA1 
TI5698 CGCGAGCTCTTAAATGGAAAGCTTCTCCTTG ALA1 
SUF9-1 CTAGATAATACGACTCACTATAGGGCGTGTG
GTCTAGTGGTATGATTCTCGCTTTGGGTGCGA
GAGGCCCTGGGTTCAATTCCCAGCTCGCCCC
CCATGCATG 
SUF9 
 
SUF9-2 GATCCATGCATGGGGGGCGAGCTGGGAATTG
AACCCAGGGCCTCTCGCACCCAAAGCGAGAA
TCATACCACTAGACCACACGCCCTATAGTGA
GTCGTATTAT 
SUF9 
 
tA(AGC)D-1 CTAGATAATACGACTCACTATAGGGCGTGTG
GCGTAGTCGGTAGCGCGCTCCCTTAGCATGG
GAGAGGTCTCCGGTTCGATTCCGGACTCGTC
CACCATGCATG 
tA(AGC)D 
tA(AGC)D-2 GATCCATGCATGGTGGACGAGTCCGGAATCG
AACCGGAGACCTCTCCCATGCTAAGGGAGCG
CGCTACCGACTACGCCACACGCCCTATAGTG
AGTCGTATTAT 
tA(AGC)D 
 
SUF9G3:U70-1 CTAGATAATACGACTCACTATAGGGCGTGTG
GTCTAGTGGTATGATTCTCGCTTTGGGTGCGA
GAGGCCCTGGGTTCAATTCCCAGCTCGTCCC
CCATGCATG 
SUF9G3:U70 
 
SUF9G3:U70-2 GATCCATGCATGGGGGACGAGCTGGGAATTG
AACCCAGGGCCTCTCGCACCCAAAGCGAGAA
TCATACCACTAGACCACACGCCCTATAGTGA
GTCGTATTAT 
SUF9G3:U70 
UA9593 CTAGATAATACGACTCACTATAG SUF9 
primer 
UA9594 TGGGGGGCGAGCTGGGAA SUF9 
primer 
UA9595 AGATAATACGACTCACTATAGG tA(AGC)D 
primer 
UA9596 TGGTGGACGAGTCCGGAAT tA(AGC)D 
primer 
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UA9597 TAGATAATACGACTCACTATAG SUF9G3:U70 
primer 
UA9598 TGGGGGACGAGCTGGA SUF9G3:U70 
primer 
UD2159 CGCATCGAGCTGAAGGGGATCCCATTCAAGG
AGGACGG 
eGFP-
Asp129Pro 
UD2160 CCGTCCTCCTTGAATGGGATCCCCTTCAGCTC
GATGCG 
eGFP-
Asp129Pro 
UF4196 CTCTCGCACCCAAAGCGAGAATCATACCACT
AG 
SUF9 intron 
removal 
UF4197 CTCGCTTTGGGTGCGAGAGGCCCTGGG SUF9 intron 
removal 
UF4198 TTCCTGAATAAACAGGAAGACAAAGCATGCG
GGAGGTCCCGGGTTC 
SUF2 intron 
UF4199 TTGTCTTCCTGTTTATTCAGGAAGTCGCCCTA
AGCGAGAATCATACC 
SUF2 intron 
UF4570 CGCATCGAGCTGAAGGGCATCGCTTTCAAGG
AGGACGG 
eGFP-
Pro129Ala 
UF4571 CCGTCCTCCTTGAAGCGATGGCCCTTCAGCTC
GATGCG 
eGFP-
Pro129Ala 
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3.7.2 Figures 
 
Figure S 3-1. tRNA aminoacylation assays. 
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A) tRNAAlaAGC, tRNA
Pro
UGG (G3:U70), and tRNA
Pro
UGG were incubated with 500 pM, 
100 nM, and 1 µM AlaRS, respectively, and 10 mM alanine. Two microliters of each 
reaction was stopped in ice-cold sodium citrate containing nuclease P1 and incubated for 
one hour at room temperature. Reaction mixtures were spotted on glass TLC plates, 
chromatographed in 0.1 M ammonium acetate and 5% acetic acid, then stopped prior to 
buffer reaching the top of each plate. TLC plates were dried, exposed onto phosphor 
screens, and visualized using a Phosphorimager to detect free 32P-labelled AMP and 32P-
labelled AMP charged with proline. B) Wild type tRNAProUGG and mutant tRNA
Pro
UGG 
(G3:U70) were incubated with 1 µM ProRS and 10 mM proline. Reactions were stopped 
at the indicated time points, separated and imaged using glass TLC plates as described in 
(A). 
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Myc
9
-Tti2 
                                                   Tti2                    Tti2L187P                Tti2L187P            no tag 
                                                  SUF9                     SUF9                 SUF9G3:U70 
Protein loaded(µg)         20            10           20             10           20          10             20 
      1               2             3               4             5              6               7 
63 kDa 
    CBB 
Figure S 3-2. Increase in TtiL187P levels by SUF9G3:U70. 
Yeast strains CY6965 (TTI2 SUF9), CY7020 containing YCplac33-SUF9 (tti2L187P 
SUF9), and CY7020 containing YCplac33-SUF9G3:U70 (tti2L187P SUF9G3:U70) were 
grown to stationary phase in YPD medium, diluted 1:20 and grown for 8 hours 
prior to protein extraction by bead lysis. The amount of protein extract loaded is 
indicated in each lane and was Western blotted using anti-Myc antibodies. The 
bottom of the gel was stained with Coomassie Brilliant Blue and shown as a 
loading control. 
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Figure S 3-3. tRNAProUGG (G3:U70) results in alanine incorporation into eGFPD129P. 
A yeast strain containing Sik1-RFP strain was transformed with either YCplac111-SUF9 
or YCplac111-SUF9G3:U70, and either YCplac33-eGFPD129P-SPT7 or YCplac33-
eGFPD129A-SPT7. Transformants were grown to stationary phase in medium lacking 
uracil and leucine, diluted 1:20 and grown for 5 hours before harvesting cells for 
imaging. Signal intensities were calculated from 150 cells per strain using integrated 
density units, background noise levels were calculated and subtracted using a Sik1-RFP 
strain with no eGFP. Integrated density values were divided by the nuclear area measured 
for each cell and plotted along the y-axis (IntDen/Area) using ggplot2 (41) on R version 
3.2.0. The line within the box represents the median, the second and third quartiles are 
outlined by the box, and whiskers indicate 1.5 times the quartile range of the box. To 
better visualize the difference between samples, an outlying value in the SUF9G3:U70 
strain is not shown, but was included in all calculations. 
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Figure S 3-4. eGFPD129P-Spt7 levels in strains containing SUF9 or SUF9G3:U70. 
The Sik1-RFP yeast strain was transformed with either YCplac111-SUF9 and YCplac33-
eGFPD129P-SPT7 or YCplac111-SUF9G3:U70 and YCplac33-eGFPD129P-SPT7, grown to 
stationary phase in medium lacking leucine and uracil, diluted 1:20 and grown for 8 
hours. Protein was extracted by bead lysis, and the indicated amounts were Western 
blotted using a PVDF membrane and anti-eGFP antibodies (Sigma). The bottom of the 
gel was stained with Coomassie Brilliant Blue for a loading control. 
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SUF9G3:U70 with intron: 
5’GGGCGTGTGGTCTAGTGGTATGATTCTCGCTTTGGGcgacttcctgaataaacaggaagacaa
agcaTGCGAGAGGCCCTGGGTTCAATTCCCAGCTCGTCCC 3’ 
SUF9G3:U70 no intron:     
5’GGGCGTGTGGTCTAGTGGTATGATTCTCGCTTTGGGTGCGAGAGGCCCTGGGTTCAA
TTCCCAGCTCGTCCC 3’ 
SUF2G3:U70 with intron: 
5’GGGCGTGTGGTCTAGAGGTATGATTCTCGCTTAGGGcgacttcctgaataaacaggaagacaa
agcaTGCGGGAGGTCCCGGGTTCGAGTCCCGGCTCGTCCC -3’ 
SUF2G3:U70 no intron: 
5’GGGCGTGTGGTCTAGAGGTATGATTCTCGCTTAGGGTGCGGGAGGTCCCGGGTTCGA
GTCCCGGCTCGTCCC 3’ 
Intron sequence:  
cgacttcctgaataaacaggaagacaaagca 
Figure S 3-5. SUF9 and SUF2 intron and intron-less sequences.  
The anticodon in each tRNA is represented in bold font, underlined nucleotides 
indicate the C70T suppressor mutation, and the intron sequence is in lower text. 
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Figure S 3-6. Growth curves comparing wild type to strains containing one or two 
copies of tP(UGG)G3:U70. 
A) Yeast strains CY7287 (SUF9 tP(UGG)N1), CY7288 (SUF9G3:U70 tP(UGG)N1) were 
grown to stationary phase in YPD medium, diluted 1:100 and grown for 10 hours. Optical 
density measurements were taken every hour across three biological replicates per strain, 
and the average densities were plotted. Error bars for each data point represent one 
standard deviation. B) Yeast strains CY7287 (SUF9 tP(UGG)N1) and CY7286 
(SUF9G3:U70 tP(UGG)N1G3:U70) were grown to stationary phase in YPD medium, diluted 
1:100 and grown for 13 hours. Measurements were taken and plotted as described in (A). 
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SUF9                  - 
SUF9G3:U70              - 
    SUF9        CEN-htt103Q 
SUF9G3:U70   CEN-htt103Q 
                  glucose                     galactose 
Figure S 3-7. Growth of cells expressing SUF9G3:U70 and htt103Q alleles. 
Yeast strain BY4741 containing YCplac111-SUF9 or YCplac111-SUF9G3:U70, and 
either YCplac33 or CEN-GAL1-htt103Q were grown to stationary phase in medium 
lacking leucine and uracil. Cell densities were normalized and cells spotted in 10-fold 
serial dilutions onto minimal media plates depleted of leucine and uracil and containing 
either glucose or galactose. 
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Chapter 4 
4 Discussion 
Protein biosynthesis involves the translation of genetic information to a peptide chain, 
and the folding of peptides by chaperones into functional protein molecules (Figure 4-1 
depicts the processes and components of protein biosynthesis and proteostasis pathways). 
Molecular chaperone systems and proteostasis pathways function in maintaining properly 
folded proteins, removal of toxic aggregates, resistance to stress, adapting to diverse 
environments, and tolerating mistranslated proteins. The PIKK family relies on Hsp90, 
the TTT, and R2TP complexes for expression and function in nutrient and growth 
signaling, transcription, and DNA damage response and repair. The PIKKs make up the 
only known client proteins of the TTT complex. How the TTT complex interacts with 
Hsp90 and whether the interaction regulates folding activity will be important for 
characterizing the TTT complex as an Hsp90 co-chaperone. 
Protein quality control pathways involving chaperones allow cells to tolerate 
some errors during protein synthesis. The cellular capacity to manage proteome 
perturbations has enabled mistranslation as an adaptive response (1-4). The upregulation 
of chaperones and protein synthesis pathways occur during elevated levels of 
mistranslation (5), a cellular response that likely played a role in the codon reassignment 
of Leu to Ser in Candida albicans (6). Therefore, not only are chaperones required for the 
integrity of the proteome, they are involved in the evolution of the genetic code.  
Defining the level of mistranslation tolerated by cells and the mechanisms that 
can be engineered to exploit codon ambiguity may allow for the development of novel 
gene therapy approaches. Moreover, manipulating ambiguously decoding tRNAs, along 
with their cognate synthetases, will continue to be valuable for synthetic biology 
applications and protein engineering.  
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Figure 4-1. Flow chart of protein biosynthesis and proteostasis pathways.  
Genetic information stored in DNA is transcribed to RNA by RNA polymerase II using 
nucleoside triphosphates (NTPs). RNA is used as template by the ribosome to specify the 
recruitment of aminoacyl-tRNA, which are used as substrates for peptide synthesis. A 
tRNA is charged with a specific amino acid by its cognate aminoacyl-tRNA synthetase to 
produce an aminoacyl-tRNA (boxed in). Next, peptides undergo folding by chaperones 
and co-chaperones and a functional protein is formed. Protein misfolding or unfolding 
can be triggered by mutations, stress conditions, or mistranslation. Oligomerization and 
intermolecular interaction of misfolded proteins can form aggregates. In some cases, 
unfolded or misfolded proteins are re-folded back to their native state by chaperones. 
Irreversible misfolded or aggregated proteins are either trafficked to aggresomes for 
storage, or sent to the lysosome/vacuole or proteasome for degradation. Such processes 
involve numerous proteins and signaling pathways, such as ubiquitin ligases, chaperones, 
and the ERAD pathway.    
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4.1 The role of Tti2 and the TTT complex in protein 
biosynthesis and PIKK regulation 
A role for the TTT complex in PIKK protein biosynthesis is indicated by the binding of 
Tel2 to newly synthesized PIKK peptides and the interactions of the TTT proteins with 
Hsp90, Hsp70, Hsp40, and the R2TP/prefoldin-like complex (7-10). In conjunction with 
results from Stirling et al. (11) regarding reduced Tel1 levels, our results indicate that 
Saccharomyces cerevisiae Tti2 is required to maintain the steady state levels of all PIKK 
proteins. The use of defective tti2 alleles identified in a random screen, and regulating 
TTI2 under the GAL10 promoter, allowed us to investigate phenotypic and proteomic 
effects associated with the loss of Tti2 function.  
 The results presented in Chapter 2 demonstrate a specialized role for Tti2, 
possibly dedicated to PIKK regulation. Tti2, like Tel2 and Tti1, is essential in nature, 
however, severely depleting Tti2 levels does not result in lethality. The low level 
requirement of Tti2 may reflect the number of molecules needed for associating with a 
small set of client proteins. While Tti2 depletion results in Hsp42 induction, Tti2 does not 
function as a general heat shock protein. Moreover, the overexpression of Hsp26, Hsp42, 
or Hsp104 in a Tti2 depleted strain could not rescue stress sensitive phenotypes, 
suggesting that general protein stress is not produced in the absence of Tti2. It seems 
likely that Hsp42 induction could be a consequence of reduced PIKK expression. In 
particular, Tra1 as part of the SAGA chromatin remodeling complex was identified in the 
coding regions of certain HSP genes and is enriched at HSP promoters during heat shock 
(12). Consistent with the reduced transcription of the heat shock element seen upon Tti2 
depletion, decreased Tra1 expression may somehow result in Hsp42 induction to 
compensate for dysregulated heat shock genes.  
The role of Tti2 and the TTT complex may be more complex than simply in the 
recruitment of PIKK proteins for maturation by Hsp90. The cytoplasmic foci and 
mislocalization of Mec1 and Tra1, as well as the absence of Mec1 aggregates when Tti2 
is depleted, suggests a potential role in PIKK trafficking. In a previous study, two 
mutations in TTI2 were found to suppress a defective tra1 allele containing a 
phenylalanine to alanine mutation in the FATC (tra1F3744A) domain that results in reduced 
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Tra1 protein levels and mislocalization (13). The rarity of gain of function mutations, and 
the number of mutations in TTI2 that suppress slow growth caused by tra1F3744A (Brandl 
lab, unpublished), suggests that suppression occurs by loss of function tti2 alleles. How 
loss of Tti2 function can restore protein expression and localization of Tra1F3744A requires 
further investigation but demonstrates a more complex role for Tti2 in PIKK 
biosynthesis. A fitting model is that Tti2 targets unstable PIKK proteins for degradation, 
and loss of function tti2 mutations provide more time for PIKK folding.  
 The stoichiometry of the TTT complex and interactions among each member is 
still largely unknown. The relative number of molecules per cell indicates that Tti2 is 
twice as abundant as Tti1 and Tel2, suggesting it could form a dimer or have functions 
outside the TTT complex (14). The conserved N-terminal region of Tel2 consisting of 
alpha-helical repeats is required for interaction with Tti1 and Tti2 (10). There lack 
structural data for the TTT complex, or for Tti1 or Tti2 alone, although Tti2 is predicted 
to consist mostly of alpha helices. Direct contact sites between the PIKK proteins and 
TTT components also remain unknown. However, the N-terminal region consisting of 
HEAT repeats of ATM and mTOR, and the C-terminal region of ATM containing the 
kinase and FATC domain, co-immunoprecipitate with Tel2 (9).  
The possibility of independent functions of TTT proteins requires further 
investigation. Tel2 was initially identified for its role in telomere length regulation (15), 
though likely an indirect effect through regulation of Tel1 as part of the TTT complex 
(11). Functions described only to certain TTT proteins and not others may be a result of 
allele-specific effects. For example, two mutations in the N-terminal region of Tel2 result 
in a telomere length defect, while C-terminal mutations are associated with rapamycin 
sensitivity (16). This may be due to PIKK-specific binding sites of Tel2 (9).  
For the most part, Tel2, Tti1, and Tti2 have mutual roles in regulating PIKK 
protein levels and complex assembly. It is likely that TTT members act in complex to 
function with Hsp90 in PIKK biosynthesis. Tel2 interaction with the R2TP complex, as 
well as the interaction between Tel2 and Tti1-Tti2, is required for PIKK stability, 
function, and complex assembly  (7,10,17,18). Although some studies report only one or 
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two of the TTT complex members in association with PIKK proteins (19,20), the absence 
of other members was not investigated. In support of a discrete function for all TTT 
members in PIKK biosynthesis, approximately 100 overlapping genetic interactions were 
identified by synthetic genetic array analyses (SGA) using temperature-sensitive alleles 
for TEL2, TTI1, or TTI2, which mapped all three genes within the same cluster of a 
global network (11).  
4.2 Defining an Hsp90 co-chaperone 
Hsp90 co-chaperones are proteins actively involved in the function of Hsp90 but are not 
client proteins. Co-chaperones of Hsp90 have one or more of the following functions: 
recruitment of client proteins, linking Hsp90 to other chaperones, protein complex 
assembly, inducing conformational changes, and regulating ATP hydrolysis for client 
protein binding and release (21). For many of the co-chaperones, direct interaction with 
Hsp90 involves a TPR domain binding to the conserved MEEVD motif of the C-terminal 
domain (C domain) of Hsp90. Other Hsp90 co-chaperones interact with the N-terminal 
nucleotide binding domain (N domain), the middle domain (M domain), or associate 
indirectly through protein-protein interactions. Table 1 lists the functions and domain 
associations of yeast Hsp90 co-chaperones. The rate of Hsp90 chaperone cycles and 
client specificity depend on the sequential binding of co-chaperones (22,23). For 
example, the transfer of Hsp70 clients to Hsp90 is mediated by Sti1, which inhibits 
Hsp90 ATPase activity by preventing N-terminal dimerization (22,24). The binding of 
ATP and p23 (human homolog of yeast Sba1) displaces Sti1, promotes nucleotide 
binding, and induces an Hsp90 closed conformation (22). The rate of ATP hydrolysis can 
also be increased by Aha1 binding to the middle domain of Hsp90 (25), which 
accelerates the release of a client protein. 
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Table 4-1. List of Hsp90 co-chaperone functions, co-chaperone domains that 
associate with Hsp90, and Hsp90 binding sites. 
Co-
chaperone 
Function Co-chaperone 
domain 
Hsp90 domain 
of interaction 
References 
Cns1 Binds Hsp90 and 
Hsp70, stimulates 
Hsp70 ATPase activity 
TPR domain C domain (26,27) 
Cpr6, Cpr7 Peptidyl-prolyl cis-
trans isomerase 
TPR domain C domain (28,29) 
Ppt1 Serine/threonine 
phosphatase, regulates 
Cdc37 
phosphorylation and 
kinase activation by 
Hsp90 
TPR domain C domain (30,31) 
Sti1 Inhibits Hsp90 ATPase 
activity 
TPR domain M and C 
domains 
(32) 
Tah1 Recruits the R2TP 
complex to Hsp90, 
mediates protein 
complex assembly, 
inhibits ATPase 
activity 
TPR domain C domain (33-37) 
Aha1, Hch1 Activates ATPase 
activity 
N-terminus M domain (25,38,39) 
Cdc37 Inhibits ATP binding, 
prevents N-terminal 
dimerization, recruit’s 
protein kinases 
C-terminus N domain (40,41) 
Sba1 Stabilizes closed 
conformation, 
promotes ATP 
hydrolysis 
N- and C-
termini 
N and M 
domains 
(42-44) 
Sgt1 Recruitment of Skp1 
and the SCF ubiquitin 
ligase complexes 
Central CS 
domain 
N domain (45,46) 
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Budding yeast is a valuable system for identifying and characterizing Hsp90 co-
chaperones using high-throughput analyses. Tandem affinity purification of Hsp90 
coupled to mass spectrometry has been successful in detecting proteins that physically 
interact with Hsp90, and can be performed under different conditions. Synthetic genetic 
array analysis (SGA) is a high-throughput technique used to screen for genetic 
interactions against a yeast deletion strain library (47). Zhao et al. (48) performed SGA 
analyses using either an Hsp90 conditional allele, or in the presence of the Hsp90 
inhibitor geldanamycin, to identify and map novel genetic and chemical-genetic 
interactions with Hsp90. In addition to defining Hsp90 as a central hub for numerous 
cellular pathways, the combination of these approaches and the clustering of interaction 
data identified a new role for Hsp90 in chromatin remodeling. Moreover, biochemical 
assays supporting SGA interactions helped define two novel Hsp90-interacting proteins, 
Tah1 and Pih1 (48).  
 The TTT complex interacts indirectly with Hsp90 through the R2TP complex (8), 
however, direct contacts may also exist. The structure of Tel2 elucidated two 
phosphoserine sites that can be bound by Pih1 and mutational analysis has defined 
residues important for interaction with Tti1-Tti2 (8,10). In support of an interaction with 
Hsp90 independent of the R2TP complex, disrupting the Tel2-Pih1 interaction by 
phosphoserine site mutations does not result in loss of the Tel2 association with Hsp90 
and PIKK proteins (7). However, the loss of Tel2-R2TP interaction causes a decrease in 
PIKK stability, and suggests a role for the R2TP complex in PIKK assembly (7).  
The mechanism of the TTT complex in PIKK recruitment still needs to be 
elucidated. Whether PIKK recruitment is the only role of the TTT members remains 
unclear. In this respect, it may be valuable to determine whether the recruitment of PIKK 
proteins to Hsp90 defines the essential nature of Tel2, Tti1, and Tti2. Moreover, 
identifying how the TTT complex interacts with Hsp90 independent of the R2TP 
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complex, and investigating the influence of the interactions on Hsp90 activity, will help 
define the TTT complex as an Hsp90 co-chaperone.  
4.3 Mistranslation 
The universality of the genetic code is usually emphasized, stating the need for high 
fidelity translation to maintain the proteome. Despite this, deviations from the standard 
genetic code are surprisingly common (reviewed in (49)). Alternate genetic codes were 
first observed in the 1970s in analyses of yeast and human mitochondrial genomes (50-
53). Naturally occurring changes to the standard genetic code come in the form of 
ambiguous decoding, codon reassignments, and genetic code expansions, such as the 
decoding of UAG and UGA stop codons with pyrrolysine and selenocysteine, 
respectively (54). Ambiguous decoding, or mistranslation, can occur in response to 
changing environments, nutrient availability, and in stress conditions (2,55-59). Thus, 
genetic code manipulations are beneficial if not essential for the organism, and cannot be 
viewed simply as translational errors.  
Nucleotides responsible for tRNA-aaRS recognition are known as identity 
elements. In contrast to the aspect of the genetic code that defines mRNA decoding as 
rules of codon-anticodon pairing, tRNA identity elements define a ‘second genetic code’ 
(60). Identity elements consist of single nucleotides, nucleotide pairs, and structural 
motifs (61). Since the anticodon of a tRNA links an amino acid to the genetic code, it is 
not surprising that tRNA recognition involves identity elements within the anticodon for 
many aaRSs (62). However, specific nucleotides in the acceptor stem also provide 
discrete structural characteristics for aaRS recognition and charging (63-65). 
      Missense suppressor mutations within tRNAs that alter reading of the genetic 
code have revealed other aspects of the specificity of tRNA structure and function. The 
base changes that convert a tRNA into a missense suppressor map to different regions of 
the tRNA molecule. The most prevalent changes are to the anticodon loop, which lead to 
altered base pairing in the A site of the ribosome. The mutations can be base substitutions 
in the anticodon (66-70) or insertions or deletions that reposition the anticodon (71,72). 
In some cases, the indels result in altered base modification, which also affects codon-
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anticodon pairing (72). Mutations to the anticodon emphasize that, even for tRNAs that 
contain anticodon identity elements, other sequences can at least partially direct 
aminoacylation.  
Base changes outside the anticodon loop can also result in misacylation, an 
example being base changes that create a G3:U70 base pair in the acceptor stem (73,74). 
The G3:U70 base pair is a major identity element for aminoacylation by alanyl-tRNA 
synthetase (AlaRS) in many species and when present in non-alanine tRNAs can confer 
charging with alanine (75-77). As charging specificity often depends on multiple 
elements in a tRNA, additional base changes can make a suppressor tRNA more or less 
efficient (78). Efficiency of suppression can also be influenced by extrinsic factors. These 
factors include the base composition of the genome and the resulting codon bias (66), and 
the number and relative expression of tRNA genes for each codon. All of these will 
influence the frequency and extent of amino acid substitution and thus the toxicity of the 
suppressor tRNA. In addition, the efficiency and accuracy of tRNA charging depends on 
the relative abundance and affinity of different aaRSs (79).  
4.4 Repercussion of mistranslation 
Mistranslation destabilizes the proteome as a result of misfolded proteins and toxic 
aggregates (80-84). To manage harmful proteins, cells upregulate molecular chaperones, 
and induce the unfolded protein and the heat shock responses (81,85). Regulating protein 
quality control pathways provides a rapid response that decreases proteome instability 
caused by mistranslation. Over a longer term, selection pressure created by translation 
errors lead to coding sequence changes that prevent protein misfolding and increase 
protein stability (82,86,87). Therefore, protein quality control pathways and codon 
alterations that reduce the cost of translation errors are important for exploiting 
mistranslation as an adaptive response.  
In addition to the observation of increased error rates at low abundance codons 
(88), high usage codons are theorized to correlate with high translational accuracy (89). 
Synonymous codon bias towards optimal codons may ensure translational accuracy for 
conserved amino acids, to minimize the cost of errors (90). Synonymous mutations to 
  
148 
conserved and structurally important amino acids within proteins can improve the 
translational accuracy of the codon (90,91). However, it is proposed that making proteins 
more robust to translation errors is a superior mechanism to adapt to mistranslation 
(86,87,92). Having translationally robust proteins maintains the function of mistranslated 
species, increases thermodynamic stability, and provides resistance to genetic mutations 
(86,92-94). These studies suggest that enhancing protein robustness, rather than 
improving the fidelity of translation, enables organisms to tolerate mistranslation. 
A study by Kalapis et al. (55) investigated how yeast evolve in response to 
mistranslation levels that cause a fitness reduction. Expression of tRNASerCAG in S. 
cerevisiae causes ambiguous decoding of Leu as Ser. The negative effects on cellular 
fitness were drastically reduced after 250 generations. Kalapis et al. (55) analyzed eleven 
independent clones in detail. They shared chromosomal duplications containing genes 
involved in ribosome biogenesis, rRNA processing, and proteasome assembly. They also 
shared a chromosome V deletion that removed two deubiquitinating enzyme genes. In 
addition to chromosomal rearrangements, genes that function in amino acid biosynthesis, 
ribosome biogenesis, and RNA processing were upregulated. Gene expression changes 
and chromosomal rearrangements correlated with increased protein synthesis and 
turnover, reduced protein aggregation, and an increase in glucose uptake (55).  
The extent to which cells tolerate mistranslation has been studied with defective 
aaRSs and mischarged tRNAs. Ruan et al. (95) studied auxotrophic and antibiotic 
resistance markers in E. coli that require missense suppression for function. Misacylated 
tRNAs were generated in cells by expressing error-prone or non-discriminating aaRSs. 
These experiments revealed that this E. coli strain grows at optimal levels even in the 
presence of proteome-wide mistranslation. As determined by quantifying amino acid mis-
incorporation frequency by mass spectrometry, E. coli tolerate ~10% mistranslated 
protein. This represented the threshold level of mistranslation where optimal growth and 
a functional proteome are still maintained (95). In the same study, cellular responses were 
analyzed. Expression of a non-discriminating aspartyl-tRNA synthetase, which charges 
tRNAAsn with aspartic acid, caused an induction of chaperones dnaK and mopA by 49 and 
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8.7-fold, respectively. Moreover, synthetic slow growth was caused by deleting major 
heat shock proteases in strains with defective aaRSs (95).  
      As described in Chapter 3, we analyzed the protein quality control pathways and 
cellular responses required for tolerating mistranslation of Pro as Ala (74). In yeast 
expressing tRNAPro (G3:U70), which causes mis-incorporation of alanine at ~6% of Pro 
CCA codons, there was a partial induction of the heat shock response but only a modest 
effect on cell growth. When grown at increased temperatures or in the presence of 
tunicamycin, slow growth was exacerbated. In addition, we found synthetic slow growth 
of a strain expressing the mistranslating tRNA and deleted for the 26S proteasomal 
regulator, Rpn4. Consistent with other reports (55,81,85,95), these results demonstrate a 
role for the heat shock response and the unfolded protein response in mistranslation 
tolerance.   
4.5 Quantifying mistranslation 
Stable isotope labeling with amino acids in cell culture (SILAC) and other isobaric 
labeling mass spectrometry methods provide a quantitative approach to measure 
proteome-wide mistranslation. Using shotgun mass spectrometry, Cvetesic et al. (96) 
identified over 2500 spectra of peptides having substitutions of leucine with norvaline, a 
non-proteinogenic amino acid. The number of spectra represents an approximate 10% 
incorporation frequency of norvaline at Leu codons in an E. coli strain containing an 
editing-defective leucyl-tRNA synthetase. In the same study, SILAC identified the 
surprising absence of isoleucine mis-incorporations at Leu positions by leucyl-tRNA 
synthetase defective of hydrolyzing isoleucyl-tRNALeu (96).  
The study by Cvetesic et al. (96) highlights the potential of mass spectrometry-
based approaches to measure proteome-wide mistranslation frequencies; but measuring 
mistranslation by mass spectrometry does have some limitations. The accuracy in 
detecting single peptide change is affected by the ratio of wild-type to mistranslated 
species (97). Mistranslation that affects peptide ionization may result in detection 
variability that is not indicative of relative in vivo abundance. By spiking wild type 
samples with known amounts of mistranslated peptides (Ser for Asn), Wen et al. (98) 
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determined that their mass spectrometry analysis yielded a 15-20% greater amount of 
mutant peptide than expected, in part due to differences in ionization. In addition, 
SILAC-labeled valine can be metabolized, making certain amino acids indistinguishable 
(96). 
Fluorescent and enzymatic reporters provide sensitive methods to calculate 
mistranslation frequencies (99-104). We and others have designed fluorescent reporter 
molecules to measure mistranslation (74,100). By mutating Asp129 to Pro, we 
diminished fluorescence of eGFP, which could be restored by mistranslation with 
alanine. Alanine at position 129 in eGFP was created to mimic complete mistranslation of 
the Pro codon. By comparing eGFPD129P fluorescence relative to eGFPD129A, we 
calculated a 6% mistranslation frequency caused by tRNAPro (G3:U70) in yeast (74). 
Gomes et al. (100), designed a dual-reporter system to internally normalize fluorescence 
in each cell. Their reporter system has a wild type eGFP molecule fused to mCherry, 
which contains a Met72 to Glu (GAA or GAG) mutation and only fluoresces when Met is 
mis-incorporated. Fluorescence of wild type eGFP is unaffected by mistranslation and is 
used to normalize mCherry fluorescence. 
Our reporter, and the one designed by Gomes et al., calculate mistranslation 
frequency at a particular codon. To detect all codon misreadings by native tRNALysUUU, 
Kramer et al. (88) engineered luciferase genes with the essential Lys529 codon changed 
to all possible single nucleotide mutations (102). Normalizations were possible due to the 
in-frame expression of a second non-mutated luciferase that could be assayed under 
different conditions (88). With this assay the authors determined that differences in 
mistranslation frequencies are a consequence of decoding competition between cognate 
and near-cognate aminoacyl-tRNAs, with frequencies being codon-dependent and 
varying from ∼4 × 10−3 to ∼3 × 10−4 per codon in E. coli and ∼4 × 10−5 to ∼6.9 × 10−4 in 
S. cerevisiae (88,102). 
β-galactosidase assays have also been used to measure amino acid mis-
incorporation. Tsai and Curran (66) used β-galactosidase activity to detect and quantitate 
mistranslation caused by suppressor tRNAs. Their reporter contained lacZ with the 
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essential Gln CAG at position 625 mutated to Arg CGA to screen mutated tRNAGln-
expressing clones for suppression. The four suppressors identified contained C-U and U-
C mutations at anticodon positions 34 and 35, respectively, allowing base pairing with 
CGA. The tRNAGln variants increased β-galactosidase activity by 8% (66). Similarly, 
Gregory and Dahlberg (105) screened tRNAGlu mutants for suppression of missense or 
nonsense mutations in lacZ. A C-A transversion mutation at position 36 in tRNAGlu 
suppressed ochre and amber lacZ mutations, while C-G transversion at position 36 
suppressed a GAG to CAG missense mutation. In each case the β-galactosidase activity 
indicated a low level of mistranslation (105). 
4.6 Benefits of mistranslation 
The ability of tRNA mutations to result in new genetic codes supports the theory of 
genetic code evolution (77,106,107). Mistranslation and genetic code expansions 
represent ways to introduce proteome diversity to improve the fitness of an organism by 
generating novel proteins. Studies of early life forms suggest that peptides contained a 
subset of the 20 canonical amino acids; those that were readily available on the 
primordial Earth (108). Crick hypothesized that introducing new amino acids improved 
protein fitness (109). As described by coevolution theory, biosynthesis of additional 
amino acids significantly influenced the evolution of the genetic code (110). Muller et al. 
(111) suggest that once an enzyme reaches a “local fitness maximum”, expanding the 
amino acid repertoire provides the chemistry to increase protein stability and activity. 
Their experiment involved the evolution of a simplified chorismate mutase composed of 
only nine different amino acids in an attempt to resurrect the primordial enzyme. 
Mutations that introduced an amino acid beyond the primordial nine were selected in a 
growth assay favouring increased activity. Modest chemical changes brought on by 
mutation of Leu to Val and Ile to Thr produced a chorismate mutase variant composed of 
11 different amino acids and increased activity 10-fold as the result of intricate structural 
changes (111). These findings emphasize that even subtle stability and functional 
alterations to proteins upon introducing new amino acids can drive genetic code evolution 
and expansion.  
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The same evolutionary pressures on the genetic code apply to organisms in the 
present day. Changing codon-amino acid designations can provide a selective advantage 
for viruses, prokaryotes and eukaryotes in response to environmental change. Examples 
of the advantage of ambiguous decoding were shown in laboratory experiments when E. 
coli and Chinese hamster ovary cells were deprived of an amino acid. Parker et al. (56) 
observed lysine mis-incorporation into bacteriophage MS2 coat protein upon starving E. 
coli host of asparagine. They speculate that mistranslation is preferred over halting 
translation entirely, thus killing the cell (56). Similarly, mistranslating Asn as Ser was 
observed in Chinese hamster ovary cells under asparagine starvation (98). Wen et al. (98) 
reasoned that Asn to Ser mistranslation was due to tRNA misacylation rather than codon 
misreading, because Ser codons differ from Asn in the first or second nucleotide position, 
and Asn misreading errors typically involve a wobble position mismatch with tRNALys. 
Other examples of adaptive mistranslation occur in E. coli, yeast, and mammalian cells in 
response to oxidative stress. Oxidative stress results in mischarging of non-cognate 
tRNAs with methionine by methionyl-tRNA synthetase (1,2,4). Methionine mis-
incorporation is proposed to sequester reactive oxygen species as a protective mechanism 
(2). 
An elaborate case of codon reassignment exists in Candida species, which have 
reassigned Leu (CUG) to Ser (112-114). Under standard conditions ~97% of CUG 
codons are decoded as Ser; however, reversion of CUG identity back to Leu is tolerated 
(80,115). Interestingly, engineered C. albicans strains with increased leucine mis-
incorporations at CUG codons are phenotypically diverse (80,115). Upon infection, C. 
albicans with increased CUG ambiguity caused an upregulation in inflammatory and 
immune responses of mice and human cells, respectively (80). Adaptive mistranslation to 
evade host immunity has also been suggested for Mycoplasma parasites (116). Mutations 
in the editing domains of phenylalanyl-tRNA synthetase, leucyl-tRNA synthetase, and 
threonyl-tRNA synthetase cause mistranslation with near-cognate amino acids. This may 
increase antigen diversity and allow the Mycoplasma to escape host defense mechanisms 
(117).  
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Bacteriophage have evolved to infect hosts that have variations to the standard 
genetic code. UGA stop codon reassignment has occurred in bacterial species from SR1 
and Gracilibacteria phyla (117,118). It had been predicted that bacteriophage would 
follow the same coding rules to utilize the host’s translation machinery (119-121). 
Ivanova et al. (122) demonstrated that the interaction is more complex. They identified 
DNA bacteriophage, of the Caudovirals order, in the human oral cavity that reassigned 
UAG stop codons to Gln during the infection process. The viral genomes contain a UAG-
decoding tRNAGlnCUA, and expresses release factor 2 (RF2), which terminates translation 
at UGA and UAA. These phage were enriched in bacteria that reassigned UGA codons, 
but express release factor 1 (RF1), which terminates translation at UAG. Based on the 
observation of reassigned-UAG codon usage bias in phage genes, Ivanova et al. proposed 
the following antagonistic model to explain phage proliferation in a bacterial host with a 
different genetic code. Low UAG codon usage of early infection stage genes of phage, 
including RF2, prevents premature termination by bacterial RF1. Bacterial RF1 levels are 
reduced by phage RF2 expression, through translational inhibition of UGA-reassigned 
codons in RF1. The absence of bacterial RF1 allows expression of late infection stage 
phage genes containing UAG-reassignments that function in packaging and assembly of 
viral DNA (122). Therefore, rather than adapting their genetic code to that of their host, 
bacteriophage can exploit the differences to manipulate gene expression in UGA-
reassigned bacteria.  
     The spontaneous appearance of suppressor tRNAs, as we found for a selected 
tRNAProUGG (G3:U70) variant that is efficiently charged with alanine (74), raises the 
question of the prevalence and maintenance of tRNA variants that result in mistranslation 
in populations of cells and in multicellular organisms. The copy numbers of the different 
tRNAs alone suggests that tRNA variants may be surprisingly abundant. We estimate that 
in our yeast experiments, the G3:U70 mutation in tRNAProUGG genes was found once per 
2x105 cells. We found that a single copy of a tRNAProUGG (G3:U70) gene resulted in 
modest effects on cell growth, and would likely be maintained in the population for some 
time, even under non-selective conditions. The tRNAProUGG (G3:U70) alleles are 
relatively nontoxic likely because they are not ideal substrates for AlaRS. This would 
contrast with the toxicity of an anticodon switch of tRNAAla, resulting in Pro decoding. 
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These demonstrably more toxic anticodon swapping mutants [72] have not been 
identified in genetic screens as spontaneous mutants. Interestingly, tRNAProUGG (G3:U70) 
is not aminoacylated by prolyl-tRNA synthetase, nor is it required because of the 
additional wild-type copies of tRNAProUGG genes remaining in the cell. The fact that 
multiple copies of the tRNA isoacceptor exist in the genome, enables the cell to acquire a 
seemingly deleterious mutation in tRNAPro (G3:U70), for at least a transient period, so 
that the tRNA can be repurposed by the cell. For example, an anticodon change to UGA 
could potentially repurpose the mutant tRNA to decode alanine UCA codons with serine 
4.7 Uses of mistranslation 
Ambiguous decoding is a mechanism to increase proteome diversity and generate novel 
proteins. Natural expansions of the genetic code that add selenocysteine and pyrrolysine 
are prime examples of this (123-125). Decoding selenocysteine involves a unique 
tRNASec species with a UCA anticodon to recognize UGA (126). Selenocysteine 
incorporation is guided by a selenocysteine insertion sequence (SECIS) element that 
forms a stem loop in the mRNA secondary structure, and the SelB translation elongation 
factor for SECIS-mediated recruitment of aminoacyl-tRNASec  (reviewed in (127)). This 
system directs incorporation of selenocysteine at specific recoded UGA codons so that 
translation termination at UGA is not disrupted. Selenocysteine-containing proteins, or 
selenoproteins, have increased nucleophilicity and reactivity relative to homologs with 
cysteine at the same position, and are required by bacterial pathogens in oxidative stress 
conditions (128,129). These advantages may explain why organisms invest a great deal of 
energy into incorporating selenocysteine into proteins.  
Pyrrolysine is found in archaeal and bacterial methanogens and is decoded by a 
UAG reassignment (reviewed in (54)). Pyrrolysyl-tRNA synthetase aminoacylates 
tRNAPyl with free pyrrolysine synthesized from two lysine molecules (reviewed in (130)). 
Encoding of pyrrolysine was discovered in the active site of methyltransferases 
(124,125,131). Pyrrolysine incorporation also allows expression of full-length tRNAHis 
guanylyltransferase, strictly by nonsense suppression of UAG (132). The importance of a 
genetic code containing pyrrolysine was further demonstrated in Methanosarcina 
acetivorans. Deleting tRNAPyl causes differential expression of >300 proteins, including 
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the down regulation of proteins involved in amino acid metabolism, translation initiation 
factors, and methanogenesis (133).  
      Natural genetic code expansions with selenocysteine and pyrrolysine signify the 
potential of introducing non-canonical amino acids (ncAAs) to the standard code and thus 
directed evolution of translation systems. Engineered translation systems are designed to 
site-specifically incorporate ncAAs that can function as imaging probes, affinity tags, or 
modified residues (134,135). Nonsense suppression is commonly used to incorporate 
ncAAs in vivo for a few reasons. Aminoacylation involving ncAAs and an engineered 
aaRS/tRNA pair must function exclusively (orthogonally) from the host system for 
efficient and non-lethal translation. Since stop codons typically do not specify amino 
acids, engineered tRNAs that translate stop codons will avoid charging by aaRSs with 
recognition for anticodon identity elements (61). Furthermore, competition with release 
factors can be eliminated in E. coli. Lajoie et al. (120) replaced all 321 UAG codons with 
UAA using multiplex automated genome engineering (MAGE) and conjugative assembly 
genome engineering (CAGE). This permitted deletion of RF1 and genome recoding of E. 
coli.  
      The current challenges being addressed when introducing ncAAs include 
identifying truly orthogonal aaRS/tRNA pairs, transcription and processing of foreign 
tRNAs in a host system, and improving the yield of proteins containing ncAAs (reviewed 
in (134,136,137)).  Genetic selections in yeast and bacteria can screen for aaRS/tRNA 
pairs that incorporate one or two ncAAs within the same protein (138-141). However, 
such selections require optimization for high yield incorporation of a ncAA by an 
orthogonal aaRS/tRNA pair. In this respect, coupling positive and negative growth assays 
in yeast that select for efficient nonsense suppression and against non-orthogonal 
aaRS/tRNA pairs has been successful (138,139). Expression of a foreign tRNA in yeast 
has been improved when transcribed in a dicistronic tRNA cassette containing upstream 
A- and B- box promoter elements (142). In addition, the half-life of the targeted mRNA 
template can be extended when transcribed in a strain deficient of the nonsense-mediated 
mRNA decay pathway (143).  
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      The pharmaceutical value of protein engineering using genetic code expansions 
has emerged. Incorporating ncAAs into therapeutic proteins increases protein stability, 
prevents immunogenicity, and generates novel antibodies (reviewed in (144)). Here we 
will discuss a few examples of therapeutic antibodies produced using codon expansions. 
Kim et al. (145) constructed Fab antibody fragments that can be specifically linked to 
recruit CD3+ T lymphocytes to HER-2+ breast cancer cells. An engineered aaRS/tRNA 
pair was used to incorporate p-acetylphenylalanine at a defined amber codon within anti-
CD3 and anti-HER-2 Fab fragments. The positioning and chemistry of p-
acetylphenylalanine allows for conjugation to a bifunctional ethylene glycol linker and 
coupling of anti-CD3 Fab and anti-HER-2 Fab fragments to form a bi-specific antibody. 
Formation of the bi-specific antibody leads to destruction of HER-2+ breast cancer cells 
(145). The same approach has since been designed to target cytotoxic T cells to leukemic 
stem cells with promise for treatment of acute myeloid leukemia (146).  
      Incorporation of ncAAs in therapeutic antibodies is an innovative strategy for 
improving drug targeting and antigen binding affinity. Site-specific incorporation of p-
acetylphenylalanine facilitates conjugation of a microtubule toxin to an anti-HER-2 
antibody by stable oxime bond formation (147). This method is advantageous over 
conjugation of toxins to canonical amino acids within antibodies. For example, antibody-
drug conjugates made by randomly modifying cysteine or lysine residues contain 
heterogeneous mixtures with a range of toxicities (148,149). Moreover, ligation of toxins 
to cysteine residues is restricted to specific positions due to multiple disulfide bond 
requirements within the antibody (150,151). Exclusive chemical reactivity, or bio-
orthogonality, can be accomplished for drug-antibody conjugation involving an ncAA at 
a defined position, and results in high yields of a homogeneous product (147). The 
synthesis of antibodies unrestricted to the standard 20 amino acids can drastically 
increase antigen binding affinity. Libraries of randomly mutated antibody fragments are 
expressed and displayed by phage, yeast, and bacteria, to screen for antibodies with high 
antigen binding affinity and specificity (152,153). Antibody library display screening in 
E. coli has been coupled with genetically encoded modified tyrosine residues. Dual 
incorporation of sulfotyrosine at nonsense and frameshift codons results in a 500-fold 
increase in the binding affinity of an anti-gp120 antibody, which recognizes HIV 
  
157 
envelope glycoprotein (154,155). These studies demonstrate the potential for synthetic 
genetic code expansions in the design of therapeutic proteins and other proteins with 
commercial value.  
It may be possible to use engineered tRNAs therapeutically. The vast number of 
suppressor tRNAs identified in genetic screens that restore function of defective alleles, 
and their limited effects on cellular fitness, suggests a potential use in gene therapy. 
Altered tRNA identity elements and anticodons can correct missense or nonsense 
mutations by mistranslation (61,73,75,77,78,156). Transfer RNAs that lack anticodon 
identity elements represent excellent candidates for efficient suppression. For example, if 
an aaRS of an engineered tRNA is anticodon agnostic, aminoacylation would be 
unaffected by anticodon switches, and the charged tRNA species can be directed to 
various codons. Each manipulation can be screened to identify tRNAs that introduce non-
toxic levels of mistranslation and act as efficient suppressors (157).  
      In addition to genetic code expansion, mistranslation or ambiguous decoding has 
long been considered as a route to counteract human disease causing alleles. Treatment of 
disease-linked or deleterious alleles with suppressor tRNAs was first considered in the 
early 1980s (158), and has since been tested in mammalian cell culture and a transgenic 
mouse model (159-162). Temple et al. (158) mutated a tRNALys anticodon to CUA and 
demonstrated nonsense suppression of an amber mutation in human β-thalassaemia after 
injection of the mutant tRNALys gene and mRNA template into Xenopus oocyte. 
Nonsense suppression was also analyzed in a transgenic mouse expressing a 
chloramphenicol acetyltransferase (CAT) gene containing a nonsense mutation. 
Suppression was examined after injection of plasmids bearing a nonsense suppressor 
tRNASer into skeletal muscle and heart tissues of live mice. Heart extracts yielded 1-2% 
CAT activity while 12% could be recovered from skeletal muscle cells (159). 
Suppression involving the selenocysteine translation components was performed in 
human primary fibroblasts (162). An engineered tRNASec species restored full-length 
expression of Selenoprotein N1 containing a nonsense mutation after transfection of 
patient samples with a plasmid expressing the tRNASec suppressor.  
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Other applications for mistranslation are likely to emerge. For example, natural 
variation in the sequence of an organism makes it difficult to identify a causative 
missense mutation in a background of numerous single nucleotide polymorphisms. It 
should be possible to use mistranslating tRNAs to narrow down the possible phenotype-
linked mutations. If the mutation is recessive, addition of a mistranslating tRNA with an 
anticodon complementary to the mutated codon will at least partially restore protein 
function. 
4.8 Conclusion 
Tolerating low levels of mistranslation and maintaining proteostasis is attributed to the 
work of chaperones and protein quality control pathways. Variations in tRNA sequences 
causing mischarging, and subsequently amino acid mis-incorporation, alters what has 
been viewed as the standard genetic code. Genetic code variations impact the cell at the 
most basic, informational level. These variations provide important regulatory 
mechanisms, allow cells to increase genetic diversity, and reveal novel tools for synthetic 
biology applications. They also emphasize that the genetic code is continuing to evolve. 
How tRNA variation affects human biology is an exciting area for future study. Given 
their prevalence, one would predict that tRNA variants may alter the penetrance of 
neurodegenerative and a myriad of other human diseases that are driven by a loss of 
proteostasis.  
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